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DIABETES MELLITUS
“So let it be written, so let it be done, I’m sent here by the chosen one.
So let it be written, so let it be done, to kill the firstborn pharaoh son.
I’m creeping death.”
– METALLICA
It is unlikely that the curse of the creeping death, as originally described in the old testament, 
referred to diabetes mellitus. The ancient Egyptians were the first to recognize this disease 
around 1500 before Christ, and they were intrigued by this rare condition where subjects lost 
weight, and seemed to urinate excessively.1,2 The Greek physician Aretaeus (80-138 A.D.) first 
coined the term ‘diabetes mellitus’. The word diabetes stems from ‘dia’, meaning ‘through’, 
and ‘betes’, meaning ‘going’. The term refers to the urine of the afflicted patients, which is 
going through the body and having a sweet (mellitus) taste. It was not until centuries later, 
in 1776, that Matthew Dobson discovered that the glucose concentration in the urine of 
patients with diabetes mellitus was increased.1,2 However, given its current track record of 
slowly becoming one of the leading causes for mortality worldwide, creeping death might 
actually be quite an adequate moniker. 
In first-world countries, diabetes mellitus is amongst the top 5 of causes of death, having 
caused 4.6 million deaths in 2011.3 Substantial evidence exists that diabetes mellitus is 
epidemic in economically developing and newly industrialised countries. Indeed, 366 
million  people were diagnosed with diabetes mellitus in 2011, whilst this number is 
expected to rise to 552 million over the next 20 years. From a public health perspective, these 
enormous figures make diabetes mellitus one of the greatest health-related problems of the 
21st century. It is estimated that diabetes mellitus was responsible for 11% of total health 
care expenditures in the global adult population in 2011, at least 465 billion dollars annually.3 
These expenses are likely to continue to rise in the coming years, as population-based 
studies consistently show that half of the people that were found to have diabetes in these 
studies had not been previously diagnosed. This suggests that globally another 183 million 
people have undiagnosed diabetes mellitus, who will become manifest in the coming 
years. Unfortunately, diagnosis of diabetes mellitus is often made after manifestation of 
complications, as in the early phase of diabetes mellitus only few symptoms are present 
which are often not adequately recognised by patients.3
In addition to diabetes, the condition of prediabetes, in which the blood glucose level is 
higher than normal but not as high as in diabetes, is a major public health problem as well. 
People with prediabetes have a higher risk of developing diabetes and have an increased risk 
of cardiovascular disease.3
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Figure 1
At a glance 2011 2030
Total world population (billions) 7.0 8.3
Adult population (20-79 years. billions) 4.4 5.6
Diabetes and prediabetes (20-79 years)
Diabetes
     Global prevalence (%) 8.3 9.9
     Number of people with diabetes (millions) 344 552
Prediabetes
     Global prevalence (%) 6.4 7.1
     Number of people with prediabetes (millions) 280 398
Global burden of diabetes (adapted from IDF Diabetes Atlas)
PATHOPHYSIOLOGY
Diabetes mellitus is a chronic disease state, which is characterized by an inability of the body 
to maintain a stable glucose homeostasis. The principle pathophysiological problem of 
diabetes mellitus is that, in response to elevations in blood glucose levels, the body is unable 
to produce sufficient levels of the hormone insulin, or cannot effectively utilize the insulin 
that is available. Insulin is produced by the pancreas, and stimulates the uptake op glucose 
from the blood into muscle and other tissue cells, where it is stored as a source of energy. 
The inability to rapidly and efficiently store glucose leads to hyperglycaemia; i.e. high blood 
glucose levels. Excessive and prolonged exposure to hyperglycaemia has important clinical 
consequences, as hyperglycaemia leads to profound damage to tissues in the body, such 
as the endothelium in the vessels. Over time, this damage to the arterial endothelium can 
lead to a variety of complications, such as neuropathy, nefropathy, retinopathy, ulceration, 
diabetic foot, impaired wound healing, cardiovascular disease, and eventually, death.4
Two main types of diabetes mellitus are distinguished. Type 1 diabetes is an auto-immune 
disease that usually occurs at a young age, which directly attacks the pancreatic beta-cells. 
This disrupts the bodies’ ability to produce insulin. This type of diabetes is often called insulin-
dependent, as patients need daily injections of insulin to maintain glucose homeostasis.2,3 
This thesis will specifically focus on patients with type 2 diabetes mellitus (T2DM). This 
disease state is characterised by the development of resistance to the effects of insulin to 
store glucose.5 In other words, a larger production of insulin is necessary to counteract an 
increase in blood glucose levels. This causes a disruption in the uptake of glucose, leading to 
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increased levels of glucose, also referred to as hyperglycaemia. Type 2 diabetes traditionally 
developed in middle-aged adults and elderly, but its prevalence in adolescents and even in 
children is currently rising.2,3
Several risk factors for developing type 2 diabetes have been identified. Important non-
modifiable factors that contribute to the development of T2DM relate to genetic factors and 
advanced age. In addition, important lifestyle-related factors have been identified which are 
believed to play a central role in the pathogenesis of this disease. The vast majority of type 2 
diabetes patients is overweight and physically inactive. The rapid decline in physical activity 
levels and increasing prevalence of overweight and obesity are believed to importantly 
contribute to the rapid increase in T2DM.3,6 Accordingly, in addition to pharmacological 
therapy, diet- and lifestyle-related interventions such as physical exercise have been 
demonstrated to be important in the prevention of T2DM and preventing complications.2,3,6-9
Figure 2
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The therapeutic strategy of T2DM has been extensively studied (see reviews).10-15 In a 
consensus statement from the American Diabetes Association and the European Association 
for the study of Diabetes, the two pillars that are distinguished in the clinical management of 
T2DM are lifestyle interventions and medication.14,15 According to this consensus statement, 
the first step in the treatment of T2DM should be the adoption of a lifestyle aimed at losing 
weight and increasing physical activity. However, as this strategy is often insufficient after the 
first year of the disease to fully counteract the increased insulin resistance, pharmacological 
treatment is added to the treatment plan. The first choice of drug is metformin, as it has been 
shown to be effective to regulate glucose levels and is generally well tolerated. Metformin 
decreases hepatic glucose output, thereby lowering blood glucose levels. Hypoglycaemia 
does not usually accompany the use of metformin, making metformin an attractive 
pharmacological agent with relatively little side effects. If metformin therapy does not suffice, 
additional insulin therapy is recommended. This may either be in the form of direct insulin 
injections, or via sulfonylureas (mainly glibenclamide), that enhances insulin secretion. This 
therapy is highly effective, although the risk for developing hypoglycaemia is higher than 
when using metformin alone. Less well validated therapeutic interventions include glinides, 
α-Glucosidase inhibitors, thiazolidinediones, glucagon-like peptide-1 agonists, amylin 
agonists, and dipeptidyl peptidase-4 inhibitors.14,15
COMPLICATIONS OF DIABETES MELLITUS
Since the central characteristic in T2DM is the inability to maintain glucose homeostasis, 
persistent hyperglycaemia represents the main cause for morbidity and mortality in 
T2DM. Improving glucose homeostasis, and therefore limiting the exposure of the body to 
hyperglycaemia, is essential in the prevention of T2DM-related complications. The most 
important complications, which represent the leading causes of morbidity and mortality 16,17 
in T2DM, are cardiovascular diseases. By estimation, of the 4.6 million deaths attributable 
to diabetes in 2011, 65%-75% were related to cardiovascular disease 6,8,9. Furthermore, most 
other common complications to T2DM have a vascular background. For example, damage 
to the peripheral nervous system (polyneuropathy) occurs frequently, mostly affecting the 
extremities, and is believed to be caused by microcirculatory changes in the vasculature 
surrounding the neurons. Symptoms of polyneuropathy include pain, tingling sensations, 
and loss of feeling. The latter is of particular importance, because diabetes patients have an 
increased risk of infections and ulcers, and often suffer from impaired wound healing through 
an impaired microcirculation. Loss of feeling can further aggravate these problems, because 
small wounds and infections are often neglected initially, and therefore are not treated in 
time.3 Consequently, T2DM-patients have a 25-fold increased risk of amputation compared 
with nondiabetic peers.18  Furthermore, T2DM is the leading cause of chronic nephropathy, 
and this disease has a distinct vascular component, and is often preceded by endothelial 
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dysfunction.19 Finally, retinopathy also represents a frequent complication to T2DM. In this 
complication, the arteries that supply blood to the retina are damaged, which leads to 
permanent loss of vision.3
Changes in vascular structure and function represent important precursors in the 
development of vascular complications to T2DM.20-22 A review by Coutinho has clearly linked 
these vascular complications to the presence of hyperglycaemia.23 The relationship between 
glucose levels and vascular disease is not fully understood, but several possible mechanisms 
have been hypothesised. Glucose may be related to atherosclerosis through increased 
oxidative stress,24-26, nonenzymatic glycation of LDL, other apolipoproteins27 and clotting 
factors (ﬁbrin and antithrombin-III) (57), and advanced glycation end-product formation in 
the vessel wall and matrix.28,29 Previous studies found an impaired endothelial function in 
patients with T2DM,30-32 which is believed to contribute to the pathogenesis of cardiovascular 
disease in T2DM patients.33,34
ROLE OF EXERCISE IN THERAPY FOR T2DM
Physical exercise has been demonstrated to have beneficial effects on insulin sensitivity, 
physical fitness and cardiovascular risk profile, leading to lower cardiovascular morbidity 
and mortality in asymtomatic subjects as well as in those with an increased cardiovascular 
risk such as T2DM.34-37 Furthermore, Blair and others have found that physically active people 
are less likely to develop T2DM than their sedentary peers.37,38 Taken together, this evidence 
shows that physical exercise has both curative and preventive capabilities regarding 
cardiovascular risk.
In an observational cohort study in 2196 middle-aged male T2DM patients, Church et al. 
calculated all-cause mortality rates across quartiles of physical fitness and BMI categories 
during 1970 to 1995, with mortality follow-up to 31 December 1996. They concluded that for 
T2DM patients, a steep inverse gradient exists between physical fitness and mortality, which 
was independent of BMI.39 Moreover, a low cardiovascular fitness and physical inactivity are 
strong predictors of mortality also in the non diabetes population.39,40 Also, specifically for 
cardiovascular disease mortality, Church found that low fitness level was associated with 
an increased risk.41, and Wei et al. showed that low physical fitness is associated with an 
increased risk for impaired glycaemic control and diabetes mellitus.42 Largely based on 
this cross-sectional evidence, the American Heart Association stated that exercise training 
in patients with type 2 diabetes is highly beneficial for improving cardiovascular health 
and preventing cardiovascular-related complications. To this end, it is recommended that 
patients perform a minimum of 150 minutes per week of at least moderate-intensity and/or 
90 minutes per week of at least vigorous-intensity cardiorespiratory exercise.
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Type of exercise training 
Combining resistance training with classic aerobic exercise may be more effective to improve 
cardiovascular risk in T2DM patients than aerobic exercise or resistance training alone.22 
Figure 3
The major diabetes complications (adapted from IDF Diabetes Atlas)
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A study by Baldi et al. found that 10 weeks of resistance training only modestly improved 
glycaemic control and fasting insulin levels in obese type 2 diabetes patients.43 However, in 
an 8-week circuit training program consisting of aerobic training and resistance exercises, 
Maiorana et al. found that this type of training markedly improved functional capacity, 
lean body mass, strength and glycaemic control in subjects with type 2 diabetes.44 Also, 
16 weeks of combined resistance and aerobic training improved glucose homeostasis in 
postmenopausal women with type 2 diabetes.45 Moreover, after a study employing a circuit 
training program for a period of 5 months, the exercising subjects showed significantly 
lower HbA1c than their sedentary peers.46 Several other studies have directly focussed on 
the effectiveness of aerobic exercise training, resistance training, or a combination of the 
types. The overall conclusion of this type of studies is that the combination of aerobic and 
resistance exercise training leads to larger improvements in glycaemic control than either 
of the two types of training alone.47,48 Taken together, these studies show that the inclusion 
of circuit-type resistance training in exercise training programmes for patients with type 2 
diabetes is advisable.
Training and vascular function 
Previous studies found that the impact of exercise training on cardiovascular risk can only 
partly be explained through changes in traditional cardiovascular risk factors, and exercise 
is believed to have a direct effect on the vasculature as well.49 Therefore, studies examining 
the impact of (various types of) exercise training have focused on measures of endothelial 
function,16,50,51 especially since this measure is strongly and independently related to future 
cardiovascular risk. Maiorana et al. found that an 8-week lower-limb exercise training program 
improved brachial artery endothelial function, suggesting that exercise training systemically 
improves vascular function.50 Okada et al. confirmed this finding in a similar 3-month training 
program, stating that the improvement in flow mediated dilation was independent of 
glycaemic control and insulin sensitivity.16 In a walking exercise training program, Sixt et al. 
found that coronary endothelial function was not significantly improved after 4 weeks, but 
was improved after 6 months.51  Taken together, these studies show that exercise training is 
an important tool to improve endothelial function in T2DM.
Training and vascular structure 
The impact of exercise training on vascular structure and wall thickness in healthy individuals 
and some groups with increased cardiovascular risk has been documented before. Exercise 
training generally leads to a decrease in arterial wall thickness (see review).52 However, in 
T2DM this relation is largely unclear, and the only studies that focussed on the effect of 
exercise on wall thickness in T2DM were either using an indirect measure for linking exercise 
to wall thickness,53 or had a lifestyle intervention program that did not solely consist of 
exercise training.54 Therefore, some indirect suggestions are present that exercise training in 
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T2DM may have a beneficial effect on conduit artery wall thickness.
Local and systemic effects of exercise training 
Cross-sectional studies in healthy subjects and athletes demonstrate that athletes have a 
generally lower artery wall thickness compared to sedentary controls, independent of the 
type of exercise they performed 55-57. A recent study in healthy young men confirmed the 
presence of a generalised impact of 8-weeks exercise training on arterial wall thickness 
58. However, the effects of exercise training on wall thickness may be different in subjects 
with increased cardiovascular risk. Endurance trained post-menopausal women show a 
smaller wall thickness in peripheral (i.e. femoral), but not the carotid artery, compared to 
sedentary controls59. furthermore, adaptations in endothelial function have a partly systemic 
stimulus, as a lower-limb training program designed to minimize arm involvement also 
results in adaptations in the brachial artery in T2DM (i.e. in inactive limbs).50 These findings 
raise the possibility that exercise training may induce site-specific changes in wall thickness 
and vascular function, with predominance in peripheral vessels, especially in subjects with 
a priori increased cardiovascular risk such as type 2 diabetes. However, no previous study 
directly examined this question.
Time-course of vascular adaptations 
Previous studies have demonstrated the presence of a time-dependent adaptation of 
vascular function during exercise training in healthy volunteers. Originally based on findings 
in animals,60 it was demonstrated that short-term exercise training enhances functional 
characteristics of the vasculature (i.e. increased eNOS and NO bioactivity),61-64, whilst 
prolonged training in healthy animals induces structural changes (i.e. increased diameter).65,66 
Recently, a series of experiments in humans was performed that involved 2-weekly 
measurements across an 8-week period of large (i.e. cycling/running exercise)67,68 or small 
muscle group (i.e. handgrip exercise)69 training in healthy, young volunteers. A consistent 
finding in these studies is that 2 weeks of exercise training is sufficient to significantly 
increase vascular function, which is normalised after 6-8 weeks of exercise training. These 
observations support the idea that exercise training, at least in healthy subjects, leads to 
time-dependent adaptations in vascular function. Although most studies performed in 
subjects with prevailing cardiovascular risk factors demonstrate that exercise training 
improves vascular function, results are conflicting.34-36 Some of this disparity may relate to the 
presence of time-dependent adaptations of the vasculature in response to exercise training. 
However, whether a time-dependent change in vascular function is present in subjects with 
increased cardiovascular risk (and therefore a lower a priori endothelial function) is currently 
unknown. 
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EXERCISE; HOW TO OPTIMIZE THE VASCULAR EFFECTS?
As outlined above, exercise training or increasing physical activity represents a potent stimulus 
to improve cardiovascular risk and vascular function in subjects with T2DM. Accordingly, 
exercise training and recommendations regarding a physically active lifestyle play a central 
role in the successful management of glucose homeostasis and prevention of complications 
to T2DM. However, relatively little effort is given to optimise the impact of exercise training. 
To be able to optimize the vascular effects of exercise training, it is important to understand 
the principle stimuli for vascular improvement during exercise.
Animal studies 
As early as 1986, Langille et al. have conducted a series of seminal experiments in rabbit 
carotid arteries. In these experiments, the rate of blood flow through the artery was artificially 
reduced with 70%. This caused a decrease in artery diameter of 21% after only 2 weeks. 
Papaverine, a smooth muscle relaxant, did not influence this response, suggesting that 
the arterial wall was structurally altered. The response to the reduced blood flow was not 
present when the endothelium was removed from the arteries. These experiments represent 
the earliest evidence that the endothelium plays a central role in vascular adaptations to 
changes in blood flow.70 Following these findings, Tuttle et al. conducted in vivo experiments 
to assess the effects of increasing and decreasing flow and shear on arterial wall remodelling. 
In a rat model, the number of microvascular perfusion units of mesenteric arteries was 
altered to 50%, 200%, and 400%, thereby influencing blood flow and shear rate to the same 
degree. After 7 days, vessel diameter was decreased in those arteries that were exposed to a 
50%-reduction in blood flow, whilst artery diameter was increased in those vessels exposed 
to 200% and 400% increases in blood flow in a dose-dependent manner (Figure 1). This 
shows that shear level influences arterial adaptation in vivo.71
Human studies 
In line with these landmark studies in animals, also in humans the beneficial impact of 
exercise training on vascular function and arterial remodelling may, at least partly, be 
caused by exercise-induced shear stress.72  To examine this hypothesis and to elucidate the 
importance of blood flow and shear rate as a stimulus for vascular adaptation, Tinken et al. 
simultaneously examined endothelial function in both brachial arteries of healthy young men 
before and after 30-minute interventions that significantly increased brachial artery blood 
flow and shear rate (cycling, handgrip and hand warming). Unilaterally, a cuff inflated to 60 
mmHg was placed to manipulate the shear rate stimulus, effectively reducing the exercise-
induced increases in blood flow and shear stress through the brachial artery. In the non-
cuffed arm, flow and shear increased similarly in response to each intervention, resulting in 
an acute increase in endothelial function. However, in the cuffed arm, where the increase in 
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shear rate was attenuated, the increase in endothelial function was abolished.73 This suggests 
that the increase in blood flow and shear rate in the brachial artery is obligatory for acute 
improvements in endothelial function in humans in vivo. In a subsequent study, subjects 
performed an 8-week bilateral handgrip exercise training program, where unilaterally, shear 
stress responses were attenuated via inflation of a blood pressure cuff to 60 mmHg. Brachial 
artery endothelial function increased in the non-cuffed arm across the 8 week training, whilst 
such an effect was not present in the cuffed arm. This confirms observations from previous 
animal studies and shows that arterial adaptations are importantly dependent on increases 
in the shear stimulus in vivo.69
BLOOD FLOW IN TYPE 2 DIABETES
Recently, Lalande and co-workers examined femoral arterial blood flow MRI scans at rest 
and during low-intensity leg exercise in eight patients with T2DM and 11 healthy individuals. 
Their main finding was that T2DM patients show an attenuated blood flow response to 
submaximal exercise compared to healthy controls.74 In another study, Bauer et al. found 
similar results in the microvasculature using near infra-red spectroscopy. They reported an 
attenuated microvascular blood flow in response to lower limb exercise. These observations 
suggest that T2DM patients show attenuated microvascular blood flow kinetics during 
exercise.75 These attenuated macro- and microvascular responses to exercise in T2DM may 
have clinical relevance. As demonstrated previously by Tinken et al., the acute increase in 
blood flow in response to exercise represents an important stimulus for arteries to adapt. 
Figure 4
Diameter changes in response to changes in blood flow/shear rate (adapted from Tuttle et al. 2001).
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Based on the limited evidence present from animal studies 71, increases in shear or blood flow 
and improvement in vascular function may represent a linear, dose-dependent relationship, 
with a larger increase in blood flow and shear stress leading to a larger adaptation in vessels. 
Accordingly, we propose that an attenuated blood flow response, such as present in T2DM, 
may reduce the efficiency of an exercise stimulus to induce structural and functional vascular 
adaptations. 
The potential clinical relevance of the exercise-induced increase in blood flow response in T2DM 
has been examined in a previous study from Womack et al.. In this study, they examined the 
differences in capillary blood flow during low- and high-intensity handgrip exercise between 
controls, uncomplicated T2DM patients, and T2DM patients with established microvascular 
complications (Figure 5). Womack reported that capillary responses to incremental levels of 
handgrip exercise were similar between healthy controls and uncomplicated T2DM patients, 
whilst patients with microvascular complications had a 60-70% reduction in capillary blood 
flow during both low- and high-intensity exercise (Figure 2).76 The authors suggested that 
skeletal muscle capillary responses to exercise are preserved in subjects with well-controlled 
Figure 5
Forearm capillary blood flow at rest and during incremental levels (25 and 80% of the maximal voluntary contraction) 
in controls (n=20), uncomplicated diabetes mellitus type 2 patients (DM, n=22), and diabetes mellitus type 2 patients 
with microvascular complications (DM+MC, n=8). (adapted from Womack et al. 2009).
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uncomplicated T2DM, but are impaired in those with microvascular complications. Despite 
the cross-sectional nature of this observation, the presence of an impaired blood flow 
response to exercise may reflect underlying abnormalities in microvascular recruitment 
during exercise in T2DM that potentially has some clinical value. However, prolonged follow-
up studies should be adopted to further examine the clinical value of the exercise-induced 
blood flow responses.
In addition to the strong and potent effects of an increased blood flow on the vasculature, 
increments of blood flow may also represent a stimulus to alter glucose homeostasis. Insulin 
has the ability to increase blood flow to skeletal muscle. This enhances delivery of both 
insulin and glucose to muscle cells, thereby improving the uptake of glucose, and glucose 
homeostasis.77 Therefore, an increased exercise-induced blood flow may even further 
enhance this delivery of insulin and glucose to muscle cells, further improving glucose 
uptake.78-81
STRATEGIES TO OPTIMIZE THE VASCULAR EFFECTS OF EXERCISE
Metformin 
Studies with different types of medication (such as ACE-inhibitors, statins, and metformin) 
have shown that pharmacological therapy can have pleiotropic effects, potentially 
improving endothelial function and reducing cardiovascular risk in type 2 diabetes 
patients and healthy controls.82-84 Given the pleiotropic effects of various pharmacological 
interventions, with a specific improvement in endothelial function, medication may 
potentiate the effects of exercise training on cardiovascular risk and endothelial function. 
Accordingly, several previous studies have hypothesised and examined the interesting 
and appealing hypothesis that combining medication with exercise training may lead 
to synergistic effects, resulting in a superior effect on the vasculature than the individual 
treatments alone. For example, Malin et al. compared the effect of 12-weeks metformin, 
placebo, training + metformin, and training + placebo in glucose intolerant adults on 
cardiovascular risk factors (i.e. adiposity, blood pressure and cholesterol levels). The 
authors concluded that metformin has an interaction with the exercise training effects, 
potentially leading to a superior effect on cardiovascular risk when metformin is combined 
with exercise training.85 Boule et al. provided further evidence for the synergistic effects of 
metformin and exercise therapies.86
Vasoconstrictors
An increased contribution of vasoconstrictors to vascular tone at rest and during exercise 
may contribute to the attenuated blood flow responses to exercise in T2DM. Theoretically, 
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targeting this interaction by pharmacological therapy, may help to optimise the effects of 
exercise training by increasing exercise-induced blood flow and shear rate. Endothelin-1 (ET-
1) is produced by the endothelium and represents a strong and potent vasoconstrictor. In type 
2 diabetes patients, ET-1 levels in the blood are elevated 87, and this is positively related with 
an elevated baseline vascular tone and increased cardiovascular risk 88,89. Pharmacological 
blockade of ET–1 increases capillary blood flow by decreasing vascular tone 90-92. Possibly, 
an increased contribution of ET-1 explains the attenuated blood flow response to exercise 
in T2DM. At least in healthy humans, Wray found that ET-1 contributes to the blood flow 
responses during exercise.93 Accordingly, ET-receptor blockade in T2DM may contribute to an 
increased exercise-induced blood flow response. Consequently, exercise training program 
combined with an ET-antagonist in T2DM patients may repeatedly enhance the exercise-
induced blood flow responses and thereby the impact of exercise training on the vasculature 
(and therefore cardiovascular risk).
Nitric oxide 
Other possible therapeutic target pathways for improving the exercise-induced blood flow 
response in T2DM relates to the administration and/or stimulation of vasodilator substances, 
such as nitric oxide and tetrahydrobiopterin. The latter is an essential cofactor in the 
regulation of eNOS, and has the potential to protect against glucose-induced endothelial 
dysfunction. 94,95 However, studies that have looked into the efficacy of these pathways 
remain inconclusive in T2DM, with several reviews reporting studies with both positive and 
negative effects of interventions on endothelial function (see reviews).96-98
Hypoxia 
Recent studies have suggested the potential of combining hypoxia with exercise training to 
further benefit from the effects of exercise training on cardiovascular adaptations. A recent 
study in healthy men has shown that the addition of hypoxia to exercise leads to an increased 
exercise-induced blood flow response and larger post-exercise endothelial function than 
exercise under normoxia.99 Given the importance of (the magnitude of) exercise-induced 
blood flow to induce vascular adaptations,69,72,100 the larger exercise-induced blood flow 
response under hypoxia may relate to the superior acute effect on endothelial function. 
When hypoxic exercise is performed repeatedly in healthy subjects, this type of exercise 
training has demonstrated to raise the maximal oxygen uptake beyond the effect of normoxic 
exercise training alone,101 whilst hypoxic exercise training further lowered leptin levels,102 
and improved insulin sensitivity.101,102 Also in T2DM, a single bout of exercise combined with 
hypoxia has demonstrated a higher increase in insulin sensitivity than  exercise training 
under normoxic conditions103. Therefore, repeated exposure to exercise under hypoxia may 
result in superior effects on the vasculature and glucose homeostasis in T2DM. However, no 
previous study directly examined this hypothesis in T2DM.
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OUTLINE OF THIS THESIS
Exercise training has an important role in the treatment strategy in T2DM, and has shown to 
improve physical fitness and glucose homeostasis.22,34,43-46,50,104,105 The effectiveness of exercise 
training in improving arterial function16,50,51 and structure53,54 has been studied extensively 
over the past years in several short- to moderate duration exercise programs. However, the 
effect of a long-term active lifestyle in T2DM on glucose homeostasis and vascular function is 
currently unknown. Chapter 2 describes insulin sensitivity, physical fitness, cardiovascular 
risk, and vascular function in a unique group of life-long, physically active T2DM patients. 
These results were compared to sedentary peers and healthy controls, providing some 
unique insight into what health effects can be achieved by regular exercise for a prolonged 
period of time in T2DM.
The beneficial effects of exercise training on the vasculature importantly depend on acute 
exercise-induced changes in blood flow.69 Interestingly, type 2 diabetes patients show an 
attenuated blood flow response to exercise compared to healthy controls,74 which may be 
related to an increased contribution of endothelin-1 to the exercise-induced blood flow 
responses. Therefore, we examined whether an increase in the exercise-induced blood 
flow and shear rate can be achieved through blockade of endothelin-receptors. Chapter 3 
acts as a ‘proof of concept’ for this idea, testing the hypothesis that ET-receptor blockade 
will increase the exercise-induced blood flow in men with T2DM, but not in age-matched 
healthy controls. Furthermore, we examined whether the increased exercise-induced blood 
flow response during ET-blockade will result in a superior effect of exercise on post-exercise 
endothelial function in T2DM.
Chapter 4 takes advantage of the results from Chapter 3, by bringing the same idea into 
a practical interventional setting. In this chapter, we performed a randomised controlled 
trial to assess the effect of an 8-week exercise-training program with daily ET-blockade or a 
placebo on the vasculature, fitness and glucose homeostasis in patients with T2DM.
Previous studies demonstrated that improvement in vascular function after dynamic exercise 
training is not a univocal finding34-36, possibly caused by the presence of a time-dependent 
adaptation of vascular function during exercise training.61-66 Studies in healthy volunteers 
provided direct evidence for this hypothesis, and showed that 2 weeks of exercise training 
is sufficient to significantly increase vascular function, which normalises after 6-8 weeks of 
exercise training67,68. This supports the idea that exercise training, at least in healthy subjects, 
leads to time-dependent adaptations in vascular function. In Chapter 5 we aim to investigate 
if a time-dependent adaptation in vascular function is present in subjects with an increased 
cardiovascular risk. To this end we performed 2-weekly measurements of vascular function 
across an 8-week lower limb-dominant exercise training program in middle-aged men and 
type 2 diabetes mellitus patients.
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Whilst the impact of exercise training in T2DM on vascular function is frequently studied, 
little attention has been paid to the impact of exercise training in type 2 diabetes on arterial 
wall thickness; a surrogate measure of atherosclerosis.106,107 Moreover, no previous study 
examined whether exercise training leads to local or systemic adaptations in conduit 
artery wall thickness. In Chapter 6 the impact of 8 weeks of supervised exercise training 
on wall thickness in peripheral and central vessels in T2DM patients and healthy controls 
was examined. Furthermore, by focusing the exercise on the lower limbs, the distinction can 
be made between the impact of exercise on central (i.e. carotid artery), and on peripheral 
arteries supplying active (i.e. superficial femoral artery) versus inactive areas (i.e. brachial 
artery).
The studies described in Chapter 3 and Chapter 4 of this thesis have attempted to optimise 
the benefits from exercise training in T2DM through combined blockade of ET-receptors. 
An alternative strategy for optimisation of the exercise stimulus is proposed in Chapter 7, 
where we have combined exercise training with hypoxia. Previous studies have suggested 
an additional effect of hypoxia during exercise training on insulin sensitivity in healthy 
subjects101,102 and T2DM,103 most likely by enhancing the exercise-induced blood flow 
responses.99 This may pave the way for hypoxic training as a viable strategy for superior 
vascular adaptation and insulin resistance compared to normoxic exercise training.69,72,100 
In Chapter 7 we test the hypothesis that the beneficial effect of the intermittent hypoxic 
exercise training on physical fitness, glucose homeostasis and endothelial function will be 
superior to that of normoxic exercise training.
In Chapter 8, we aim to further understand the shear stimulus, and examine whether the 
impact of incremental levels of retrograde SR differs between atherosclerosis-prone (i.e. 
superficial femoral artery) and –resistant vessels (i.e. brachial artery) in healthy men.
Chapter 9 deals with the current state-of-the-art knowledge in light of the studies in this 
thesis, and attempts to provide some pieces of the puzzle to answer the question how to 
optimize the effects of exercise training in type 2 diabetes patients. In this chapter, we also 
speculate on possible future interventions and alternative strategies for optimization of 
exercise in type 2 diabetes.
Methods applied in this thesis
To assess the effects of physical exercise and the effect of our interventions, we used different 
techniques to measure physical fitness, cardiovascular risk, vascular function and structure, 
and glucose homeostasis. The different methods will be explained in this section. 
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Incremental cycling test
To examine maximal workload, peak oxygen consumption, and maximal heart rate, subjects 
performed an incremental cycle exercise test on a cycling ergometer (Lode, Excalibur, 
Groningen, the Netherlands). The tests started at a power output of 10 W for 1 min and 
power output increased by 10 W/min until voluntary exhaustion. Subjects were instructed 
to maintain a cadence of between 60 and 80 rpm during the test. Oxygen consumption 
(VO2, in ml O2/kg per min), ventilation (Ve, in l/min), respiratory quotient (RQ) (Oxycon IV, 
Jaeger, Germany) and heart rate (HR, in bpm) were recorded continuously. Furthermore, we 
measured blood lactate levels (mmol/l) using Accutrend® Lactate (Roche Diagnostics GmbH, 
type 3012522, Mannheim, Germany) before and 2 min after finishing the maximal exercise 
test. For a test to be classified as successful, at least 3 out of the following 4 criteria had to 
be met: clinical signs of exhaustion of the participant, respiratory quotient ≥1.10, finishing 
within 10 beats of the maximum predicted heart rate (=220-age), and flattening of VO2 uptake 
curve (≤110mL increase during the last minute).108
Lifetime Risk Score for Cardiovascular Disease
The lifetime Risk Score (LRS, %) is a relatively new measure for cardiovascular risk that can be 
calculated using a web-based interface (www.lifetimerisk.org). Using this interface, the risk of 
death due to cardiovascular disease in the next 30 years is calculated using the parameters 
gender (male/female), age (years), systolic blood pressure (mmHg), diabetes (yes/no), total 
cholesterol (mg/dL), smoker (yes/no), fitness level (METs), body mass index (kg/m2). This 
algorithm was validated in two recent high impact papers and showed to have a stronger 
predictive capacity than other frequently used risk prediction models.109,110
Brachial artery endothelium-dependent dilation
A 10 MHz multifrequency linear array probe attached to a high resolution ultrasound machine 
(T3000; Terason, Burlington (Massachusetts), USA) was used to image the brachial artery in 
the distal one-third of the upper arm. When an optimal image was obtained, the probe was 
held stable and the ultrasound parameters were set to optimize the longitudinal, B-mode 
images of lumen–arterial wall interface. All ultrasound measurements were performed by 
an experienced sonographer. We have measured the FMD according to recent guidelines.111
Subjects rested in the supine position for a period of at least 15 minutes to facilitate baseline 
assessment of artery diameter and blood flow. To examine brachial artery FMD, the arm was 
extended and positioned at an angle of ∼80 deg from the torso. A rapid inflation and deflation 
pneumatic cuff (Hokanson, Bellevue (Washington), USA) was positioned on the forearm of 
the imaged arm immediately distal to the olecranon process to provide a stimulus of forearm 
ischemia.  Continuous Doppler velocity assessment was obtained using the lowest possible 
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insonation angle (always < 60 deg), which did not vary during each measurement. The 
forearm cuff was inflated to 220 mmHg for 5 min. Diameter and flow recordings resumed 30 s 
prior to cuff deflation and continued for 3 min thereafter. We have adopted recent guidelines 
to examine the FMD.111 The FMD is a valid and frequently used technique to examine the 
endothelial function, which reflects largely nitric oxide (NO)-mediated, endothelium-
dependent vasodilation.111,112
Superficial femoral artery endothelium-dependent dilation
Measurement of superficial femoral artery endothelium-dependent function was performed 
as described above for the brachial artery, except that the cuff was placed at the thigh of the 
imaged leg, directly above the knee, and measurements continued for 5 minutes after cuff 
deflation.
Endothelium-independent dilation (GTN response + FMD/GTN-response)
Following a >15-minute rest period, a 1-minute baseline recording of brachial artery diameter 
and flow was taken using a procedure as described above. Subsequently, brachial artery 
endothelium-independent vasodilation was examined after administration of a single spray 
of sublingual glyceryl trinitrate (GTN, 400 µg), a nitric oxide donor. This was followed by 10 
minute continuous recording of brachial artery diameter and blood flow. Where applicable, 
the FMD/GTN-ratio was calculated, to correct the flow mediated dilation for potential 
differences between and within subjects in the endothelium-independent dilation (i.e. 
smooth muscle cell function). This is of special importance given recent observations of 
differences between (clinical) groups with and without atherosclerosis.113,114
Brachial artery dilator capacity and peak blood flow
After a >15-min rest period and assessment of a 1 min baseline recording of brachial artery 
diameter and blood flow, brachial artery dilation was examined after a 5-min period of 
ischemic handgrip exercise (1 min ischemia, 3 min isotonic handgrip exercise, 1 min ischemia). 
Handgrip exercise involved 1 contraction every 2 s of a 3-kg load. Peak blood flow was defined 
as the blood flow area under the curve of the highest 10s window after cuff deflation. The 
peak hyperemic forearm blood flow in response to this stimulus in humans provides a valid 
and accepted index of resistance artery size or remodeling as such peak blood flow responses 
are largely independent on the fluctuating influence of vascular tone and function.115 We 
resumed diameter and flow recordings 30 s prior to cuff deflation and continued for 3 min 
thereafter. In the same way as in the flow mediated dilation measurement, dilation relative to 
baseline was calculated, which is believed to be the maximal dilation the brachial artery can 
achieve. This protocol has recently been demonstrated to result in a peak conduit diameter 
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and also peak blood flow response in brachial artery.116
Exercise-induced blood flow
After resting in the supine position for >15 minutes to facilitate measurement of baseline 
brachial artery diameter, blood flow and shear rate, subjects performed a metronome-
assisted dynamic handgrip exercise protocol (frequency of 0.5 Hz; 1 second active, 1 second 
relaxation). First, subjects performed 3 bouts of 3 minutes of handgrip exercise at 15, 30 
and 45% MVC, with a 5 minute rest period after each exercise bout.  Subsequently, subjects 
performed a 30-minute period of continuous handgrip exercise at 15% MVC.
Brachial artery diameter, blood flow, and shear rate were assessed before and during 
handgrip exercise, using a high resolution ultrasound machine (T3000; Terason, Burlington, 
MA, USA). First, baseline values were recorded during a 1 minute period immediately before 
the incremental and continuous handgrip exercise. During the incremental part (15, 30 and 
45%), data was recorded during the last minute of each exercise bout. During the continuous 
part at 15% MVC, the last minute of each 10-minute epoch was recorded.
Intima-Media Thickness, diameter, and wall:lumen-ratio
After a rest period of at least 15 minutes in the supine position, we performed assessment of 
baseline resting diameter and wall thickness of the superficial femoral, brachial and carotid 
artery. Clearly demarcated intimal-medial boundaries were obtained via perpendicular 
incidence imaging in relation to the orientation of the vessel. Images were optimized by using 
contrast controls on the ultrasound machine, which was consistently maintained between 
arteries for each individual.117 Ultrasound parameters were set to optimize longitudinal 
B-mode images of the lumen/arterial wall interface.  Diameter and wall thickness were 
collected from 2 distinct angles and data was recorded for at least 10 seconds at a sampling 
frequency of 30 Hz. Also, wall:lumen-ratio was calculated to correct for differences in vascular 
tone between measurements. In addition, subjects arrived in a fasted state (>6 hours) and 
were instructed not to take caffeine of vitamin C, or perform vigorous exercise for at least 24 
hours before the start of the measurements.
Assessment of the common carotid artery was performed with the subject supine and the 
neck slightly extended to allow scanning of the artery. Images for the carotid artery were 
made on the proximal 1.5 cm straight portion of this artery. Assessment of the superficial 
femoral artery diameter and wall thickness was performed in the proximal third of the thigh, 
at least 3 cm distal from the bifurcation. Assessment of the brachial artery was performed 
on the distal 1/3rd of the upper arm. The repeated measurements were made on the same 
segment of the artery.
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Subject characteristics and venous blood
Subjects completed a questionnaire concerning their medical history and medication 
use. Height, weight, resting blood pressure (after a 5-minute seated rest using a manual 
sphygmomanometer) were recorded. A venous blood sample was taken for assessment of 
fasting glucose, insulin, glycosylated haemoglobin (HbA1c), total cholesterol, high-density 
lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, aspartate aminotransferase 
(ASAT) and alanine amonitransferase (ALAT). From the glucose and insulin levels the 
homeostasis model for assessment of insulin resistance (HOMA-IR) index was calculated as a 
valid measure of insulin resistance.118 
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ABSTRACT
Purpose Short-to-moderate duration exercise training improves fitness and lowers 
cardiovascular risk in type 2 diabetes (T2DM). However, the impact of long-term compliance 
to an active lifestyle of T2DM patients on cardiovascular risk factors has never been studied 
but could provide information on the maximal achievable health effect of physical activity 
in T2DM. This study examined the impact of a life-long active lifestyle by comparing physical 
fitness, cardiovascular risk and vascular function between long-term physically active T2DM 
patients versus sedentary T2DM patients and controls.
Methods Fitness, HOMA-IR, brachial artery flow-mediated dilation (FMD) and lifetime risk 
for cardiovascular disease were assessed in 15 exercising T2DM patients, 12 age-, sex- 
and weight-matched sedentary T2DM patients and 9 sedentary men free of established 
cardiovascular and metabolic disease as controls. Long-term regular exercise was defined 
as self-reported participation of >2.5 hours of (predominantly) endurance exercise per week, 
which was performed for 18-47 years.
Results Sedentary T2DM patients showed lower fitness (21.8±2.3, 32.6±6.0 and 31.1±3.2 
mlO2/kg/min), higher HOMA-IR (8.3±5.0, 2.0±1.8 and 1.1±0.5 100/%S) and higher lifetime risk 
scores (17.3±5.4, 9.3±5.0 and 8.9±3.9%) compared to active peers and controls, respectively. 
Brachial artery FMD was lower in sedentary T2DM patients compared with active peers, but 
not controls (3.3±1.2, 5.2±2.1 and 3.8±1.2%).
Conclusions Life-long active T2DM patients have superior fitness levels, HOMA-IR, 
cardiovascular risk and FMD compared to sedentary peers, whilst no differences were found 
when compared to controls. This study provides evidence that a life-long active lifestyle, 
even in T2DM, may be able to effectively normalize cardiovascular risk.
KEYWORDS: physical fitness; cardiovascular risk; endothelial function; glucose homeostasis
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ABBREVIATIONS
ACSM  American College of Sports Medicine
ANOVA  Analysis of variance
BA  Brachial Artery
bpm  beats per minute
CADC  Conduit artery dilator capacity
CCA  Common Carotid Artery
deg  degrees
FMD  Flow mediated dilation
GTN  Glyceryl Trinitrate
HR  Heart rate
IPAQ  International Physical Activity Questionnaire
IR  Insulin resistance
LRS  Lifetime Risk Score for cardiovascular disease
METs  Metabolic equivalents
NO  Nitric Oxide
rpm  rotations per minute
RQ  Respiratory quotient
SD  Standard Deviation
SE  Standard Error
T2DM  type 2 diabetes mellitus
Ve  ventilation
VO2  volume of oxygen consumption
VO2 max  maximal volume of oxygen consumption
W  watt
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INTRODUCTION
Type 2 diabetes mellitus (T2DM) represents a major health problem in Western society and 
affects over 300 million people worldwide. Although the central characteristic in T2DM is the 
inability to maintain glucose homeostasis, the main co-morbidity and cause of mortality1,2 are 
related to vascular maladaptations.3-5 Changes in vascular structure and function represent 
important precursors in the development of these vascular complications.3,4
Previous studies in T2DM patients reported beneficial effects of short- and moderate-duration 
exercise training on insulin sensitivity, physical fitness and cardiovascular risk profile.5-10 
In addition, exercise training also exerts its beneficial effect through direct improvements 
on the artery, such as an improvement in endothelial function2,11,12 and decrease in wall 
thickness.13,14
However, these relatively short periods of exercise training may not be representative for 
long-term effects on insulin sensitivity and vascular remodelling and unlikely allow for 
normalisation of the cardiovascular risk profile.15
To date, no previous study examined the hypothesis that life-long physically active lifestyle 
in T2DM patients demonstrate better insulin sensitivity, physical fitness, cardiovascular risk, 
and vascular function compared to their inactive peers, and that such lifestyle in T2DM can 
normalise these variables compared to those found in sedentary men free of established 
cardiovascular and metabolic disease (i.e. controls). Therefore, the aim of this study was 
to compare insulin sensitivity, physical fitness, cardiovascular risk, and vascular function 
between age-, sex- and weight-matched life-long physically active and sedentary T2DM 
patients and controls.
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METHODS
Participants 
We included 12 sedentary men with T2DM (61±6 years), 15 life-long physically active men 
with T2DM of similar age and weight (58±7 years), and 9 sedentary men free of established 
cardiovascular and metabolic disease of similar age and weight as controls (60±5). Long-term 
regular exercise was defined as self-reported participation of >2.5 hours of (predominantly) 
endurance exercise per week for at least 10 years. 
We excluded subjects with (a history of) cardiovascular disease, smokers, type I diabetes 
mellitus, age <40 or >65, and presence of diabetes-related vascular complications. The study 
procedures were approved by the medical ethical committee of the Radboud University 
Nijmegen Medical Centre and adhered to the Declaration of Helsinki. All subjects gave written 
informed consent before participation in this study.
Experimental design 
In this cross-sectional study, all groups reported once to the laboratory for assessment of 
physical fitness, glucose homeostasis, brachial artery endothelial function and Lifetime 
Risk Score for cardiovascular disease. To assess physical activity level for group placement 
purposes, we administered an adapted version of the International Physical Activity 
Questionnaire (IPAQ), with additional questions regarding past physical activity between 
17-29, 30-49, 50-64, and 65+ years of age. Specifically, for each category of age, we asked 
if subjects performed physical activity (‘yes’, ‘no’, or ‘not applicable’), how many hours of 
physical activity per week (‘hours per week’), and at what level of intensity exercise was 
generally performed (‘light’ (i.e. normal breathing), ‘medium’ (i.e. heavier breathing but still 
able to speak), or ‘heavy intensity’ (i.e. heavy breathing, unable to speak)).
Measurements 
All subjects refrained from alcohol, caffeine, chocolate, and vitamin C for at least 18 hours, 
and vigorous physical exercise for at least 24 hours prior to testing. Also, subjects did not eat 
in the 6 hours prior to the ultrasound measurements. After the ultrasound measurements, 
subjects were allowed to eat and drink before undergoing physical fitness testing. All tests 
were performed in laboratory conditions with constant temperature (21°C) and humidity 
(35%).
Physical fitness 
Each subject performed an incremental maximal exercise test on a cycling ergometer 
(Lode, Excalibur, Groningen, the Netherlands). These tests started at a power output of 
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10 W for 1 min and power output was increased by 10 W/min until exhaustion. Subjects 
were instructed to maintain a cadence of between 60 and 80 rpm during the test. Starting 
2 min prior to and throughout the maximal exercise tests, oxygen consumption (VO2, in 
ml O2/kg per min), ventilation (Ve, in L/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, 
Germany) and heart rate (HR, in bpm) (Polar T31, Polar Electro Oy, Finland) were measured 
and recorded continuously. Furthermore, we measured blood lactate levels (mmol/l) using 
Accutrend® Lactate (Roche Diagnostics GmbH, type 3012522, Mannheim, Germany) before 
the test and between 1.5 and 2 minutes after finishing the maximal exercise test. For a test 
to be classified as successful, at least 3 out of the following 4 criteria had to be met: clinical 
signs of exhaustion of the participant, respiratory quotient ≥1.10, finishing within 10 beats of 
the maximum predicted heart rate (=220-age), and flattening of VO2 uptake curve (≤110mL 
increase during the last minute).16
Venous blood 
A venous blood sample was taken for assessment of fasting glucose, insulin, and total 
cholesterol. From the glucose and insulin levels we calculated the HOMA-IR index.
Endothelium-dependent dilation 
Measurements were performed by an experienced vascular sonographer. A 10 MHz 
multifrequency linear array probe attached to a high resolution ultrasound machine (T3000; 
Terason, Burlington (Massachusetts), USA) was used to image the brachial artery in the distal 
one-third of the upper arm. When an optimal image was obtained, the probe was held stable 
and the ultrasound parameters were set to optimize the longitudinal, B-mode images of 
lumen–arterial wall interface.
Subjects rested in the supine position for a period of at least 15 minutes to facilitate baseline 
assessment of artery diameter and blood flow. To examine brachial artery FMD, the arm was 
extended and positioned at an angle of ∼80 deg from the torso. A rapid inflation and deflation 
pneumatic cuff (Hokanson, Bellevue (Washington), USA) was positioned on the forearm of 
the imaged arm immediately distal to the olecranon process to provide a stimulus of forearm 
ischemia.  Continuous Doppler velocity assessment was obtained using the lowest possible 
insonation angle (always < 60 deg), which did not vary during each measurement. The 
forearm cuff was inflated to 220 mmHg for 5 min. Diameter and flow recordings resumed 30 s 
prior to cuff deflation and continued for 3 min thereafter.
Brachial artery dilator capacity 
After a >15-minute rest period, a 1 min baseline recording of brachial artery diameter and 
blood flow was performed. Next, brachial artery dilation was examined after a 5-minute 
period of ischemia, consisting of 1 min ischemia, followed by 3-min isotonic handgrip 
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exercise and a final 1 min of ischemia. Handgrip exercise involved 1 contraction every 2 s of a 
3-kg load. The peak diameter that occurs after hyperemic forearm blood flow in response to 
this stimulus provides a valid and accepted index of artery size or remodelling.17 We resumed 
diameter and flow recordings 30 s prior to cuff deflation and continued for 3 min thereafter.
Endothelium-independent dilation 
Following a >15-minute rest period, a 1-minute baseline recording of brachial artery diameter 
and flow was taken. Subsequently, brachial artery endothelium-independent vasodilation 
was examined after administration of a single spray of sublingual GTN (400 µg), an NO donor. 
This was followed by 10 minute continuous recording of brachial artery diameter and blood 
flow.
Lifetime Risk Score for Cardiovascular Disease 
The lifetime Risk Score (LRS, %) is a measure that can be calculated using a web-based 
interface (www.lifetimerisk.org). Using this interface, the risk of death due to cardiovascular 
disease in the next 30 years is calculated using the parameters gender (male/female), age 
(years), systolic blood pressure (mmHg), diabetes (yes/no), total cholesterol (mg/dL), smoker 
(yes/no), fitness level (METs), body mass index (kg/m2).
Data Analysis 
Post-test analysis of brachial artery diameter was performed using custom-designed edge-
detection and wall-tracking software, which is independent of investigator bias.18 Baseline 
diameter, flow and shear rate were calculated as the mean of data acquired across the 1 min 
preceding the cuff inflation period. Peak diameter following cuff deflation was automatically 
detected according to an algorithm which identified the maximum bracket of data subsequent 
to performance of a moving window smoothing function. This smoothing routine calculates 
the median value from 100 consecutive samples, before the window shifts to the next bracket 
of data, which shares 20% overlap with the preceding bracket. The maximum value of all the 
calculated median values is then automatically detected and chosen to represent the peak 
of the post-deflation artery diameter curve. FMD was calculated as the percentage rise of this 
peak diameter from the preceding baseline diameter. The time to peak diameter (in seconds) 
was calculated from the point of cuff deflation to the maximum post-deflation diameter. 
Calculation of FMD and time to peak were therefore observer-independent and based on 
standardized algorithms applied to data which had undergone automated edge-detection 
and wall-tracking. Calculation of dilator capacity and corresponding time to peak diameter 
were performed in the same manner for dilator capacity and GTN measurements.
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Statistical analysis 
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago, Ill) software. All data 
are reported as mean (SD) unless stated otherwise, and statistical significance was assumed 
at P<0.05. One-way ANOVA were used to assess differences between groups. We used 
post-hoc t-tests with Bonferroni correction to identify where these differences between 
groups occurred. Reported correlations are Pearson correlations. Categorical variables 
were compared using the χ2 test. According to a recent study, inadequate scaling for FMD 
would be present if the upper confidence limit of the regression slope of the relationship 
between logarithmically transformed base diameter and peak diameter is less than one.19 
In such an event, FMD% is not an appropriate measure to estimate endothelial function. We 
checked our data for this phenomenon, and subsequently performed allometric modelling.19 
Furthermore, we corrected for the shear rate stimulus by adding this factor as a covariate in 
our analysis.
Number of subjects 
The main outcome parameter in this study is the brachial artery flow mediated dilation. 
Woodman et al calculated that to find an improvement in FMD of 2% with a power of 80% at 
α=0.05, 12 subjects per group should be included.18 The most important comparison in this 
study is inactive T2DM patients versus life-long active T2DM patients, therefore we included 
12 inactive and 15 active patients. To find an improvement of 2.5% at that same power, 8 
subjects per group should be included. As the comparison with controls is of secondary 
importance in this study, we included 9 controls.
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RESULTS
General characteristics of study participants 
The three groups, inactive T2DM patients, life-long active T2DM patients and controls were 
successfully matched regarding age, height, weight, BMI, and blood pressure (table 1). The 
active group reported a physically active lifestyle before diagnosis of T2DM (7.8±6.9 years 
duration of T2DM at time of study), and reported having been physically active for 37.4±8.4 
years (18-47 years), with an average number of hours per week of 5.3±1.8 hours (3.0-8.0 hours).
Inactive T2DM patients showed a significantly lower maximal oxygen uptake and maximal 
workload than both life-long active T2DM patients and controls. No differences between 
groups were found for maximal heart rate, respiratory exchange ratio, and peak lactate 
(table 1). Fasting glucose, insulin and HOMA-IR were significantly higher in the inactive 
T2DM patients compared with both life-long active T2DM patients and controls, whereas no 
differences were found between life-long active patients and controls (table 1). Lifetime Risk 
Score, which represents the chance of cardiovascular-related death in the next 30 years, was 
significantly higher in inactive T2DM patients compared to their life-long active peers and 
controls, but similar between life-long active T2DM patients and controls (figure 1). Maximal 
oxygen uptake correlated significantly with HOMA-IR (r= -0.627, p=0.001).
Medication use across groups is shown in table 2. Life-long active T2DM patients show 
significantly lower use of metformin (p=0.003), ACE-inhibitors (p=0.004), diuretics (p=0.038) 
and statins (p=0.050) than their inactive peers.
Vascular function 
We found a significantly higher brachial artery FMD in life-long active T2DM compared to 
their inactive peers, but not in comparison to controls using the traditional FMD% calculation 
(P=0.022) as well as adopting allometric modelling (Table 3). No differences were found 
amongst groups regarding baseline and peak diameters, time-to peak, and shear rate or 
regarding peak blood flow or peak diameter after ischemic exercise. Also brachial artery 
endothelium-independent dilation in response to sublingual glyceryl trinitrate was similar 
between groups (table 3). Maximal oxygen uptake correlated significantly with brachial artery 
FMD (r=0.351, p=0.045).
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Table 1 
Table 1. Body characteristics in inactive (n=12) and life-long active (n=15) patients with 
type 2 diabetes mellitus (T2DM) and controls (n=9). Data is presented as mean±SD. P-value 
represents a one-way ANOVA. 
 
 Inactive T2DM Active T2DM Control  P-value  
Age (years) 61±6 58±7 60±5 0.306 
Height (cm) 178±6 181±8 179±5 0.443 
Weight (kg) 95±14 89±12 89±5 0.316 
BMI (kg/m2) 30±4 27±3 28±2 0.098 
Systolic BP (mmHg) 135±10 139±18 133±15 0.663 
Diastolic BP (mmHg) 84±9 82±7 84±7 0.649 
Activity/week (hours) 1.0±2.7 5.3±1.8 c 0.9±1.5 <0.001 
VO2max (mL/min/kg) 21.8±2.3a 32.6±6.0 31.1±3.2 <0.001 
Maximal Load (Watt) 148±30a 234±22 225±36 <0.001 
Maximal Heart Rate (1/min) 153±11 166±15 160±11 0.068 
Respiratory Exchange Ratio 1.18±0.10 1.16±0.09 1.21±0.13 0.662 
Peak Lactate 6.5±2.5 12.2±1.9 10.7±3.8 0.076 
Glucose (mmol/L)  9.7±2.9a 7.2±2.1 5.2±0.5 <0.001 
Insulin (mU/L)  18.4±7.2a 6.0±3.4 4.8±1.8 <0.001 
HOMA-IR (100/%S)  8.3±5.0a 2.0±1.8 1.1±0.5 <0.001 
Total cholesterol (mmol/L)  4.2±0.8b 5.1±1.1 5.6±1.1 0.009 
a Post-hoc significant difference from life-long active T2DM and controls 
b Post-hoc significant difference from controls 
c Post-hoc significant difference from inactive T2DM and controls 
 
Body characteristics in inactive (n=12) and life-long active (n=15) patients with type 2 diabetes mellitus (T2DM) and 
controls (n=9). Data is presented as mean±SD. P-value represents a one-way ANOVA.
a Post-hoc significant difference from life-long active T2DM and controls
b Post-hoc significant difference from controls
c Post-hoc significant difference from inactive T2DM and controls
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Figure 1 Figure 1 
 
 
Lifetime Risk Score (%, risk of cardiovascular mortality in the next 30 years) in inactive type 2 diabetes mellitus 
patients (T2DM) (black bar, n=12) and age-, sex- and body weight-matched life-long active T2DM (white bar, n=15) 
and controls (grey bar, n=9). A significant difference in physical fitness was found across groups (one-way ANOVA, 
P<0.001). Post-hoc tests revealed a significantly higher lifetime risk score in the inactive T2DM group compared to 
both other groups. Error bars represent standard deviations. 
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Table 2 
Table 2. Medication use in inactive (n=12) and life-long active (n=15) patients with type 2 
diabetes mellitus (T2DM) and controls (n=9). Data is presented as total number of users per 
group and user percentage per group. 
 
 Inactive 
T2DM 
Active 
T2DM 
Pearson χ2 
 
Control 
Insulin 1 (8.3%) 1 (6.7%) P=0.869  
Metformin 11 (91.7%) a 8 (53.3%) P=0.003  
Sulfonylurea 9 (75.0%) 6 (40.0%) P=0.069  
Dipeptidylpeptidase-4 
inhibitors 
 3 (20.0%) P=0.100  
Thiazolidinediones 1 (8.3%)  P=0.255  
ACE-inhibitors 8 (66.7%) a 2 (13.3%) P=0.004 1 (11.1%) 
Angiotensin II receptor 
antagonists 
1 (8.3%) 3 (20%) P=0.396  
Diuretics 6 (50.0%) a 2 (13.3%) P=0.038 2 (22.2%) 
Calciumantagonists 2 (16.7%) 1 (6.7%) P=0.411  
β-blockers 3 (25.0%) 1 (6.7%) P=0.183  
Acetylsalicylic Acid 2 (16.7%) 2 (13.3%) P=0.809  
Coumarin derivatives 1 (8.3%)  P=0.255  
Statins 10 (83.3%) a 7 (46.7%) P=0.050 2 (22.2%) 
a Significant difference from life-long active T2DM 
 Medication use in inactive (n=12) and life-long active (n=15) patients with type 2 diabetes mellitus (T2DM) and 
controls (n=9). Data is presented as total number of users per group and user percentage per group.
a Significant difference from life-long active T2DM
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Table 3
Table 3. Ultrasound measurements in brachial artery of inactive and life-long active 
patients with type 2 diabetes mellitus (T2DM) and controls. Data is presented as mean±SD. 
P-value represents a one-way ANOVA. 
 
Flow mediated dilation Inactive T2DM Active T2DM Control P-value 
Baseline diameter (mm) 4.5±0.6 4.4±0.6 4.8±0.4 0.250 
Time to peak (s) 56±26 69±27 89±38 0.058 
Shear rate 20773±5030 14714±8261 14885±10547 0.123 
Flow mediated dilation (%) 3.3±1.2a 5.2±2.1 3.8±1.2 0.005 
Conduit artery dilator capacity     
Peak diameter (mm) 5.0±0.5 4.8±0.6 5.3±0.4 0.173 
Dilation (%) 14.2±4.7 14.1±6.0 13.6±4.8 0.962 
Peak blood flow (mL/min) 821±357 710.0±261 813.0±255 0.563 
Glyceryl Trinitrate     
Peak diameter (mm) 5.1±0.4 5.0±0.7 5.5±0.5 0.114 
Dilation (%) 14.4±5.6 13.4±4.1 16.2±6.8 0.474 
a Post-hoc significant difference from life-long active T2DM 
 Ultrasound measurements in brachial artery of inactive and life-long active patients with type 2 diabetes mellitus 
(T2DM) and controls. Data is presented as mean±SD. P-value represents a one-way ANOVA.
a Post-hoc significant difference from life-long active T2DM
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DISCUSSION
In this study we aimed to examine the effects of a life-long physically active lifestyle in 
subjects with diabetes mellitus type 2. First, we confirmed that a physically active lifestyle 
is associated with a higher physical fitness, but also with better insulin sensitivity and a 
lower 30-years risk for cardiovascular mortality compared to a sedentary lifestyle in T2DM. 
Secondly, in the brachial artery, we found that a life-long physically active lifestyle in T2DM is 
associated with a significantly better endothelial function compared to their age-, sex- and 
weight-matched inactive peers. These observations indicate that a life-long physically active 
lifestyle in T2DM may lead to superior fitness levels, insulin sensitivity, cardiovascular risk 
and vascular function compared to sedentary peers, and may be able to effectively normalize 
cardiovascular risk compared to controls. This study reveals the optimal/maximal health 
benefits that can be achieved by years of exercise training in T2DM.
A novel aspect in our study is the inclusion of life-long physically active T2DM patients, 
which is supported by the 50% higher VO2max in life-long active compared to inactive T2DM 
patients. This difference is substantially larger than the increase in physical fitness typically 
observed in 3-6 month exercise training studies.5,11,20,21 Indeed, in a meta-analysis including 
212 participants with T2DM, it was reported that 20 weeks of exercise training results in a 
mean increase in maximal oxygen uptake of 11.8%.22 Since fitness levels of our inactive T2DM 
is comparable to values reported in earlier studies,11 it is unlikely that the marked difference 
in physical fitness level between life-long active and inactive T2DM patients in our study, is 
explained by low cardiorespiratory fitness levels of the inactive group. The remarkably larger 
fitness levels in this cross-sectional comparison allow for novel insight into the impact of life-
long physical activity on cardiovascular risk in T2DM patients. 
We found markedly lower metabolic and cardiovascular risk in life-long active T2DM patients 
compared with inactive T2DM patients. These findings were bolstered by the significant 
correlations between maximal oxygen uptake and HOMA-IR, Lifetime Risk Score, and brachial 
artery FMD. First, we found that insulin sensitivity, as measured with the HOMA-IR, was 
significantly lower in the life-long active subjects. Such finding is in agreement with previous 
exercise training studies, which typically find a 8% improvement in glycemic control after 
17 weeks of exercise training in T2DM.20,23 However, we importantly extend this observation 
since we found that HOMA-IR in life-long active T2DM was 75% lower than in inactive T2DM 
and normalized towards values in the control group. Clinically, this is a very important finding 
because it shows the ability of a life-long active lifestyle to normalize insulin resistance, even 
in T2DM patients. 
Recently, the lifetime risk score for cardiovascular disease was introduced as a valid predictor 
for future cardiovascular events, which was demonstrated to possess stronger predictive 
capacity than the Framingham Risk Score.24-26 Interestingly, we found a significantly lower 
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lifetime risk score in the life-long active T2DM patients compared to their inactive peers. 
Moreover, the group of life-long active T2DM patients showed no difference in lifetime risk 
compared with sedentary controls, even though the presence of T2DM is included in the 
algorithm of the Lifetime Risk Score.24-26 This last comparison clinically means that by being 
habitually active, T2DM patients have managed to negate the effect of their disease where 
cardiovascular risk is concerned.
A previous study from Mora et al. demonstrated that traditional and novel cardiovascular 
risk factors explain only 59% of the lower cardiovascular risk that is associated with a higher 
physical activity level.27 Since exercise exerts a direct effect on the vessel wall, changes in 
vascular function may also contribute to the benefits of exercise training on cardiovascular 
risk.28 In our study, we found that life-long active T2DM patients showed a significantly 
higher brachial artery FMD, a measure of endothelium-dependent dilation, compared with 
their inactive peers. These differences remained present after statistically correcting for 
potential differences between groups in diameter and the eliciting shear response. This 
difference in FMD is most likely a result of differences in endothelial function as the brachial 
artery endothelium-independent response to sublingual glyceryl trinitrate was not different 
between groups. Studies that have adopted within-subject comparisons before and after 2-6 
month exercise training typically find an increase in brachial artery FMD. This study adds the 
novel knowledge that long-term physical activity in subjects with increased cardiovascular 
risk (i.e. T2DM), is associated with better endothelial function, which may contribute to the 
lower cardiovascular risk in this group. 
Life-long active T2DM patients reported significantly less intake of metformin, ACE-inhibitors, 
diuretics and statins than inactive patients. This suggests that our findings on cardiovascular 
risk and function between life-long active patients and inactive peers cannot explained by 
differences in medication use. Moreover, the established pleiotropic effects of some drugs on 
endothelial function (e.g. statins,29 ACE-inhibitors30 and metformin31), suggests that we may 
have underestimated the impact of a life-long physically active lifestyle on cardiovascular 
risk and function.
Recent studies have introduced and validated the Lifetime Risk Score,24,32 which have 
randomly included >250,000 men and women, who were measured at the ages of 45, 55, 65 
and 75 years. Our groups of type 2 diabetes mellitus patients and the age- and sex-matched 
control groups will likely fall in this larger cohort. However, these previous studies on the 
Lifetime Risk for Cardiovascular disease did not specifically address the question whether the 
risk score is equally valid for subjects with established diabetes mellitus or other metabolic 
or cardiovascular disease.
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Limitations 
A strong aspect of our study is the inclusion of T2DM patients who have complied with a 
life-long active lifestyle. Whilst this represents a unique group, the cross-sectional nature of 
our study represents a limitation. Matching the groups on physical characteristics such as 
age, sex, and BMI between the inactive and life-long active T2DM patients will have reduced 
this influence, however, another possible limitation is that our subjects were already active 
before they were diagnosed with T2DM, suggesting that non-exercise related factors (e.g. diet 
or genes) were more important to the development of T2DM than physical activity. Another 
limitation is that some control subjects reported medication use and/or were overweight, 
which may explain the somewhat lower brachial artery FMD% compared to previous reports in 
comparable, healthy groups from our laboratory.33,34 However, none presented with manifest 
metabolic and/or cardiovascular disease, and is representative for the general population of 
middle-aged subjects. Whilst the inclusion of this group limits the ability to reveal the upper 
limit of the spectrum, our set-up is relevant to examine the impact of a lifelong physically 
active lifestyle in T2DM compared to their inactive peers and healthy age- and sex-matched 
controls. Furthermore, we used HOMA-IR as a measure of insulin resistance, which has the 
limitation of potential overestimation of insulin resistance in subjects on insulin injections. 
However, we included only 2 subjects on insulin, equally divided between groups, who were 
instructed to abstain from insulin on the morning of the test. Also, excluding these subjects 
from analysis did not alter the major outcome of the study.
Finally, a potential limitation is that we did not control for differences in lifestyle factors 
between groups, such as dietary habits. Although the impact of diet on cardiovascular 
function has been described previously, whether a poor dietary habit is characteristic in 
physically inactive T2DM patients remains controversial. Nonetheless, a significant correlation 
is present between maximal oxygen uptake and brachial artery FMD (r=0.351, p=0.045). Whilst 
this could represent an epiphenomenon, the correlation supports the presence of a strong 
link between physical activity levels and vascular health.
In conclusion, life-long physically active T2DM patients have better fitness levels, insulin 
sensitivity, cardiovascular risk and vascular function compared to sedentary peers. More 
importantly, our study revealed that life-long physical activity in T2DM may be able to 
normalize these values to those observed in non-diabetic and non-insulin resistant controls. 
Taken together, this study provides novel evidence that a life-long active lifestyle, even in 
subjects with T2DM, may be able to effectively counteract the increased cardiovascular risk 
and abnormal vascular function and shows the extent of the benefits that can be achieved 
by a physically active lifestyle.
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ABSTRACT
Positive vascular effects of exercise training are mediated by acute increases in blood flow. 
Type 2 diabetes patients show attenuated exercise-induced increases in blood flow, possibly 
mediated by the endothelin-pathway, preventing an optimal stimulus for vascular adaptation. 
We examined the impact of endothelin-receptor-blockade (Bosentan) on exercise-induced 
blood flow in the brachial artery, and on pre- and post-exercise endothelial function in type 
2 diabetes patients (N=9, 60±7 years) and controls (N=10, 60±5 years). Subjects reported 
twice to the laboratory to perform handgrip exercise with endothelin-receptor-blockade 
or placebo. We examined brachial artery endothelial function (via flow mediated dilation) 
before and after exercise, and blood flow during exercise. Endothelin-receptor-blockade 
resulted in a larger increase in blood flow during exercise in type 2 diabetes patients 
(P=0.046), but not in controls (P=0.309). Exercise increased shear rate across the exercise 
protocol, unaffected by endothelin-receptor-blockade. Exercise did not alter brachial artery 
diameter in both groups, but endothelin-receptor-blockade resulted in a larger brachial 
artery diameter in type 2 diabetes patients (P=0.033). Exercise significantly increased brachial 
artery flow mediated dilation in both groups, unaffected by endothelin-receptor-blockade. 
Endothelin-receptor-blockade increased exercise-induced brachial artery blood flow in type 
2 diabetes, but not in controls. Despite this effect of endothelin-receptor-blockade on blood 
flow, we found no impact on baseline or post-exercise endothelial function in type 2 diabetes 
patients or controls, possibly related to normalization of the shear stimulus during exercise. 
The successful increase in blood flow during exercise in type 2 diabetes patients through 
endothelin-receptor-blockade may have beneficial effects in repeated exercise training.
ClinicalTrials.gov identifier: NCT01779596
KEYWORDS: cardiovascular risk; exercise; metabolic disease; shear stress; bosentan
ABBREVIATIONS
BA, Brachial artery; ET, Endothelin; FMD, Flow mediated dilation; MVC, Maximal voluntary 
contraction; SR, Shear rate; T2DM, type 2 diabetes mellitus.
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INTRODUCTION
Type 2 diabetes mellitus is a rapidly growing problem in Western society. Approximately 
4 million deaths worldwide may have been attributable to diabetes in 2010, accounting 
for 6.8% of global mortality. By estimation, 65%-75% of those deaths were related to 
cardiovascular disease.1-5 Physical fitness is inversely correlated with cardiovascular risk in 
diabetes.6,7 Exercise training has proven to be an effective method to improve physical fitness 
and glycaemic control, but it also improves endothelial function and arterial structure and 
plays a central role in the clinical management of diabetes.8-11
The beneficial effects of exercise training on the vasculature largely depend on acute 
exercise-induced changes in blood flow.12 Attenuating the exercise-induced increase in blood 
flow prevents vascular adaptations in healthy subjects.12 Interestingly, a previous study by 
Lalande et al found that type 2 diabetes patients show an attenuated blood flow response 
to exercise compared to healthy controls.13 This diminished blood flow response to exercise 
may prevent an optimal stimulus for arterial adaptation in type 2 diabetes patients.13,14
Endothelin-1 (ET-1) is produced by the endothelium and represents a strong and potent 
vasoconstrictor. Subjects with type 2 diabetes demonstrate elevated levels of ET-1, which 
are positively related with cardiovascular risk.15,16 Moreover, these elevated levels of ET-1 
contribute to an elevated baseline tone and ET–blockade increases capillary blood flow by 
decreasing vascular tone.17-19 To date, no previous study examined whether ET-1 contributes 
to the blood flow response to exercise in type 2 diabetes. Therefore, the primary aim of our 
study was to examine the hypothesis that ET-1 blockade will increase the exercise-induced 
blood flow in men with type 2 diabetes, but not in age-matched healthy controls.
We and others have demonstrated that handgrip exercise immediately improves vascular 
function in healthy volunteers,12,20-23 possibly via an increased blood-flow. Accordingly, an 
increased exercise-induced blood flow response during ET-receptor blockade may lead to 
a larger improvement in vascular function immediately after exercise. Therefore, the second 
aim of our study was to examine the impact of ET-1-receptor blockade on pre-and post-
exercise endothelial function in patients with type 2 diabetes and their age-matched healthy 
peers. We hypothesize that the increased exercise-induced blood flow response during ET-
receptor blockade will result in a superior effect of exercise on post-exercise endothelial 
function in type 2 diabetes.
CHAPTER 3
58
METHODS
We included 9 sedentary men with type 2 diabetes (>2 years since diagnosis, age 60±7 
years) and 10 healthy age-matched healthy controls (60±5 years). We excluded subjects 
with (a history of) cardiovascular disease, smokers, type 1 diabetes mellitus, age <50 or >65, 
and subjects with diabetes-related manifest vascular complications. Because of potential 
interaction with the use of the oral ET-receptor blocker Bosentan, we excluded subjects that 
used glibenclamide, HIV drugs, calcineurin inhibitors or drugs that interfere with CYP3A4 
and CYP2C19. The study procedures were approved by the medical ethical committee of the 
Radboud University Nijmegen Medical Centre and adhered to the Declaration of Helsinki. 
All subjects gave written informed consent before participation in this study. The study is 
registered at ClinicalTrials.gov (NCT01779596).
Experimental design 
In this randomized, double-blind, cross-over trial, all subjects reported twice to the laboratory. 
During both days, subjects performed an incremental handgrip exercise protocol (3-minutes 
at 15, 30, and 45% of maximal voluntary contraction (MVC)), followed by 30-minutes at 15% 
MVC. We used ultrasound to examine brachial artery (BA) endothelial function (using the 
flow-mediated dilation (FMD); before and after the exercise protocol) and BA blood flow 
during handgrip exercise. Testing procedures were kept similar between days, whilst subjects 
ingested dual ETA/B-receptor blocker Bosentan (Tracleer, 125 mg, Actelion Pharmaceuticals) 
or placebo 4 hours before testing (order randomized between subjects). Previous studies 
have demonstrated that infusion of endothelin-1 after systemic administration of Bosentan, 
such as applied in our study, does not lead to changes in vascular tone,24,25 and have clearly 
demonstrated the potency of Bosentan to effectively and selectively block ETA- and ETB-
receptors.26-28 Although previous studies have demonstrated an important role for an 
upregulation of ETA-receptors to explain the increased contribution of endothelin-1 to 
vascular tone in type 2 diabetes,19,29,30 the role of the ETB-receptors is less clear.
31 To truly 
understand the role of endothelin-1 in exercise-mediated blood flow responses, we used a 
dual ETA/B-receptor blocker.
Measurements 
All subjects refrained from alcohol, caffeine, chocolate, and vitamin C for at least 18 hours, 
and vigorous physical exercise for at least 24 hours prior to testing. Also, subjects did not eat 
in the 6 hours prior to the ultrasound measurements. Testing was performed at the same 
time of day. Ultrasound assessments were conducted in a quiet, temperature controlled 
environment (22-24°).32 A venous blood sample was taken for assessment of fasting glucose, 
HbA1c, total cholesterol, HDL, LDL, and triglycerides. 
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Maximum voluntary contraction (MVC) 
Upon arrival during the first visit, we assessed maximum voluntary contraction (MVC) using 
a handheld dynamometer. Subjects performed three 2-second maximal contraction trials, 
separated by 5 minutes of rest. Contraction force was recorded via a customized system 
(MIDAC, Instrumentation Department, Radboud University Nijmegen Medical Centre). MVC 
was calculated as the mean force achieved during the second and third trial.
Brachial artery flow-mediated dilation (FMD) 
Measurement of BA endothelial function (via the FMD) was performed by an experienced 
vascular sonographer. A 10 MHz multifrequency linear array probe attached to a high 
resolution ultrasound machine (T3000; Terason, Burlington, MA, USA) was used to image 
the BA in the distal one-third of the upper arm. When an optimal image was obtained, the 
probe was held stable and the ultrasound parameters were set to optimize the longitudinal, 
B-mode images of lumen–arterial wall interface. For assessment of the pre-exercise FMD, 
subjects rested in the supine position for a period of at least 15 minutes to facilitate baseline 
assessment of BA diameter and blood flow. To examine BA FMD, the arm was extended 
and positioned at an angle of ∼80 degrees from the torso. A rapid inflation and deflation 
pneumatic cuff was positioned on the forearm of the imaged arm immediately distal to the 
olecranon process to provide a stimulus of forearm ischaemia.  Continuous Doppler velocity 
assessment was obtained using the lowest possible insonation angle (always <60 degrees), 
which did not vary during each measurement. The forearm cuff was inflated to 220 mmHg 
for 5 minutes. Brachial artery diameter and flow recordings resumed 30 seconds prior to cuff 
deflation and continued for 3 minutes thereafter. Assessment of BA FMD was repeated after 
the exercise bout and started within 2 minutes of cessation of exercise. Time to peak was 
calculated from the point of cuff deflation to the maximum postdeflation brachial artery 
diameter. Calculation of FMD and time to peak were therefore observer-independent and 
based on standardized algorithms applied to data which had undergone automated edge-
detection and wall-tracking.
Dynamic Handgrip Exercise protocol 
After assessment of the pre-exercise FMD, subjects rested in the supine position for another 
period of 20 minutes to facilitate BA blood flow and diameter to return to baseline levels. 
Subjects performed a metronome-assisted dynamic handgrip exercise protocol (frequency 
of 0.5 Hz; 1 second active, 1 second relaxation). First, subjects performed 3 minutes bouts of 
handgrip exercise at 15, 30 and 45% MVC, with a 5 minute rest period after each exercise bout. 
Subsequently, subjects performed a 30-minute period of continuous handgrip exercise at 
15% MVC. 
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Brachial artery blood flow, shear, and diameter
Using a high resolution ultrasound machine (T3000; Terason, Burlington, MA, USA), we 
examined BA diameter and red blood cell velocity (to calculate blood flow and shear 
rate) before and during handgrip exercise. First, we examined baseline blood flow during 
a 1 minute period immediately before the incremental and continuous handgrip exercise. 
During the incremental part (15, 30 and 45%), we recorded BA diameter and velocity during 
the last minute of each exercise bout. During the continuous part at 15% MVC, we recorded 
data during the last minute of each 10-minute epoch.
Data analysis 
Post-test analysis of BA diameter and velocity was performed using custom-designed edge-
detection and wall-tracking software, which is independent of investigator bias 33. Briefly, the 
echo-Doppler signal was real-time encoded and stored as a digital file. Subsequent software 
analysis of these data was performed at 30 Hz using an icon-based graphic programming 
language and toolkit (LabView 6.02; National Instruments, Austin, TX). The program allows 
users to identify a region of interest on the clearest portion of the vascular wall. It then 
identifies, via the intensity of the brightness of the walls versus the lumen of the vessel, the 
walls of the artery. B-mode images were viewed, and regions of interest were selected for 
BA diameter and blood velocity. From this synchronized diameter and velocity data, blood 
flow (the product of lumen cross-sectional area and Doppler velocity) was calculated at 30 
Hz. Baseline BA diameter, flow and shear rate were calculated as the mean of data acquired 
across the 1 minute preceding the cuff inflation period. FMD was calculated using the baseline 
and peak BA diameter following cuff deflation. Peak BA diameter was automatically detected 
according to an algorithm which identified the maximum bracket of data subsequent to 
performance of a moving window smoothing function. This smoothing routine calculates 
the median value from 100 consecutive samples, before the window shifts to the next bracket 
of data, which shares 20% overlap with the preceding bracket. The maximum value of all the 
calculated median values is then automatically detected and chosen to represent the peak 
of the post-deflation BA diameter curve. FMD was calculated as the percentage rise of this 
peak BA diameter from the preceding baseline BA diameter. Reproducibility of BA diameter 
measurements using this semi-automated software is significantly better than manual 
methods, reduces observer error significantly, and possesses an intra-observer coefficient 
of variance of 6.7%.33
Statistical analysis 
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago (Illinois), USA) software. 
All data are reported as mean ± SD unless stated otherwise, and statistical significance was 
assumed at P<0.05. A paired or unpaired Student’s t-test was used to compare baseline values 
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between both testing days within groups or between type 2 diabetes patients and controls, 
respectively. A three-way repeated measures ANOVA was used to examine whether changes 
in BA blood flow, diameter and shear rate changes across the exercise protocol (main effect 
for ‘exercise’: rest, 15%, 30%, 45%, rest, 10-min 15%, 20-min 15%, 30-min 15%), and whether 
these changes depend on group (type 2 diabetes versus controls) or ET-receptor blockade 
(ET-receptor block versus placebo). Since the incremental and continuous exercise protocols 
were performed in a single session, all data points were combined to minimise the number 
of statistical testing and to provide a direct answer to our main research question. When a 
significant main- or interaction-effect was found, post-hoc comparisons were performed to 
identify differences across the exercise protocol, between groups and/or with/without ET-
receptor blockade using two-way ANOVA and t-tests. A similar comparison was performed 
for FMD, although this measure was only taken before and after exercise. Based on a power 
of 80%, and a standard deviation of 503 mL/min in the T2DM group and 467 mL/min in the 
controls for the difference in blood flow AUC between placebo and Bosentan, our sample 
sizes allow us to detect a change of 418 mL/min and 368 mL/min, respectively. Between 
groups, we are able to detect a difference of 633 mL/min under placebo conditions.
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RESULTS
 We found no significant differences between type 2 diabetes patients and their age-matched 
healthy controls in maximal voluntary contraction, diastolic blood pressure, total cholesterol 
and lipid profile (Table 1). Subjects with type 2 diabetes demonstrated a significantly higher 
weight, BMI, systolic blood pressure, glucose and HbA1c levels (Table 1). Under resting 
conditions, we found no differences between groups in BA diameter and blood flow (P=0.791 
and 0.301, respectively).
Table 1 
Schreuder	  et	  al.	  	   	  	  	  	  	  	  	  	  Diabetes,	  endothelin	  and	  blood	  flow	  during	  exercise	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1	  
 
 Type 2 
diabetes 
Control P-value  
Age (yrs) 60±7 60±5 0.942 
Height (cm) 181±6 180±9 0.695 
Weight (kg) 100±12 86±7 0.008 
Body mass index (kg/m2) 30±2 27±2 0.007 
Maximal Voluntary Contraction (N) 53±9 56±17 0.713 
Systolic blood pressure (mmHg) 136±14 124±8 0.027 
Diastolic blood pressure (mmHg) 77±10 76±5 0.746 
Glucose (mmol/L)  7.6±1.6 4.8±0.4 <0.001 
NGSP HbA1c (%) 8.1±0.8 5.5±0.3 <0.001 
IFCC HbA1c (mmol/mol) 64.7±8.1 36.2±2.9 <0.001 
Cholesterol (mmol/L) 4.7±1.6 5.0±1.5 0.608 
High-density lipoprotein (mmol/L) 1.0±0.2 1.4±0.7 0.117 
Low-density lipoprotein (mmol/L) 3.0±1.3 3.4±1.1 0.429 
Triglycerides (mmol/L) 1.7±0.7 1.4±0.8 0.366 
 
 
 
Body characteristics in patients with type 2 diabetes mellitus and their healthy age- and sex-matched peers. Data is 
presented as mean ± SD. P-value represent independent student’s T-tests.
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Exercise-induced brachial artery blood flow, shear and diameter: ET-receptor 
blockade versus placebo
Blood flow. In type 2 diabetes patients and healthy controls, exercise resulted in a significant 
increase in BA blood flow (Figure 1). The 3-way ANOVA revealed a significant interaction 
for ET-receptor blocker*group (Table 2). Subsequent analysis showed that ET-receptor 
blockade resulted in an increase in BA blood flow in type 2 diabetes patients (P=0.046, Figure 
1B), whilst ET-receptor blockade did not alter BA blood flow in healthy controls (P=0.309, 
Figure 1A). Moreover, we found a strong trend that the impact of ET-receptor blockade on 
the exercise-induced increase in blood flow was different between groups (ET-receptor 
blockade*Exercise*Group-interaction P=0.054). 
Shear rate. In type 2 diabetes patients and healthy controls, exercise resulted in a significant 
increase in BA shear rate across the exercise protocol (Figure 2). We found no significant 
impact of ET-receptor blockade or group on the exercise-induced increase in shear (Table 2).
BA diameter. In type 2 diabetes patients and healthy controls, exercise did not alter BA 
diameter (Table 2). The 3-way ANOVA revealed a significant interaction for ET-receptor 
blocker*group (P=0.002). Subsequent analysis showed that ET-receptor resulted in an 
increase in BA diameter in type 2 diabetes patients (P=0.033), whilst a significantly smaller 
BA diameter was present in healthy controls during ET-receptor blockade (P=0.028, Table 2).
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Figure 1 
Brachial artery blood flow (mL/min) before (rest) and during incremental (15, 30, 45%) and continuous handgrip 
exercise (10, 20 and 30 min) in healthy controls (A, n=10) and age-matched type 2 diabetes mellitus patients (B, n=9) 
under ET-receptor blockade (black bars) or placebo (white bars). Error bars represent SE. Data for the 2-way ANOVA 
(main effects for ‘exercise’, ‘ET-block’ and ‘exercise*ET-block’) are provided for both groups. * = post-hoc significant 
difference between interventions at p<0.05.
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Figure 2
Brachial artery shear rate (s-1) before (rest) and during incremental (15, 30, 45%) and continuous handgrip exercise 
(10, 20 and 30 min) in healthy controls (A, n=10) and age-matched type 2 diabetes mellitus patients (B, n=9) under 
ET-receptor blockade (black bars) or placebo (white bars). Error bars represent SE. Data for the 2-way ANOVA (main 
effects for ‘exercise’, ‘ET-block’ and ‘exercise*ET-block’) are provided for both groups.
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Exercise and flow-mediated dilation: ET-receptor blockade versus placebo
At baseline, we found no significant differences in BA FMD% on consecutive testing days for 
type 2 diabetes patients and controls (P=0.610 and 0.365, respectively). Handgrip exercise 
resulted in a significant increase in BA FMD (Figure 3). The magnitude of increase in BA FMD% 
was not different between groups or after ET-receptor blockade (Figure 3). BA FMD (mm) 
significantly increased after exercise, independent of group and ET-receptor blockade (Table 
3). We found no impact of exercise, group or ET-receptor blockade on the shear rate area-
under-the-curve (Table 3).
Correlations: Exercise induced shear rate versus flow-mediated dilation
We found a significant correlation between exercise-induced BA shear rate (area-under-the-
curve during the handgrip exercise bout, corrected for baseline area-under-the-curve) and 
exercise-induced change in BA flow-mediated dilation (%) in the healthy controls (placebo: 
r=0.794, p=0.011; ET-blockade: r=0.763, p=0.010, figure 4), but not in type 2 diabetes patients 
(placebo: r=0.253, p=0.511; ET-blockade: r=0.113, p=0.772, figure 4).
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Figure 3 
Brachial artery flow-mediated dilation (%) before (pre-exercise) and after handgrip exercise (post-exercise) in 
healthy controls (A, n=10) and age-matched type 2 diabetes mellitus patients (B, n=9) under ET-receptor blockade 
(black bars) or placebo (white bars). Error bars represent SE.
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Table 3 
Schreuder	  et	  al.	  	   	  	  	  	  	  	  	  	  Diabetes,	  endothelin	  and	  blood	  flow	  during	  exercise	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   3	  
 
 Pre-
exercise 
Post-
exercise 
3-way ANOVA  
FMD (mm)   ET-block P=0.439 
   ET-block*Group P=0.581 
Control – placebo 0.21±0.10 0.31±0.12 Exercise P<0.001 
Control – ET-block 0.25±0.08 0.34±0.12 Exercise*Group P=0.265 
Diabetes - placebo 0.17±0.05 0.26±0.08 ET-block*Exercise P=0.467 
Diabetes – ET-block 0.20±0.12 0.25±0.09 ET-block*Exercise*Group P=0.684 
SRAUC (s, 103)   ET-block P=0.471 
   ET-block*Group P=0.944 
Control – placebo 14.1±6.5 18.6±7.8 Exercise P=0.044 
Control – ET-block 16.4±9.2 18.8±8.1 Exercise*Group P=0.943 
Diabetes - placebo 14.4±4.1 18.1±6.6 ET-block*Exercise P=0.709 
Diabetes – ET-block 15.5±7.9 19.0±8.9 ET-block*Exercise*Group P=0.762 
Brachial artery flow-mediated dilation (in mm) and shear rate area-under-the-curve (SRAUC) before and after 
handgrip exercise in patients with type 2 diabetes mellitus and their healthy age-matched controls under ET-
receptor blockade (ET-block) and placebo. Data is presented as mean ± SD. 
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Figure 4
Correlation between exercise-induced brachial artery shear rate (area-under-the-curve during the handgrip exercise 
bout) and exercise-induced change in brachial artery flow-mediated dilation (%) in healthy controls (solid circles, 
n=10) and age-matched type 2 diabetes mellitus patients (open circles, n=9) under ET-blockade (A) and placebo (B). 
Solid black and dotted lines represent the correlation for healthy controls and type 2 diabetes mellitus, respectively.
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DISCUSSION
The primary purpose of our study was to examine the hypothesis that ET-receptor blockade 
increases exercise-induced blood flow in men with type 2 diabetes and, subsequently, 
improves the post-exercise endothelial function. Here we present the following findings. First, 
we found that handgrip exercise significantly increased BA blood flow and, consequently, 
elevates post-exercise endothelial function in type 2 diabetes patients and their age-
matched healthy peers. Secondly, ET-receptor blockade resulted in a significantly larger 
exercise-induced increase in BA blood flow in type 2 diabetes patients, but not in healthy 
controls.  This suggests that in type 2 diabetes patients, but not in controls, ET-1 attenuates 
the blood flow response to handgrip exercise. Nonetheless, ET-receptor blockade did not 
alter the baseline levels or post-exercise increases in BA endothelial function in both groups. 
In contrast to a previous study, we did not find a priori differences in exercise-induced blood 
flow between type 2 diabetes patients and healthy controls. A potential explanation for this 
finding may relate to differences in forearm lean muscle mass between our groups. Lalande 
et al. showed a lower exercise-induced femoral artery blood flow in type 2 diabetes patients 
when indexed to thigh lean mass.13 Although we did not measure (forearm) lean body mass, 
type 2 diabetes patients in our study have a higher weight than controls, which may also 
impact forearm lean mass.  Differences in forearm mass between our groups may contribute 
to the lack of differences in exercise-induced blood flow in our study. Furthermore, differences 
between limbs (upper versus lower limbs), type of exercise (handgrip versus lower limb 
exercise) and intensity (matched for absolute workload versus relative workload) may explain 
the different findings between our data and those of Lalande and colleagues. Nonetheless, 
our data shows that exercise leads to an exercise-intensity dependent increase in blood flow 
in both type 2 diabetes patients and controls, which reinforces previous findings examining 
blood flow during exercise.13,34,35
An important and novel finding of our study is that ET-receptor blockade increased blood 
flow in type 2 diabetes patients, but not in controls. We recently found that changes in blood 
flow during hand grip exercise is related to baseline FMD.36 However, ET-receptor blockade 
did not alter resting endothelial function in both groups. Therefore, the increase in blood 
flow we have seen during exercise in type 2 diabetes patients is likely related to a direct 
effect of ET-receptor blockade on blood flow regulation rather than a change in endothelial 
function per se. A previous study has shown that in healthy humans, vascular ET-receptors are 
highly sensitive to metabolic inhibition, decreasing the role of ET in blood flow regulation as 
exercise intensity increases.37 It is possible that this inhibition is attenuated in type 2 diabetes 
patients, indicating that ET plays a larger role during exercise than during resting conditions 
in type 2 diabetes patients. Taken together, our data indicates that ET contributes to blood 
flow during exercise in type 2 diabetes patients, but not controls, as blocking the ET-pathway 
enhances blood flow responses in this group.
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Previous studies have found that the exercise-induced blood flow increase, and associated 
shear rate increase, is related to immediate improvements in FMD after exercise.20-23 Indeed, 
a previous study found that blocking the exercise-induced increase in blood flow and shear 
rate prevents a change in FMD.38 Also in our study, we found that the increase in blood flow 
during exercise was associated with an increase in FMD (Figure 4). Interestingly, the correlation 
between the exercise-induced increase in shear rate with the improvement in FMD observed 
in controls was absent in type 2 diabetes patients. This suggests that, although a priori 
endothelial function was similar between groups, the immediate adaptive response of the 
endothelium in type 2 diabetes patients after elevations in shear rate is diminished. This may 
have potential clinical consequences for vascular adaptations in type 2 diabetes patients 
during periods of exercise training.
The absence of an impact of ET-receptor blockade on the post-exercise FMD in type 2 
diabetes patients as well as in controls may relate to the shear stimulus during exercise; i.e. 
an important stimulus for increasing endothelial function after acute exercise.38 Indeed, we 
found a strong relation between the exercise-induced increase in shear rate levels and the 
improvement in post-exercise FMD. Although ET-receptor blockade significantly increased 
exercise induced blood flow in type 2 diabetes patients, we also demonstrated an increase in 
vessel BA diameter, consequently leading to a preserved shear rate level. This is in line with 
previous studies in animals39 and humans,40 which suggest that (changes in) BA diameter 
are mediated by an attempt to normalize shear stress levels. The preserved exercise-
induced shear stress may explain the lack of change in post-exercise FMD with ET-receptor 
blockade. Furthermore, we found that ET-receptor blockade led to a decrease in BA diameter 
in controls, despite the lack of a change in blood flow or shear rate in this group. Subjects 
were blinded, as well as the sonographer who collected and analysed the data. Therefore, 
we believe that the decrease in BA diameter in controls after ET-receptor blockade is not 
due to any bias in the analysis. Possibly, this finding is related to differences between the 
groups in selectivity of our ET-blocker for the ETA/B-receptor. Possibly, the ETB receptor, 
which mediates vasodilation, is predominantly present in the healthy controls, leading to 
a constriction during ET-receptor blockade. Taken together, our data indicate that the shear 
rate stimulus during exercise was not altered by ET-receptor blockade. This may explain why 
ET-receptor blockade did not alter the exercise-induced change in FMD.
Limitations
Strong points of our study include the randomized, double-blind cross-over design, within 
subject comparisons, the use of semi-automated software, the use of an exercise intensity 
relative to the individual subjects maximal voluntary force, and a meticulously controlled 
exercise protocol. Some limitations need to be addressed. First, we used a dual ET-blocker, 
which prevented us from examining the effect of the individual ETA/B-receptors. Our study, 
however, was designed to assess the role of ET, and not of the individual receptors. Second, 
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a potential limitation is that our group of type 2 diabetes patients demonstrated a larger 
BMI and higher glucose levels. A previous study found that obesity is associated with an 
increased contribution of ET-1 to baseline vascular tone.41 Therefore, we cannot exclude the 
possibility that the presence of overweight or obesity contributes to our findings. Similarly, 
we hyperglycaemia may have also influenced our results. However, the larger BMI as well as 
higher blood glucose levels are typically found in patients with type 2 diabetes. Therefore our 
study population accurately describes the clinical population of type 2 diabetes patients, 
which contributes to the extrapolation of our results to the general population of type 
2 diabetes patients. Another limitation is that we did not measure pre- and post-exercise 
plasma endothelin levels as differences in exercise-induced endothelin-1 release between 
diabetes and controls may contribute to the differences in exercise-induced blood flow 
between both groups. A final limitation relates to the relatively small number of participants. 
Therefore, cannot exclude the possibility of the occurrence of type II errors in our study. For 
example, we found a non-significant, lower exercise-induced blood flow in the Bosentan-
treated control group. Although the direction of the effect contrasts with previous studies,37 
the effect size is comparable to the effect observed in type 2 diabetes patients. Nonetheless, 
we cannot exclude the possibility of a type II error and may be related to the relatively small 
number of participants. 
In conclusion, we found that ET-receptor blockade effectively increases BA blood flow 
response to handgrip exercise in type 2 diabetes patients, but not in controls. Despite this 
effect of ET-receptor blockade on BA blood flow, we found no impact of ET-receptor blockade 
on baseline or post-exercise endothelial function in type 2 diabetes patients or healthy 
controls, which is possibly related to normalization of the shear stimulus during exercise via 
an increased BA diameter. The successful increase in BA blood flow (i.e. nutrient flow) during 
exercise in type 2 diabetes patients by ET-receptor blockade may have potential beneficial 
effects on vascular adaptations during repeated exposure to exercise training. However, this 
remains to be elucidated and should be subject of future research.
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ABSTRACT
In type 2 diabetes patients, endothelin(ET)-receptor-blockade may enhance blood flow 
responses to exercise training. The combination of exercise training and ET-receptor-
blockade may represent a more potent stimulus to improve vascular function, physical 
fitness, and glucose homeostasis. We assessed the effect of an 8-week exercise training 
program combined with either ET-blockade or placebo on vasculature, fitness and glucose 
homeostasis in people with type 2 diabetes. In a double blind randomized controlled trial, 
brachial endothelium-dependent and –independent dilation (using flow-mediated dilation 
(FMD) and glyceryl trinitrate (GTN), respectively), glucose homeostasis (using HOMA-IR), 
and physical fitness (maximal cycling test) were assessed in 18 men with type 2 diabetes 
(60±6 years). Subjects underwent an 8-week exercise training program with half of the 
subjects receiving ET-receptor-blockade (Bosentan) and the other half a placebo, followed 
by reassessment of the tests above. Exercise training improved physical fitness to a similar 
extent in both groups, but we did not detect changes in vascular function in either group. 
This study suggests no adaptation in brachial and femoral artery endothelial function after 
8 weeks of training in type 2 diabetes patients. ET-blockade combined with exercise training 
does not additionally alter conduit artery endothelial function or physical fitness in type 2 
diabetes.
ClinicalTrials.gov identifier: NCT01779609
KEYWORDS: cardiovascular risk; exercise training; metabolic disease; shear stress; bosentan
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INTRODUCTION
Type 2 diabetes mellitus is a rapidly growing problem in Western society. Cardiovascular 
disease and vascular complications represent the leading cause of morbidity and mortality 
in type 2 diabetes. Previous studies found an impaired endothelial function in patients with 
type 2 diabetes,1-3 which is believed to contribute to the pathogenesis of cardiovascular 
disease in type 2 diabetes patients.4,5 Exercise training represents an effective strategy to 
improve endothelial function in conduit and resistance vessels and, consequently, reduce 
the risk of cardiovascular disease in symptomatic and asymptomatic subjects (see reviews).6,7
Previous studies in animals8,9 and humans10 demonstrated that repeated elevation in blood 
flow, and consequently shear stress,11 is a key stimulus for vessels to adapt in function and 
structure.12 More specifically, recent studies demonstrated that the beneficial effects of 
exercise training on the vasculature largely depend on acute exercise-induced elevations 
in blood flow.12-16 A previous study found that type 2 diabetes patients show an attenuated 
blood flow response to exercise compared to healthy controls.17 This diminished blood flow 
and shear stress response to exercise may prevent an optimal stimulus for adaptation of the 
vasculature in type 2 diabetes,17,18 and may even contribute to microvascular complications.19 
Therefore, exercise training combined with pharmacological up- or downregulation of 
vasoactive substances may potentially lead to superior effects on the vasculature than 
exercise training alone.20
We recently demonstrated that systemic ET-1 blockade leads to an increased exercise-
induced blood flow response during handgrip exercise in type 2 diabetes, but not in healthy 
controls.21 Accordingly, exercise training combined with an ET-antagonist in type 2 diabetes 
patients may enhance the blood flow response and thereby the impact of exercise training 
on the vasculature and physical fitness. An increased blood flow has been demonstrated 
to represent a stimulus to upregulate glucose homeostasis, possibly via potentiation of 
insulin-driven capillary recruitment.22-25 Therefore, the purpose of this study was to perform a 
randomised controlled trial (RCT) to assess the effect of an 8-week exercise-training program 
with either ET-blockade or a placebo on the vasculature, fitness and glucose homeostasis in 
patients with type 2 diabetes.
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METHODS
Subjects
18 men (60±6 years) who were diagnosed with type 2 diabetes for at least two years were 
recruited from the general population through advertisements for our double blind 
randomized controlled trial (RCT; ClinicalTrials.gov identifier: NCT01779609). Exclusion 
criteria included overt cardiovascular disease, smoking, type I diabetes mellitus, age 
<40 or >65, diabetes-related manifest vascular complications, increased levels of liver 
aminotransferases (ASAT >120 U/L ALAT >135 U/L), glibenclamide use, use of calcineurin 
inhibitors, use of HIV-drugs due to a possible interference with Bosentan, and use of drugs 
that interfere with CYP3A4, CYP2C9, CYP3A4 and/or CYP2C9. The study procedures were 
approved by the medical ethical committee of the Radboud University Nijmegen Medical 
Centre and adhered to the Declaration of Helsinki. All subjects gave written informed consent 
before participation in this study. During this study, no adverse events occurred in the study 
population.
Experimental design
Patients reported to the laboratory for initial assessment of brachial artery function and 
structure, glucose homeostasis, and physical fitness. Subsequently, all subjects underwent 
an 8-week exercise-training program. In a randomized, double-blind manner, subjects 
combined exercise training with either a dual ET-blocker (EX+ET-blocker) or a placebo 
(EX+placebo) for 8 weeks. Ingestion of the dual ET-blocker (Tracleer, Actelion Pharmaceuticals) 
during the first 4 weeks represented 62.5 mg twice per day, followed by four weeks of 125 mg 
twice daily. This dosage has been used in previous studies and has proven to be effective 
and well tolerated.26 The other group used a placebo that had the same size, weight, taste, 
and colour as the dual ET-blocker and was also taken twice daily. Subjects and researchers 
were blinded for the ingestion of placebo or the ET-blocker. Randomization was executed 
by the Radboud University Nijmegen Medical Centre pharmacy, who provided sequentially 
numbered containers. Immediately after the 8-week intervention, within seven days of the 
last exercise bout, we repeated all tests as listed above.
Measurements: physical fitness and subject characteristics
Subject characteristics. During a screening procedure at the first visit all subjects completed 
a questionnaire concerning their medical history and medication use. We measured 
height, weight, resting blood pressure after a 5-minute seated rest using a manual 
sphygmomanometer. A venous blood sample was taken for assessment of fasting glucose, 
insulin, total cholesterol, HDL, LDL, triglycerides, ASAT and ALAT. From the glucose and insulin 
levels we calculated the HOMA-IR index as a valid measure of insulin resistance.27
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Physical fitness. On a subsequent day, subjects performed an incremental cycle exercise 
test to examine maximal workload and peak oxygen consumption. Also, data from this test 
were used to determine maximal heart rate, which was used to calculate work-load during 
exercise training. Each subject performed an incremental maximal exercise test on a cycling 
ergometer (Lode, Excalibur, Groningen, the Netherlands) before and after the training 
program. These tests started at a power output of 10 W for 1 min and power output increased 
by 10 W/min until exhaustion. Subjects were instructed to maintain a cadence of between 60 
and 80 rpm during the test. We continuously recorded oxygen consumption (VO2, in ml O2/
kg per min), ventilation (Ve, in l/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) 
and heart rate (HR, in bpm). Furthermore, we measured blood lactate levels (mmol/l) using 
Accutrend® Lactate (Roche Diagnostics GmbH, type 3012522, Mannheim, Germany) before 
and 2 min after finishing the maximal exercise test.
Measurements: vascular function
All subjects refrained from alcohol, caffeine, and vigorous physical exercise for at least 
24 hours prior to testing, and were fasted for at least 6 hours. All tests were performed in 
laboratory conditions with constant temperature (20°C) and humidity (35%). We performed 
all tests between 8 AM and 4 PM, but to control for variation in FMD pre- and post exercise 
training measurements for each subject were performed at the same time of day to prevent 
diurnal variation in the FMD response.28
Brachial artery endothelium-dependent dilation. Measurement of brachial artery 
endothelium-dependent dilation (using flow-mediated dilation (FMD)) was performed by 
an experienced vascular sonographer. A 10 MHz multifrequency linear array probe attached 
to a high resolution ultrasound machine (T3000; Terason, Burlington, MA, USA) was used to 
image the brachial artery in the distal one-third of the upper arm. When an optimal image 
was obtained, the probe was held stable and the ultrasound parameters were set to optimize 
the longitudinal, B-mode images of lumen–arterial wall interface.
For assessment of the pre-exercise FMD, subjects rested in the supine position for a period 
of at least 15 minutes to facilitate baseline assessment of artery diameter and blood flow. 
To examine brachial artery FMD, the arm was extended and positioned at an angle of ~80 
degrees from the torso. A rapid inflation and deflation pneumatic cuff was positioned on 
the forearm of the imaged arm immediately distal to the olecranon process to provide 
a stimulus of forearm ischaemia.  Continuous Doppler velocity assessment was obtained 
using the lowest possible insonation angle (always <60 degrees), which did not vary during 
each measurement. The forearm cuff was inflated to 220 mmHg for 5 min. Diameter and 
flow recordings resumed 30 s prior to cuff deflation and continued for 3 min thereafter. 
Assessment of brachial artery FMD was repeated after the exercise bout and started within 2 
min of cessation of exercise. Time to peak was calculated from the point of cuff deflation to 
the maximum postdeflation diameter. Calculation of FMD and time to peak were therefore 
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observer-independent and based on standardized algorithms applied to data, which had 
undergone automated edge-detection and wall-tracking.
Brachial artery endothelium-independent dilation. Following a rest period of at least 
15 minutes to allow brachial artery diameter and flow to return to baseline levels, a 
1-min baseline recording of diameter and flow was taken. Subsequently, brachial artery 
endothelium-independent vasodilation was examined after administration of a single spray 
of sublingual GTN (400 µg), an NO donor. This was followed by 10 min continuous recording 
of brachial artery diameter and blood flow.
Brachial artery peak blood flow. After a >15-min rest period, a 1 min baseline recording 
of brachial artery diameter and blood flow was performed. Next, brachial artery dilation 
was examined after a 5-min period of ischemia, consisting of 1 min ischemia, followed by 
3-min isotonic handgrip exercise and a final 1 min of ischemia. Handgrip exercise involved 
1 contraction every 2 s of a 3-kg load. Peak blood flow was defined as the blood flow area 
under the curve of the highest 10s window after cuff deflation. The peak hyperemic forearm 
blood flow in response to this stimulus in humans provides a valid and accepted index of 
resistance artery size or remodeling.29 We resumed diameter and flow recordings 30 s prior to 
cuff deflation and continued for 3 min thereafter.
Superficial femoral artery endothelium-dependent dilation. After measurement of the 
brachial artery, we continued with measurements of the superficial femoral artery. The 
Terason ultrasound equipment was used to measure femoral artery diameter and flow. 
The cuff was placed at the thigh of the imaged leg, directly above the knee. Measurement 
of superficial femoral artery endothelium-dependent function was performed as described 
above for the brachial artery. Measurements continued for 5 minutes after cuff deflation. A 
previous study found that this procedure results in a largely NO-mediated, endothelium-
dependent dilation of the superficial femoral artery.30
Exercise training
Exercise training was performed over an 8-week training period with subjects visiting our 
facility 3 times a week. Each exercise session was supervised by a well-trained researcher and 
consisted of a 5-minute warming-up, followed by a circuit of resistance exercises (leg press, 
calf raise, leg curl, leg extension, lower back, abdominal crunch, 3 series of 12 repetitions each, 
with 1 minute of rest between sets within each exercise) interspersed with aerobic activities 
(e.g. cycling, running).31,32 The total protocol was as follows: 5 minutes warming-up (cycling), 
5 minutes of cycling, leg curl, leg extension, 5 minutes of running, lower back, abdominal 
crunch, 5 minutes of cycling, leg press, calf raise, 5 minutes of running. The total duration 
of a training session was approximately 60 minutes. A heart rate monitor (Polar Electro Oy, 
Kempele, Finland) was used to continuously monitor heart rate during the aerobic exercise 
and heart rate was maintained at 70-75% of heart rate reserve. The intensity level for each 
of the resistance exercises was set at a level which enables the participant to complete the 
three series of 12 repetitions. Intensity was increased each week under the guidance of the 
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trainers. If a participant missed a supervised exercise session, an extra session was planned 
in the same or following week, so that each participant performed a total of 24 supervised 
sessions (100% compliance).
Data Analysis
Post-test analysis of brachial artery diameter and velocity was performed using custom-
designed edge-detection and wall-tracking software, which is independent of investigator 
bias 33. Briefly, the echo-Doppler signal was real-time encoded and stored as a digital file. 
Subsequent software analysis of these data was performed at 30 Hz using an icon-based 
graphic programming language and toolkit (LabView 6.02; National Instruments, Austin, 
TX). The program allows users to identify a region of interest on the clearest portion of the 
vascular wall. It then identifies, via the intensity of the brightness of the walls versus the 
lumen of the vessel, the walls of the artery. B-mode image were viewed, and regions of 
interest were selected for diameter and blood velocity. From this synchronized diameter and 
velocity data, blood flow (the product of lumen cross-sectional area and Doppler velocity) 
was calculated at 30 Hz. Baseline diameter, flow, and shear rate were calculated as the mean 
of data acquired across the 1 minute preceding the cuff inflation period.
FMD was calculated using the baseline and peak diameter following cuff deflation. Peak 
diameter was automatically detected according to an algorithm, which identified the 
maximum bracket of data subsequent to performance of a moving window smoothing 
function. This smoothing routine calculates the median value from 100 consecutive 
samples, before the window shifts to the next bracket of data, which shares 20% overlap 
with the preceding bracket. The maximum value of all the calculated median values is 
then automatically detected and chosen to represent the peak of the post-deflation artery 
diameter curve. FMD was calculated as the percentage rise of this peak diameter from the 
preceding baseline diameter. We have shown that reproducibility of diameter measurements 
using this semi-automated software is significantly better than manual methods, reduces 
observer error significantly, and possesses an intra-observer coefficient of variance of 6.7%.33 
Analysis of the conduit artery dilator capacity and glyceryl trinitrate measurements was 
performed using the same methods. Shear rate is represented as shear rate area-under-the-
curve between the moment the cuff is released and the end of the FMD measurement (3 min 
for brachial, 5 min for superficial femoral artery).
Statistical analysis
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago (Illinois), USA) software. 
According to Woodman et al. our sample size is sufficient to detect clinically relevant 
differences in our primary outcome measures.33 All data are reported as mean (SD) unless 
stated otherwise, and statistical significance was set a priori at P≤0.05. Unpaired Student’s 
t-tests were used to compare baseline values between groups. A two-way repeated measures 
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ANOVA was used to examine changes in physical fitness, glucose homeostasis and vascular 
function/structure across the exercise-training period (‘training’; 0 versus 8 weeks), and 
whether the magnitude of exercise training mediated adaptations differ between groups 
(‘group’; EX+ET-blockade versus EX+placebo). When a significant main- or interaction-
effect was found, post-hoc comparisons were performed to identify differences with/
without ET-receptor blockade. Post-hoc analysis was performed using the least significant 
difference (LSD) method for pair-wise multiple comparisons when a significant main effect 
was observed.34 According to a recent study by Atkinson et al., inadequate scaling for FMD 
would be present if the upper confidence limit of the regression slope of the relationship 
between logarithmically transformed base diameter and peak diameter is less than one.35 
In such an event, FMD% is not an appropriate measure to estimate endothelial function. We 
checked our data for this phenomenon, and where appropriate we performed the allometric 
modelling solution proposed by Atkinson et al.35
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RESULTS 
Baseline characteristics
Prior to the 8-week intervention, we found no significant differences between EX+ET-blockade 
(N=8) and EX+placebo (N=10) for height, weight, BMI, blood pressure, total cholesterol, lipid 
profile, and plasma-Endothelin-1 (all comparisons P>0.05, Table 1). The 8-week exercise 
training intervention did not alter these parameters in EX+ET-blockade nor in EX+placebo, 
except for a significant decrease in triglycerides in both groups (Table 1).
Table 1Table 1. Body characteristics in patients with type 2 diabetes mellitus that used bosentan (EX+ET), and patients with type 2 diabetes mellitus that used 
placebo (EX+placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
EX+ET-blockade 
N=8 
EX+placebo 
N=10 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Age (yrs) 60±5  59±6   0.611  
Height (cm) 174±8  178±4   0.185  
Weight (kg) 99.5±23.9 98.1±22.8 101.5±16.3 102.1±17.1 0.582 0.750 0.177 
Body mass index (kg/m2) 32.8±8.3 32.4±8.2 31.9±4.6 32.1±4.9 0.644 0.843 0.199 
Systolic blood pressure (mmHg) 136±10 132±11 138±17 135±12 0.227 0.841 0.641 
Diastolic blood pressure (mmHg) 83±9 78±5 86±11 83±8 0.079 0.727 0.239 
Cholesterol (mmol/L) 4.7±0.9 4.4±0.7 4.0±1.1 3.8±0.9 0.133 0.138 0.815 
High-density lipoprotein 
(mmol/L) 
1.0±0.5 1.0±0.3 1.0±0.2 1.0±0.2 0.480 0.926 0.808 
Low-density lipoprotein 2.9±0.6 2.8±0.6 2.2±1.1 2.2±1.1 0.561 0.172 0.998 
(mmol/L) 
Triglycerids (mmol/L) 1.8±0.6 1.4±0.5 1.6±0.9 1.4±1.0 0.011 0.790 0.395 
ET-1 (pg/mL) 1.0±0.6 0.9±0.6 0.5±0.4 0.7±0.6 0.856 0.095 0.247 
 
Body characteristics in patients with type 2 diabetes mellitus that used bosentan (EX+ET), and patients with type 2 
diabetes mellitus that used placebo (EX+placebo). Data is presented as mean ± SD. P-values represent a two-way 
repeated measures ANOVA.
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Physical fitness
Prior to the intervention, we found significantly lower maximal workload in EX+ET-blockade 
compared to EX+placebo, but no differences in maximal oxygen uptake (Table 2). Exercise 
training resulted in a significant increase in maximal oxygen uptake and maximal load, which 
was comparable between both groups (Table 2). For both groups, maximal heart rate and 
peak lactate were similar before and after the exercise training program (Table 2).
Table 2
Table 2. Outcome parameters pre and post 8-weeks of exercise training in patients with type 2 diabetes mellitus with either ET-blockade (EX+ET) or 
placebo (EX+placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
 
EX+ET-blockade 
(N=8) 
EX+placebo 
(N=10) 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Peak Oxygen Uptake (mLO2/min/kg) 20.7±1.6 23.8±4.2* 23.3±6.4 25.6±6.0* 0.006 0.339 0.619 
Peak workload (Watt) 137±29 173±40* 171±34# 205±34* 0.001 0.048 0.834 
Maximal Heart Rate (1/min) 159±11 159±10 156±12 159±12 0.467 0.788 0.371 
Peak lactate (mmol/L) 7.1±3.8 8.6±1.0 8.4±2.0 9.8±2.7 0.284 0.447 0.932 
*Post-hoc significantly different from Pre at P≤0.05, #Significantly different between groups at baseline at P≤0.05 
 
Outcome parameters pre and post 8-weeks of exercise training in patients with type 2 diabetes mellitus with either 
ET-blockade (EX+ET) or placebo (EX+placebo). Data is presented as mean ± SD. P-values represent a two-way 
repeated measures ANOVA.
*Post-hoc significantly different from Pre at P≤0.05, #Significantly different between groups at baseline at P≤0.05
Glucose homeostasis
Before training, we found no differences in insulin, glucose and HOMA-IR between EX+ET-
blockade and EX+placebo groups (all comparisons P>0.05, Table 3). In both groups, we found 
no main or training*group-interaction effect on blood glucose and insulin levels, and insulin 
resistance (HOMA-IR) (Table 3).
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Vascular function
At baseline, we found no differences between groups in brachial artery FMD, peak diameter, 
peak blood flow and GTN or superficial femoral artery FMD (all comparison P>0.05, Table 4).
Brachial artery endothelium-dependent dilation. Exercise training with or without ET-
receptor blockade did not change brachial artery flow mediated dilation, baseline diameter 
or shear rate area-under-the-curve (Table 4). We found a significant training*group interaction 
for shear rate area-under-the-curve (P=0.009, table 4). Post-hoc testing revealed that the 
exercise training program significantly decreased shear rate area-under-the-curve in the 
EX+ET-blockade group (P=0.006), but not in the EX+placebo group (P=0.363).
Brachial artery endothelium-independent dilation. Endothelium-independent vascular 
function, measured as the dilatory response to a single sublingual dose of glyceryl trinitrate 
(GTN), was not influenced by exercise training with or without ET-receptor blockade (Table 4). 
We also found no impact of exercise training and/or ET-blockade on FMD/GTN-ratio (Table 4).
Brachial artery peak blood flow. We found a significant training*group interaction for the 
impact of the 8-week intervention on brachial artery peak blood flow. Post-hoc testing 
revealed that the exercise training program significantly increased peak blood flow in the 
EX+ET-blockade group (P=0.050), but not in the EX+placebo group (P=0.086) (Table 4).
Superficial femoral artery endothelium-dependent dilation. In the superficial femoral artery, 
exercise training with or without ET-receptor blockade did not change flow mediated dilation, 
baseline diameter or shear rate area-under-the-curve (Table 4).
Table 3Table 3. Glucose homeostasis outcome parameters pre and post an 8-week training intervention in patients with type 2 diabetes mellitus with either ET-
blockade  (EX+ET) or placebo (EX-placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
EX+ET-blockade 
(N=8) 
EX+placebo 
(N=10) 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Glucose (mmol/L) 6.7±1.1 6.9±0.5 7.6±2.5 6.4±1.5 0.454 0.696 0.239 
Insulin (mU/L) 10.8±5.3 11.0±4.4 15.4±9.4 17.0±13.0 0.582 0.214 0.666 
HOMA-IR (10/%S) 3.2±1.4 3.4±1.5 5.4±3.8 5.1±4.5 0.990 0.176 0.700 
 
 
 
Glucose homeostasis outcome parameters pre and post an 8-week training intervention in patients with type 2 
diabetes mellitus with either ET-blockade  (EX+ET) or placebo (EX-placebo). Data is presented as mean ± SD. P-values 
represent a two-way repeated measures ANOVA.
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DISCUSSION
As a logical follow-up of a recent study where we found ET-blockade to enhance exercise-
induced blood flow in type 2 diabetes,21 the purpose of this study was to perform a 
randomised controlled trial (RCT) to assess the effect of an 8-week exercise-training program 
combined with ET-blockade. First, we confirmed the potent effect of exercise training given 
the significantly improved peak oxygen uptake (P=0.006) and peak workload (P=0.001). In 
contrast to our hypothesis, we found no effect of exercise training on glucose homeostasis or 
vascular function in the upper or lower limbs. More importantly, we found that ET-blockade 
did not have any superior effects on the impact of exercise training on our primary outcome 
parameters. This suggests that ET-blockade, despite the acute effects on blood flow, does not 
potentiate the effect of exercise training on the vasculature, fitness and glucose homeostasis 
in type 2 diabetes.
Exercise training significantly increased peak oxygen consumption with 12%, indicating that 
our training intervention was successful in improving physical fitness levels. The increase in 
peak oxygen consumption relates to training itself, since we did not find any differences in 
peak heart rate and lactate between both incremental cycling tests. Despite these training 
effects, we found no effect of our 8-week intervention on glucose homeostasis. Several other 
studies that investigated the effect of an 8-26 weeks training exercise program have found 
that exercise training improves glucose homeostasis,31,36,37 whereas other studies with similar 
duration and intensity do not confirm this finding.38-40 A potential explanation for this disparity 
in the literature is that glucose homeostasis in older type 2 diabetes patients (>55 years) is 
less likely to improve during exercise training compared to younger subjects.41 An alternative 
explanation is that a priori levels of glucose influence the ability of exercise training to improve 
glucose homeostasis. Indeed, Maiorana et al. found an improvement in fasting glucose from 
12.0±0.5 to 9.8±0.5 mmol/L,31 which both represent relatively high resting levels of glucose. In 
contrast, we found pre-training fasting glucose levels that were well below the post-training 
values reported by Maiorana et al. When comparing responders (n=6) and non-responders 
(n=12) in our study regarding the impact of exercise training on glucose levels, we did not 
find differences between groups for baseline characteristics or medication use. Therefore, 
it is unlikely that differences in baseline characteristics or medication use influenced our 
outcome parameters.
In the present study, we did not find any effect of adding ET-blockade to exercise training 
on circulating resting insulin or insulin sensitivity. Animal studies have suggested that ET-1 
stimulates insulin release in pancreatic islets.42-44 However, ET-1 has also been shown to 
reduce pancreatic blood flow,45,46 which could interfere with normal pancreatic function. ETA-
blockade may reverse this decreased flow, but literature is not unequivocal on this point.44,47 
Nonetheless, in our study we observed no impact of 8 weeks Bosentan ingestion on insulin 
levels or insulin resistance.
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We found no effect of exercise training on flow-mediated dilation in the brachial or superficial 
femoral artery. Given the number of subjects (total n=18), the fact that both arteries show 
similar responses, the double-blind nature of our study (including the analysis), and the 
small coefficient of variance that is achieved by our FMD-technique, we believe it is unlikely 
that measurement or methodological errors explain our effect. A potential explanation for 
our findings may relate to a time-course in vascular adaptations during exercise training 
in type 2 diabetes. A previous study found that changes in flow mediated dilation occur in 
the first two weeks of exercise, followed by a normalisation when exercise was continued in 
healthy men.48 If subjects in our study demonstrate a similar time-course, the post-exercise 
FMD after 8 weeks of training missed any adaptation that occurred in the FMD in response 
to exercise training. However, no previous study examined the potential presence of a time-
course in adaptation in FMD in response to exercise training in subjects with cardiovascular 
risk or disease, who typically demonstrate a priori endothelial dysfunction. Alternatively, it is 
possible that exercise training in subjects with a priori endothelial dysfunction takes longer 
than normal to induce significant improvements in endothelial function. Either way, future 
studies should perform multiple assessments of FMD to examine the time-course and/or 
adopt a longer exercise training duration.
Although changes in endothelial function after exercise training are frequently reported,49,50 
not all studies have consistently found this effect in type 2 diabetes.51,52 One explanation for 
the conflicting results relates to the baseline FMD, with a higher pre-training FMD allowing for 
less adaptation after exercise training. For instance, Maiorana et al found a significant increase 
in brachial artery FMD from 1.7±0.5% to 5.0±0.4%, where in our study, the mean baseline 
FMD in the EX+ET-blockade and EX+placebo groups was 4.3±1.2 and 3.6±2.3, respectively. An 
alternative explanation for our unexpected observation of a preserved FMD response after 
training is that shear rate during the FMD measurement was significantly lower in the EX+ET-
blockade group. As shear is the main stimulus for flow mediated dilation,30 this finding may 
indicate that the sensitivity of the endothelium was increased in the EX+ET-blockade group. 
Previous studies in animals53 and humans6,12,54,55 have demonstrated that repeated increases 
in shear rate represent a key stimulus for vascular adaptation. In an earlier study we have 
shown that Bosentan acutely increases exercise-induced blood flow, but not shear rate. This 
may explain why ET-blockade did not result in a superior effect on changing endothelial 
function in the present study.
Limitations
Strong points of our study include a randomised, double-blind design, the use of semi-
automated software, and the use of a highly controlled exercise protocol. Some limitations 
need to be addressed. First, we used a dual ET-1 blocker. Previous studies have demonstrated 
that type 2 diabetes is specifically associated with an upregulation of the ETA-, but not ETB-
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receptors. Even though in a previous study we have successfully increased exercise-induced 
blood flow during a single bout of exercise using a dual ET-1 blocker,21 larger effects may 
be achieved with selective ETA-receptor blockade.56,57 A second limitation is that our main 
comparison was between, as opposed to within subjects. A randomised cross-over design, 
with a sufficient ‘wash-out and detraining’ period between training periods would yield 
smaller variations and possibly larger effects. However, a major concern would be that 
subjects are truly untrained at baseline, and any feasible detraining period would not be 
comparable to the inactive period prior to the start of the study. Therefore, we believe that 
our set-up utilising between-subjects comparisons is the best practical option. Finally, we 
have powered our sample size to detect changes in endothelial function. Therefore, our 
sample size may be too small to detect changes in insulin and glucose levels, potentially 
explaining why we did not find an effect of training or Bosentan on glucose homeostasis.
In conclusion, 8 weeks of exercise training significantly improved physical fitness in patients 
with type 2 diabetes mellitus, but we did not detect any effect on brachial and femoral 
artery endothelial function. Furthermore, in contrast to our hypothesis, ET-blockade had 
no additional effect on our primary outcome parameters. This suggests that ET-blockade 
does not potentiate the effect of exercise training on conduit artery endothelial function and 
physical fitness in type 2 diabetes.
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ABSTRACT
PURPOSE Exercise training in healthy volunteers rapidly improves vascular function, 
preceding structural remodelling. No study examined the time-course of such adaptations 
in subjects with a priori endothelial dysfunction. METHODS We examined brachial artery 
endothelial and smooth muscle function using flow-mediated dilation (FMD) and glyceryl 
trinitrate (GTN) administration in 13 type 2 diabetes patients (59±6 years) and 10 healthy 
subjects (58±7 years) before, during (2-weekly) and after an 8-week training program. Arterial 
structure was assessed via peak blood flow and artery diameter. RESULTS Training increased 
peak oxygen uptake (P=0.03), comparable between groups (P=0.276). We observed a similar 
impact of training on brachial artery vasomotor function across the training period in diabetes 
patients and controls (FMD/GTN-ratio), with a higher FMD/GTN-ratio at 2, 6 and 8 weeks 
(P=0.036). Artery diameter, peak blood flow or peak diameter had not changed after training. 
CONCLUSION Training leads to rapid improvement in brachial artery vascular function 
in diabetes patients and controls. In contrast to previous observations in healthy young 
subjects, the increase in function was preserved after 8 weeks of training in middle-aged 
diabetes patients and controls, suggesting a different time-course in vascular adaptations in 
subjects with endothelial dysfunction.
KEYWORDS: cardiovascular risk; exercise training; metabolic disease; time course
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ABBREVIATIONS
ANOVA  analysis of variance
BMI  body mass index
bpm  beats per minute
eNOS  endothelial nitric oxide synthase
FMD  flow mediated dilation
GTN  glyceryl trinitrate
HDL  high density lipoprotein
HOMA-IR homeostasis model assessment for insulin resistance
HR  heart rate
LDL  low density lipoprotein
LSD  least significant differences
NO  nitric oxide
rpm  rotations per minute
RQ  respiratory quotient
T2DM  type 2 diabetes mellitus
W  watt
CHAPTER 5
98
INTRODUCTION
Regular exercise training has strong and independent cardioprotective effects in 
asymptomatic subjects and in those at increased cardiovascular risk,1 an impact that can only 
partly be explained by changes in traditional cardiovascular risk factors.2 One explanation 
for this ‘risk factor gap’ invokes direct effects of exercise on the vasculature.3,4 Insight into 
adaptations in vascular function will therefore contribute to a better understanding of the 
cardioprotective effects of exercise training.
Previous studies suggest that improvement in vascular function after dynamic exercise 
training is not universal,5,6 especially in healthy volunteers. The presence of time-
dependent adaptations in vascular function in response to exercise training may partly 
explain this observation. Originally based on findings in animals,7 human studies have also 
demonstrated that short-term exercise training enhances conduit artery function in subjects 
with cardiovascular risk factors or disease,5,8,9 whilst prolonged training induces structural 
changes (i.e. increased diameter).10,11 Studies involving 2-weekly measurements across an 
8-week period of large (i.e. cycling/running exercise)12,13 or small muscle group (i.e. handgrip 
exercise)14 training in healthy young volunteers have consistently demonstrated that 2 
weeks of exercise training is sufficient to significantly enhance vascular function. This initial 
rapid increase in vascular function is often normalised after 6-8 weeks of training. These 
observations support the idea that exercise training leads to time-dependent adaptation in 
conduit artery function, which is superseded by arterial remodelling.
Studies performed in patients at increased cardiovascular risk, such as those with type 2 
diabetes, have demonstrated that exercise training improves vascular function,8,15 but the 
presence of time-dependent adaptations in this group has not, to our knowledge, been 
addressed. Given that a priori endothelial dysfunction is evident in subjects with type 2 
diabetes, a different time-dependent adaptation in vascular function may be apparent 
compared to that observed in healthy young subjects. The purpose of the present study was 
therefore to assess brachial artery function at 2-weekly intervals across an 8-week exercise 
training program16-19 in patients with type 2 diabetes and controls. We hypothesize that, in 
keeping with findings in healthy young subjects, a rapid increase in vascular function would 
be present during the initial weeks of training, followed by a normalisation after 6-8 weeks. 
METHODS
Subjects
We recruited 13 male patients from the community with type 2 diabetes (59±6 years) and 10 
middle-aged apparently healthy men (58±7 years) as controls. Type 2 diabetes patients had 
been diagnosed for at least 2 years. Exclusion criteria for both type 2 diabetes and controls 
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included overt coronary artery disease, smoking, type I diabetes mellitus, age <40 or >65, 
and diabetes-related manifestations of vascular disease. We also excluded subjects who 
performed regular physical exercise. The study procedures were approved by the medical 
ethical committee of the Radboud University Nijmegen Medical Centre and adhered to the 
Declaration of Helsinki. All subjects gave written informed consent before participation in 
this study.
Experimental design
First, subjects reported to the laboratory for pre-training assessment of brachial artery 
function and structure, subject characteristics and physical fitness. Subsequently, all subjects 
underwent an 8-week exercise-training program. Vascular assessments were repeated at 
2-weekly intervals to examine the time-course of adaptation in these parameters across 
the 8-weeks of exercise training. Physical fitness and subject characteristics were examined 
before and after the 8-week exercise training program only.
Measurements: Vascular function. 
All subjects refrained from alcohol, caffeine, and vigorous physical exercise for at least 24 
hours prior to testing. The morning of the test, subjects were instructed not to take any 
medication. All tests were performed in laboratory conditions with constant temperature 
(20°C for physical fitness testing, 22°C for vascular testing) and humidity (35%). We 
performed all tests between 8 AM and 4 PM. To control for diurnal variation in FMD, all 
measurements within subjects were performed at the same time of day.20
Brachial artery endothelium-dependent dilation. 
Measurement of brachial artery endothelium-dependent dilation (using flow-mediated 
dilation FMD) was performed by an experienced vascular sonographer. A 10 MHz 
multifrequency linear array probe attached to a high resolution ultrasound machine (T3000; 
Terason, Burlington, MA, USA) was used to image the brachial artery in the distal 1/3rd of the 
upper arm. When an optimal image was obtained, the probe was held stable and ultrasound 
parameters were set to optimize the longitudinal, B-mode images of lumen–arterial wall 
interface.
For assessment of FMD, subjects rested in the supine position for a period of at least 20 
minutes to facilitate stable baseline measurement of artery diameter and blood flow. To 
examine brachial artery FMD, the arm was extended and positioned at an angle of ∼80 
degrees from the torso. A rapid inflation and deflation pneumatic cuff was positioned on 
the forearm of the imaged limb, immediately distal to the olecranon process, to provide a 
stimulus of forearm ischaemia. Continuous Doppler velocity assessment was obtained using 
CHAPTER 5
100
the lowest possible insonation angle (consistently <60 degrees), which did not vary during 
or between measurements. The forearm cuff was inflated to 220 mmHg for 5 min. Diameter 
and flow recordings resumed 30 s prior to cuff deflation and continued for 3 min thereafter. 
Time to peak was calculated from the point of cuff deflation to the maximum post-deflation 
diameter. Calculation of FMD and time to peak were therefore observer-independent and 
based on standardized algorithms applied to data, which had undergone automated edge-
detection and wall-tracking.
Brachial artery endothelium-independent dilation. 
Following a rest period of at least 15 minutes to allow brachial artery diameter and flow 
to return to baseline levels, a 1-min baseline recording of diameter and flow was taken. 
Subsequently, brachial artery endothelium-independent vasodilation was examined after 
administration of a single spray of sublingual GTN (400 µg), a nitric oxide donor. This was 
followed by 10 min continuous recording of brachial artery diameter and blood flow.
Brachial artery peak blood flow. 
After a further rest period (>15-min), a 1 min baseline recording of brachial artery diameter 
and blood flow was performed. Brachial artery dilation was then examined after a 5-min 
period of ischaemia. During this ischaemic period, consisting of 1 min ischaemia, followed 
by 3-min isotonic handgrip exercise and a final 1 min of ischaemia, the cuff remained inflated 
at 220 mmHg. Handgrip exercise involved 1 contraction every 2 s of a 3-kg load. The peak 
hyperemic forearm blood flow in response to this stimulus in humans provides an index of 
resistance artery size or remodeling whilst the brachial dilator response provides a surrogate 
for maximal dilator capacity.21 We resumed diameter and flow recordings 30 s prior to cuff 
deflation and continued for 3 min thereafter.
Measurements: Physical fitness and subject characteristics
Subject characteristics. 
During the first visit all subjects completed a questionnaire concerning their medical history 
and medication use. We measured height, weight and resting blood pressure after a 5-minute 
seated rest using a manual sphygmomanometer. A venous blood sample was taken for 
assessment of fasting glucose, insulin, total cholesterol, HDL, LDL, triglycerides. From the 
glucose and insulin levels we calculated the HOMA-IR index as a valid measure of insulin 
resistance.22
Physical fitness. 
On a subsequent day, subjects performed an incremental cycle exercise test to examine 
maximal workload and peak oxygen consumption. Data from this test were used to 
determine maximal heart rate, which was used to calculate workload during exercise 
training. Each subject performed an incremental maximal exercise test on a cycle ergometer 
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(Lode, Excalibur, Groningen, the Netherlands) before and after training. The test started at a 
power output of 10 W and power output increased by 10 W/min until voluntary exhaustion. 
Subjects were instructed to maintain a cadence of between 60 and 80 rpm during the test. 
We continuously recorded oxygen consumption (VO2, in mlO2/kg/min), ventilation (Ve, in l/
min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) and heart rate (HR, in bpm). 
Furthermore, we measured blood lactate levels (mmol/l) using Accutrend® Lactate (Roche 
Diagnostics GmbH, type 3012522, Mannheim, Germany) before and 2 min after finishing the 
maximal exercise test. For a test to be classified as successful, at least 3 out of the following 
4 criteria had to be met: clinical signs of exhaustion of the participant, respiratory quotient 
≥1.10, finishing within 10 beats of the maximum predicted heart rate (=220-age), and flattening 
of VO2 uptake curve (≤110mL increase during the last minute).
23 Cardiac rhythm via ECG was 
assessed at rest (before the test), and continuously throughout the maximal exercise test. All 
subjects were screened by a physician before commencing the test, and all maximal exercise 
tests were supervised by a physician. An automated external defibrillator was present in the 
room where the test took place, and the supervisors of the tests were trained in its use. No 
subjects were excluded from the intervention based on medical grounds following this test.
Exercise training intervention
Exercise training was performed over an 8-week training period with subjects visiting our 
facility 3 times per week. Each session was supervised by one of our researchers and consisted 
of a warm-up, followed by a circuit of resistance exercises (leg press, calf raise, leg curl, leg 
extension, lower back, abdominal crunch, 3 series of 12 repetitions each, with 1 minute of 
rest between sets within each exercise) interspersed with aerobic activities (e.g. cycling, 
running).9,24 The total protocol was as follows: 5 minutes warming-up (cycling), 5 minutes 
of cycling, leg curl, leg extension, 5 minutes of running, lower back, abdominal crunch, 5 
minutes of cycling, leg press, calf raise, 5 minutes of running. Total duration of each session 
was approximately 60 minutes. A heart rate monitor (Polar Electro Oy, Kempele, Finland) 
was used to continuously monitor heart rate during the aerobic exercise and heart rate was 
maintained at 70-75% of heart rate reserve. The intensity level for each of the resistance 
exercises was set at a level which enables the participant to complete the three series of 
12 repetitions. Intensity was increased each week under the guidance of the trainers. If a 
participant missed a supervised exercise session, an extra session was planned in the same 
or following week, so that each participant performed a total of 24 supervised sessions 
(100% compliance). This type of training is demonstrated to improve vascular function and 
structure in healthy subjects13,25 as well as in those with cardiovascular risk or disease.24,26,27
Data Analysis
Post-test analysis of brachial artery diameter and velocity was performed using custom-
designed edge-detection and wall-tracking software, which is independent of investigator 
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bias.28 The echo-Doppler signal was real-time encoded and stored as a digital file. Subsequent 
software analysis of these data was performed at 30 Hz using an icon-based graphic 
programming language and toolkit (LabView 6.02; National Instruments, Austin, TX). The 
program allows users to identify a region of interest on the clearest portion of the vascular 
wall. It then identifies, via the intensity of the brightness of the walls versus the lumen of 
the vessel, the walls of the artery. Regions of interest were selected for diameter and blood 
velocity on the duplex images. From this synchronized diameter and velocity data, blood 
flow (the product of lumen cross-sectional area and Doppler velocity) was calculated at 30 
Hz. Baseline diameter, flow and shear rate were calculated as the mean of data acquired 
across the 1 minute preceding the cuff inflation period.
FMD was calculated using the baseline and peak diameter following cuff deflation. Peak 
diameter was automatically detected according to an algorithm, which identified the 
maximum bracket of data subsequent to performance of a moving window smoothing 
function. This smoothing routine calculates the median value from 100 consecutive 
samples, before the window shifts to the next bracket of data, which shares 20% overlap 
with the preceding bracket. The maximum value of all the calculated median values is 
then automatically detected and chosen to represent the peak of the post-deflation artery 
diameter curve. FMD was calculated as the percentage rise of this peak diameter from the 
preceding baseline diameter. We have shown that reproducibility of diameter measurements 
using this semi-automated software is significantly better than manual methods, reduces 
observer error significantly, and possesses an intra-observer coefficient of variance of 6.7%.28 
We also present the FMD/GTN-ratio as this ratio corrects the FMD for potential differences 
between and within subjects in the endothelium-independent dilation (i.e. GTN%). This is of 
special importance given recent observations of differences between (clinical) groups with 
and without atherosclerosis.29,30
Statistical analysis
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago (Illinois), USA) 
software. According to Woodman et al. our sample size is sufficient to detect clinically 
relevant differences in our primary outcome measures.28 All data are reported as mean ± 
SD unless stated otherwise, and statistical significance was assumed at P<0.05. Unpaired 
Student’s t-tests were used to compare baseline values between groups, and checked our 
data for normality. A two-way repeated measures ANOVA was used to examine changes in 
our primary outcome parameter FMD across the exercise-training period (‘training’; 0, 2, 4, 
6, versus 8 weeks), and whether the magnitude of exercise training-mediated adaptations 
differ between groups (‘group’; T2DM versus control). A similar statistical approach was used 
to examine changes in diameter, peak blood flow/diameter, physical fitness, and glucose 
homeostasis. When a significant main- or interaction-effect was found, post-hoc comparisons 
were performed to identify which time-points significantly differ from pre-training. Post-hoc 
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analysis was performed using the least significant difference (LSD) method for pair-wise 
multiple comparisons when a significant main effect was observed.31 According to a recent 
study by Atkinson et al., inadequate scaling for FMD would be present if the upper confidence 
limit of the regression slope of the relationship between logarithmically transformed base 
diameter and peak diameter is less than one.32 In such an event, FMD% is not an appropriate 
measure to estimate endothelial function. We checked our data for this phenomenon, 
and found that in the case of our FMD data it was not necessary to perform the allometric 
modelling solution proposed by Atkinson et al.32
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RESULTS 
Subject characteristics
Prior to the 8-week intervention, subjects with type 2 diabetes demonstrated a significantly 
higher weight and BMI and lower cholesterol and LDL compared with controls (Table 1). 
In addition, type 2 diabetes possessed significantly higher glucose, insulin, and HOMA-IR 
compared with controls (Table 1). No significant differences between groups were found for 
age, height, systolic and diastolic blood pressure, HDL and triglycerides. The 8-week exercise 
training intervention did not alter these characteristics in type 2 diabetes patients or in 
middle-aged men (Table 1). Medication use is described in table 3.
Physical fitness
Before training, a significantly lower peak oxygen uptake and peak workload were observed 
in type 2 diabetes patients compared to controls (Table 1). Exercise training resulted in a 
significant increase in maximal oxygen uptake and maximal load, with the magnitude of 
increase comparable between groups (Table 1). For both groups, maximal heart rate and 
peak lactate were similar before and after the exercise training program (Table 1).
Vascular function
At baseline, we observed no significant differences between groups in brachial artery 
diameter, FMD%, peak blood flow, peak diameter, GTN% and FMD/GTN-ratio (all comparisons 
P>0.05, Table 2).  We found no effect of exercise training on brachial artery diameter, FMD%, 
shear rate area-under-the-curve or GTN% in type 2 diabetes patients or controls. However, 
when the FMD was corrected for the endothelium-independent dilation, the FMD/GTN-ratio, 
a time-dependent increase across the exercise training program was present in both groups 
(Table 2, Figure 1). Post-hoc analysis revealed that FMD/GTN-ratio was significantly higher 
after 2, 6, and 8 weeks of training compared with baseline.  Brachial artery dilator capacity, 
peak diameter, and peak blood flow did not change by exercise training in type 2 diabetes 
patients or controls (Table 2, Figure 1).
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Table 1
 
 T2DM (N=13) Control (N=10) 2-way ANOVA 
Body characteristics Pre Post Pre Post Training Group Training*Group 
Age (yrs) 59±6  58±7   0.872  
Height (cm) 179±4  180±5   0.669  
Weight (kg) 103.3±15.4# 103.5±15.8 86.8±8.6 86.0±8.5 0.554 0.008 0.341 
Body mass index (kg/m2) 32.4±4.2# 32.5±4.4 26.9±3.5 26.6±3.4 0.533 0.003 0.310 
Systolic blood pressure (mmHg) 142±17 139±12 132±15 125±10 0.055 0.042 0.521 
Diastolic blood pressure (mmHg) 88±11 86±9 83±6 80±4 0.077 0.100 0.950 
Cholesterol (mmol/L) 4.2±1.0# 4.0±0.9 5.5±1.1 5.4±1.4 0.147 0.006 0.929 
High-density lipoprotein (mmol/L) 1.0±0.2 1.0±0.2 1.2±0.2 1.2±0.2 0.528 0.088 0.108 
Low-density lipoprotein (mmol/L) 2.2±1.0# 2.2±1.0 3.6±1.0 3.5±1.2 0.484 0.007 0.449 
Triglycerids (mmol/L) 2.0±1.3 2.0±2.0 1.7±1.0 1.7±0.9 0.945 0.627 0.913 
Physical fitness  
Peak Oxygen Uptake (mLO2/min/kg) 
 
23.7±5.8# 
 
25.8±5.4 
 
33.0±7.5 
 
33.8±8.8 
 
0.031 
 
0.010 
 
0.276 
Peak Oxygen Uptake (mLO2/min) 2381±342 2614±298 2812±338 2876±489 0.029 0.029 0.169 
Peak workload (Watt) 175.0±33.4# 206.7±31.8 232.8±47.5 265.6±46.7 <0.001 0.003 0.900 
Maximal Heart Rate (bpm) 158.2±11.7 159.0±10.9 163.4±13.3 165.3±13.1 0.440 0.266 0.743 
Peak lactate (mmol/L) 8.4±2.0 9.8±2.7 11.8±3.0 11.1±3.4 0.689 0.179 0.177 
Glucose homeostasis  
Glucose (mmol/L) 
 
8.2±2.8# 
 
6.9±2.3 
 
4.9±0.3 
 
4.8±0.6 
 
0.300 
 
<0.001 
 
0.394 
Insulin (mmol/L) 18.4±11.8# 24.7±21.7 6.0±3.1 7.0±4.1 0.202 0.006 0.351 
HOMA-IR (10/%S) 6.6±4.1# 8.7±9.9 1.3±0.7 1.6±1.0 0.331 0.008 0.427 
Body characteristics in patients with type 2 diabetes mellitus (T2DM), and controls (Control). Data is presented as 
mean ± SD. P-values represent a two-way repeated measures ANOVA.
#Significantly different between groups at baseline at P<0.05
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Table 2
 
  Weeks of exercise training 2-way ANOVA 
Brachial artery  0 2 4 6 8 Training Group Training*Group 
Diameter (mm) T2DM 4.7±0.5 4.6±0.5 4.6±0.6 4.5±0.5 4.5±0.6 0.216 0.352 0.958 
 Control 4.8±0.3 4.7±0.5 4.9±0.5 4.8±0.5 4.6±0.5    
Flow mediated dilation (FMD, %) T2DM 3.4±2.1 4.4±3.5 4.1±2.1 4.3±1.9 3.9±1.9 0.094 0.225 0.532 
 Control 3.9±1.9 5.6±3.3 4.3±2.3 5.4±2.4 6.0±4.0    
Shear rateAUC (s, 103) T2DM 15.3±6.0 14.3±7.6 16.0±7.4 19.0±6.4 16.6±6.8 0.228 0.641 0.957 
 Control 15.2±10.0 14.4±7.9 13.2±8.2 18.1±9.6 15.7±7.0    
GTN (%) T2DM 13.4±5.9 13.4±7.2 13.1±6.0 10.2±5.2 11.5±6.7 0.489 0.102 0.642 
 Control 16.1±5.7 14.4±4.9 16.6±5.2 15.1±5.9 15.8±7.3    
CADC (%) T2DM 12.0±4.6 10.3±3.8 11.8±4.9 10.7±4.1 9.9±4.5 0.322 0.100 0.524 
 Control 15.0±6.3 12.7±5.1 13.9±6.0 14.5±6.4 15.0±7.9    
Peak diameter (mm) T2DM 5.2±0.7 5.1±0.7 5.1±0.4 5.4±0.6 5.0±0.7 0.592 0.660 0.125 
 Control 5.2±0.4 5.3±0.7 5.1±0.3 5.2±0.3 5.4±0.4    
Peak blood flowAUC (mL/min) T2DM 920±417 868±325 855±323 971±304 844±339 0.674 0.173 0.888 
 Control 800±241 682±346 759±272 804±141 813±147    
FMD/GTN T2DM 0.27±0.15 0.41±0.34 0.32±0.14 0.52±0.28 0.53±0.49 0.036 0.640 0.903 
 Control 0.28±0.22 0.43±0.24 0.29±0.16 0.43±0.32 0.46±0.34    
Vascular outcome parameters at 0, 2, 4, 6 and 8 weeks of exercise training in patients with type 2 diabetes mellitus 
(T2DM), and controls. Data is presented as mean ± SD. P-values represent a 2-way ANOVA for the effect of training (0, 
2, 4, 6 and 8 weeks) and group (T2DM vs control).
#Significantly different between groups at baseline at P<0.05
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Table 3
Table 3. Medication use in patients with type 2 diabetes mellitus (T2DM), and controls (Control). Data is presented as mean ± SD. P-values represent 
Pearson’s χ2. 
 
Medication use T2DM 
(N=13) 
Control 
(N=10) 
P-value 
Insulin 3 0 0.103 
Metformin 11 0 <0.001 
Sulfonylurea 6 0 0.012 
DPP4 inhibitor 0 0 - 
Thiazolidinedione 0 0 - 
ACE inhibitor 5 1 0.123 
Angiotensin II inhibitor 2 0 0.194 
Diuretic 3 2 0.859 
Statin 9 2 0.019 
Beta-blocker 4 0 0.054 
Calcium antagonist 2 0 0.194 
Acetylsalicylic acid 2 0 0.194 
Coumarin derivative 1 0 0.370 
Medication use in patients with type 2 diabetes mellitus (T2DM), and controls (Control). Data is presented as mean 
± SD. P-values represent Pearson’s χ2.
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Figure 1
Brachial artery flow mediated dilation (A, FMD (%)), glyceryl trinitrate response (B, GTN (%)), and FMD/GTN ratio (C) 
at weeks 0, 2, 4, 6, and 8 of an 8-week exercise training program in T2DM (black squares, n=13) and age-matched 
healthy controls (open squares, n=10) Error bars represent SE. Data for the 2-way ANOVA (main effects for ‘training’, 
‘group’ and ‘training*group’) are provided. *Post-hoc significantly different from week 0 at P<0.05.
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DISCUSSION
The purpose of the present study was to examine whether an 8-week exercise training 
program induces time-dependent adaptation in conduit artery function in type 2 diabetes 
mellitus patients and controls. In keeping with previous studies in healthy young volunteers, 
exercise training lead to a rapid functional increase in both groups. Whilst continued exercise 
training has been associated with normalisation of vasomotor function after 6-8 weeks 
in young healthy subjects,12-14 we observed preservation of the increase in brachial artery 
vasomotor function after 6-8 weeks in both groups in this study. This suggests the presence 
of a distinct time-course in vascular adaptations to exercise training in middle-aged type 
2 diabetes patients and older subjects, compared with young healthy individuals. The 
preserved improvement in brachial artery endothelial function may have clinical relevance.
We found an 8% increase in peak oxygen uptake after the exercise-training program in type 
2 diabetes patients, indicating that the training intervention was successful in improving 
physical fitness. Although we did not include a non-exercising control group, previous 
experiments have shown that physical fitness was not altered in subjects that did not 
perform exercise training.8,33 The magnitude of improvement in physical fitness after 8 weeks 
is in agreement with studies that used an exercise training program of similar duration 
and intensity.24,33,34 Healthy subjects also demonstrated a similar magnitude of benefit in 
physical fitness and workload. Despite these effects of exercise training on physical fitness, 
we found no effect on subject characteristics and traditional cardiovascular risk factors. 
Although somewhat counterintuitive, this finding is in agreement with others who have also 
demonstrated no consistent change in traditional cardiovascular risk factors after exercise 
training.24,35-37. It is also broadly consistent with the notion that exercise benefits, in terms of 
vascular function and cardiovascular risk, are largely due to factors other than modification 
of traditional risk factors.2,4,35
An important question in our study relates to the presence of time-dependent adaptations 
in vascular function across 8-weeks of exercise training in subjects with a priori endothelial 
dysfunction. Although we did not directly compare our results to a young control group, 
the pre-training values of brachial artery FMD in type 2 diabetes and controls (3.4-3.9%) are 
lower than typically reported in studies examining healthy young men.12-14 Regarding the 
impact of exercise training on endothelial function in type 2 diabetes and controls, we did 
not find a significant change in brachial artery FMD across the 8-week exercise training. This 
observation contrasts with previous studies that report an increase in FMD after training in 
type 2 diabetes.8,38 However, a recent study by Barone Gibbs et al. demonstrated no effect 
of exercise on FMD in type 2 diabetes, despite marked improvements in fitness, body 
composition, and glycaemic control.39 When we corrected the brachial artery responses 
for underlying changes in endothelium-independent dilation, exercise training resulted 
in a significant increase in FMD/GTN-ratio in both groups. This measure is believed to 
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reflect compound vascular function by correcting FMD for differences and/or changes in 
endothelium-independent dilation. We detected time-dependent effects of exercise training 
on the FMD/GTN-ratio in both type 2 diabetes and age-matched controls. In agreement with 
studies of healthy young volunteers,12-14 two weeks of exercise training in type 2 diabetes 
and age-matched controls significantly enhanced endothelial function. Whilst continuing 
exercise training in young healthy controls was associated with return to baseline levels 
after 6-8 weeks,12-14 the present study revealed sustained elevation in FMD/GTN-ratios with 
prolonged training. This suggests that, somewhat in contrast with younger healthy subjects, 
exercise training leads to improvement in endothelial function that remains elevated in 
subjects with a priori endothelial dysfunction.
The notion that exercise training can lead to rapid initial changes in function is supported 
by previous human and animal data.  For example, Sun et al. found that daily exercise 
bouts for 2-4 weeks enhanced endothelial nitric oxide synthase (eNOS) in rat endothelial 
cells40 and Sessa et al. found that mRNA-levels of the calcium-dependent eNOS were rapidly 
upregulated in exercised dogs.41 Upregulation of eNOS in response to episodic changes in 
shear stress induced by repeated exercise bouts seems a sensible hypothesis to explain the 
initial improvements in vascular function we observed.42 In previous human and animal 
experiments, the normalization of function in the longer term has been attributed structural 
adaptation,7,14 which is also believed to be endothelium and NO-mediated43,44 and acts to 
supersede the functional response. The current results differ from this paradigm in that 
function remained elevated in older healthy subjects and type 2 diabetes and there was no 
suggestion of arterial remodelling. Therefore, a longer, higher intensity, higher frequency, or 
a different type of training such as interval exercise training program may be necessary to 
induce improvements in vascular structure in these clinical groups. Furthermore, we cannot 
fully rule out the possibility that the structural remodelling was negatively influenced by 
the resistance training, as the transfers between different exercises in the circuit may have 
decreased the overall workload. Previous studies have also observed that FMD is elevated 
after prolonged (3 months) exercise training in type 2 diabetes patients15 and sedentary 
middle-aged subjects.45 Furthermore, subjects with established coronary heart disease46 
show no larger increase in vascular function after prolonged exercise training than studies 
adopting a 4-8 week training protocol, providing some support for our findings that the initial 
improvement in vascular function remains when continuing exercise training. There are 
limited animal data on the interaction between arterial function and structure in response to 
prolonged exercise training, but our findings suggest that adaptations may differ in groups 
with antecedent endothelial dysfunction. This may be due to differences in the impact of 
oxidative stress or inflammation, but future studies examining the impact of (short-and long-
term) exercise training (in those with endothelial dysfunction) on a molecular level will be 
required to shed further light on this observation.
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Another explanation for our consistent improvement in vascular function across the training 
program may relate to time-dependent changes in NO-sensitivity of the smooth muscle 
cells, rather than changes in the endothelium per se. Relatively little is known about the 
impact of exercise training on smooth muscle cell sensitivity to vasodilators, such as NO, in 
humans. In animals, studies have been inconclusive. A recent study in rats indicated that, 
although 8-12 weeks of exercise training increased eNOS function, it did not alter vascular 
sensitivity to NO.47 However, evidence also exists that exercise training changes response of 
coronary smooth muscle cells to vasoactive substances and enhances myogenic reactivity 
in animals.48,49 Exercise training improves smooth muscle cell sensitivity in animals via the 
regulation of intracellular Ca2+ and an enhanced K+ channel regulation of tone.50 It is unknown 
if these adaptations are time-dependent.50 Future research should examine the potential of 
exercise training to alter NO sensitivity of smooth muscle cells in humans.
We found no differences in vascular function or structure between middle-aged type 2 
diabetes patients and controls. As baseline values for vascular function in both groups were 
lower than typically reported in young healthy subjects in previous studies, this finding 
suggests that we included 2 groups with a priori endothelial dysfunction. Furthermore, the 
similarity in FMD between groups suggests that the type 2 diabetes patients included in 
our study have no additional impairment in vascular function relative to their age-matched 
peers. As a result, our findings in time-course between middle-aged and young subjects may 
relate to the impact of age, rather than to a pathological mechanism in type 2 diabetes.
A limitation of this study is that it has been powered to answer our primary research 
question, to detect changes in brachial artery FMD in the type 2 diabetes group. As we have 
not powered our study on the other outcome parameters, including the derivative outcome 
parameter FMD/GTN, we cannot make any conclusive statements regarding its power.
In conclusion, exercise training leads to rapid improvement in brachial artery vascular function 
in type 2 diabetes and controls. Contrary to previous findings in healthy young subjects, in 
whom vascular function normalises when exercise training continues, the impact of exercise 
training on vascular function was preserved after 8 weeks exercise training in middle-aged 
type 2 diabetes patients and controls. These data suggest a distinct time-course in vascular 
adaptations in middle-aged type 2 diabetes patients and controls compared with previous 
observations in young healthy subjects which warrants further investigation.
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ABSTRACT
Objective Little is known about the impact of exercise training on conduit artery wall 
thickness in type 2 diabetes. We examined the local and systemic impact of exercise training 
on superficial femoral (SFA), brachial (BA), and carotid artery (CA) wall thickness in type 2 
diabetes patients and controls. 
Methods Twenty patients with type 2 diabetes and 10 age- and sex-matched controls 
performed an 8-week training study involving lower-limb based combined aerobic and 
resistance exercise training. We examined the SFA to study the local effect of exercise, and 
also the systemic impact of lower-limb based exercise training on peripheral (i.e. BA) and 
central (i.e. CA) arteries. Wall thickness (WT), diameter and wall:lumen(W:L)-ratios were 
examined using automated edge-detection of ultrasound images. 
Results Exercise training did not alter SFA or CA diameter in type 2 diabetes or controls (all 
P>0.05). BA diameter was increased after training in type 2 diabetes, but not in controls. 
Exercise training decreased WT and W:L-ratio in the SFA and BA, but not in CA in type 2 
diabetes. Training did not alter WT or W:L-ratio in controls (P>0.05).
Conclusion Lower-limb dominant exercise training causes remodelling of peripheral arteries, 
supplying active and inactive vascular beds, but not central arteries in type 2 diabetes.
KEYWORDS: intima-media thickness; cardiovascular risk; exercise training; arterial 
remodelling
ABBREVIATIONS
BA Brachial Artery
CA Carotid Artery
CV Coefficient of Variation
HDL High Density Lipoprotein
LDL Low Density Lipoprotein
ROI Region of Interest
SD Standard Deviation
SE Standard Error
SFA Superficial Femoral Artery
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INTRODUCTION 
Exercise training is an important adjunct to medical therapy in type 2 diabetes which is 
associated with improved glucose homeostasis.1,2 In addition, regular exercise training has 
strong and independent cardioprotective effects, leading to lower cardiovascular morbidity 
and mortality in type 2 diabetes.3 These effects of exercise training may, at least partly, be 
mediated through the direct effect of exercise on the arterial wall.4,5 Indeed, exercise training 
improves vascular function measured as flow-mediated dilation in peripheral vessels in type 
2 diabetes, most likely contributing to the cardioprotective effects of exercise training.6-8
Little attention has been paid to the impact of exercise training in type 2 diabetes on arterial 
wall thickness (WT); a surrogate measure of atherosclerosis,9,10 which has been shown 
to be increased in subjects with type 2 diabetes.11-13 Cross-sectional studies in healthy 
subjects demonstrated that athletes have a generally lower artery wall thickness compared 
to sedentary controls.14-16 A recent study in healthy young men confirmed the presence of 
a generalised decrease in arterial wall thickness after 8-weeks cycling exercise training (3 
sessions per week) on both the carotid and the superficial femoral artery.17 However, the 
effects of exercise training on wall thickness may be different in subjects with increased 
cardiovascular risk, such as type 2 diabetes. Endurance trained post-menopausal women 
show a smaller wall thickness in peripheral (i.e. superficial femoral artery (SFA)), but not the 
carotid artery (CA), compared to sedentary controls.18 These findings raise the possibility that 
exercise training may induce site-specific changes in wall thickness, with predominance in 
peripheral vessels, especially in subjects with a priori increased cardiovascular risk such as 
type 2 diabetes.
Reduced wall thickness of the carotid artery,19 but also of peripheral vessels such as the 
brachial artery (BA)20,21 and SFA,22 is associated with reduced risk of cardiovascular events. 
Exercise training-induced remodeling in wall thickness may, therefore, have prognostic 
implications. Evidence indicates an inverse relationship between physical fitness and carotid 
intima-media thickness in type 2 diabetes,23 whilst a recent study provided evidence that 
aerobic exercise training attenuates CA wall thickness.24 However, relatively little is known 
about the potential impact of exercise training on wall thickness of peripheral arteries in type 
2 diabetes, and whether changes in peripheral arteries are in agreement with central conduit 
artery wall thickness. We, therefore, examined the impact of 8 weeks of supervised exercise 
training on wall thickness in peripheral (SFA and BA) and central (CA) vessels in type 2 diabetes 
and controls. By performance of lower limb-dominant exercise, we can distinguish between 
the impact of exercise on peripheral arteries supplying active (i.e SFA) versus inactive (i.e. BA) 
areas. We hypothesise that training would result in a generalised decrease in wall thickness 
in controls, and in a decrease in wall thickness of peripheral, but not central arteries in type 
2 diabetes.
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METHODS
Subjects
Twenty sedentary (i.e. no regular physical exercise) men with type 2 diabetes (>2 years since 
diagnosis, 59±6 years of age) and ten sedentary, age-matched men (58±7 years) without 
diabetes were recruited. Insulin resistance in the group with diabetes was 5.2±3.8 10/%S, 
calculated via the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR)25 
as HOMA-IR=(glucose(mmol/L)*insulin(mmol/L))/22.5. Exclusion criteria included overt 
cardiovascular disease (previously diagnosed by a physician), smoking in the last 15 years, 
type I diabetes mellitus, age <40 or >65, and diabetes-related manifest vascular complications, 
neuropathy. The study procedures were approved by the medical ethical committee of the 
Radboud University Nijmegen Medical Centre and adhered to the Declaration of Helsinki. All 
subjects gave written informed consent before participation in this study.
Experimental Measures
Subjects were allocated to 8-weeks lower limb-dominant exercise training (3 exercise sessions 
per week). Each exercise session was supervised by a well-trained researcher and consisted 
of a 5-minute warming-up, followed by a circuit of resistance exercises (leg press, calf raise, 
leg curl, leg extension, lower back, abdominal crunch, 3 series of 12 repetitions each, with 1 
minute of rest between sets within each exercise) interspersed with aerobic activities (e.g. 
cycling, running).26,27 The total protocol was as follows: 5 minutes warming-up (cycling), 
5 minutes of cycling, leg curl, leg extension, 5 minutes of running, lower back, abdominal 
crunch, 5 minutes of cycling, leg press, calf raise, 5 minutes of running. The total duration 
of a training session was approximately 60 minutes. A heart rate monitor (Polar Electro Oy, 
Kempele, Finland) was used to continuously monitor heart rate during the aerobic exercise 
and heart rate was maintained at 70-75% of heart rate reserve. The intensity level for each of 
the resistance exercises was set at a level which enables the participant to complete the three 
series of 12 repetitions. Intensity was increased each week under the guidance of the trainers. 
If a participant missed a supervised exercise session, an extra session was planned in the 
same or following week, so that each participant performed a total of 24 supervised sessions 
(100% compliance). Assessments were performed before and after 8-week combined 
resistance and aerobic exercise training. A subset of our type 2 diabetes participants (n=8) 
also received a dual endothelin-receptor blocker (Bosentan, Actelion Pharmaceuticals) 
during the first 4 weeks represented 62.5 mg taken orally twice per day, followed by four 
weeks of 125 mg twice daily.28 A priori we expected no impact of this intervention on arterial 
wall thickness and, to increase the power of our study, we have combined these subjects 
with type 2 diabetes patients that performed exercise training only (n=12). However, to 
acknowledge any possible impact of Bosentan on our outcome parameters, we perform an 
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extra statistical analysis in our type 2 diabetes group with ‘Bosentan’ as an additional factor. 
All subjects followed the same exercise training protocol.
All studies were conducted in a quiet, temperature controlled environment and each visit 
for a given subject was performed at the same time of day.  Subjects were asked to fast for 
>4 hours, abstain from alcohol and caffeine for 16 hours, and not to perform any exercise for 
24 hours before testing to exclude variation in resting tone, as this can importantly influence 
wall thickness.29
After reporting to the laboratory, anthropometrics were measured, and a venous blood 
sample was taken to determine glucose and insulin (for calculating HOMA-IR), cholesterol, 
HDL, LDL, and triglycerides. Subsequently, subjects were positioned in the supine position 
on a comfortable bed. After a rest period of at least 15 minutes, blood pressure was 
measured twice using a manual sphygmomanometer, and the mean blood pressure was 
used for analysis. This was followed by assessment of baseline diameter and wall thickness 
at rest of the SFA, BA and CA by a trained sonographer. A 10 MHz multifrequency linear 
array probe attached to a high-resolution ultrasound machine (T3000, Terason, Burlington, 
MA) was used to image the artery lumen (the area from the intima to lumen border on the 
near wall to the lumen to intima border on the far wall) and far wall thickness (WT). Clearly 
demarcated intimal-medial boundaries were obtained via perpendicular incidence imaging 
in relation to the orientation of the vessel. Images were optimized by using contrast controls 
on the ultrasound machine, which was consistently maintained between arteries for each 
individual.30 Ultrasound parameters were set to optimize longitudinal B-mode images of the 
lumen/arterial wall interface. Diameter and WT was collected from 3 distinct angles and data 
was recorded for at least 10 seconds at a sampling frequency of 30 Hz. Values for lumen and 
WT were calculated as the average of all frames and all angles for each sample.
Assessment of the CA was performed with the subject supine and the neck slightly extended 
to allow scanning of the artery. Images for the CA were made on the proximal 1.5 cm 
straight portion of this artery. This was followed by assessment of the SFA diameter and wall 
thickness, which was performed in the proximal third of the thigh, at least 3 cm distal from 
the bifurcation. Assessment of the BA was performed on the distal 1/3rd of the upper arm. The 
repeated measurements were made on the same segment of the artery.
On a subsequent day, subjects performed an incremental cycle exercise test to examine 
maximal workload and peak oxygen consumption. Data from this test were used to determine 
maximal heart rate, which was used to calculate work load during exercise training. Each 
subject performed an incremental maximal exercise test on a cycling ergometer (Lode, 
Excalibur, Groningen, the Netherlands) before and after the training program. These tests 
started at a power output of 10 W for 1 min and power output increased by 10 W/min until 
exhaustion. Subjects were instructed to maintain a cadence of between 60 and 80 rpm 
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during the test. We continuously recorded oxygen consumption (VO2, in ml O2/kg per min), 
ventilation (Ve, in l/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) and heart 
rate (HR, in bpm). Furthermore, we measured blood lactate levels (mmol/l) using Accutrend® 
Lactate (Roche Diagnostics GmbH, type 3012522, Mannheim, Germany) before and 2 min 
after finishing the maximal exercise test. For a test to be classified as successful, at least 3 
out of the following 4 criteria had to be met: clinical signs of exhaustion of the participant, 
respiratory quotient ≥1.10, finishing within 10 beats of the maximum predicted heart rate 
(=220-age), and flattening of VO2 uptake curve (≤110mL increase during the last minute).
31
Analysis of Conduit Artery Diameter and Wall Thickness
Post-test analysis of the CA, BA and SFA was performed by a researcher who was blinded to 
the subject identity and timing of the assessment. Furthermore, we used custom-designed 
edge-detection and wall-tracking software which is largely independent of investigator 
bias.30,32 Briefly, the echo signal was encoded in real-time and stored as a DICOM file using 
an IMAQ-PCI-1407 card. Subsequent software analysis of this data was performed at 30 Hz 
using an icon-based graphical programming language and toolkit (LabVIEWä 6.02, National 
Instruments, Austin, TX). The initial phase of image analysis involved the identification 
of regions of interest (ROI) on the first frame of every individual study. The ROI enables 
automated calibration for diameters on the B-mode image. A ROI was then drawn around the 
optimal area of the B-mode image and within this ROI a pixel-density algorithm automatically 
identified the angle-corrected near and far-wall e-lines for every pixel column within the ROI. 
The same algorithm also identifies the far wall media-adventitia interface. Detection of the 
near and far wall lumen edges and the far wall media-adventitia interface is performed on 
every frame. We have shown that the diameter measurements using this semi-automated 
software possess an intra-observer CV of 5.1%.32  Furthermore, our method of WT assessment 
is closely correlated with a “phantom” artery system.30 To correct for differences in diameter, 
we also calculated the wall-to-lumen ratio (W:L).
Statistics
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago, Illinois). Two-way 
repeated measures ANOVA in both groups were used to examine whether the effect of 
the 8-week lower limb-dominant exercise training (‘training’; 0 versus 8 weeks) on arterial 
diameter, wall thickness and wall-to-lumen ratio differed between the arteries (‘artery’; BA, 
SFA, versus CA). Pretraining values were compared between groups using unpaired t-tests. 
According to guidelines we adopted the least significant difference approach to multiple 
comparisons.33,34 All data are reported as mean (±SD) and statistical significance was assumed 
at P<0.05.
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RESULTS
At baseline, participants with type 2 diabetes demonstrated significantly higher weight, BMI, 
glucose, insulin and HOMA-IR, and lower cholesterol, low-density lipoprotein, peak oxygen 
uptake and peak workload compared to their age-matched controls (Table 1). We found 
no significant differences between groups in (systolic and diastolic) blood pressure and 
triglycerides. Across the 8-week exercise training period, there were no significant changes 
in weight, body mass index, systolic blood pressure, HDL, triglycerides, glucose, insulin, and 
HOMA-IR in either type 2 diabetes or controls (Table 1). We found a significant main effect of 
training for peak oxygen uptake, peak workload, diastolic blood pressure, total cholesterol, 
and low-density lipoprotein, whilst these changes after the 8-week exercise training were 
comparable between type 2 diabetes and controls (Table 1). The group with type 2 diabetes 
significantly used more metformin, sulfonyurea, and statin users compared with the control 
group (Table 1).
Diameter. Prior to exercise training, we found no differences between type 2 diabetes and 
controls in baseline diameter of the BA, SFA and CA. A two-way ANOVA in both groups 
revealed a difference in diameter between vessels in type 2 diabetes and controls (p<0.001, 
Table 2), as well as a significant training*vessel interaction in type 2 diabetes (p=0.023, Table 
2). Subsequent post-hoc testing revealed that training significantly increased BA diameter in 
type 2 diabetes, but not in controls (Table 2).
Wall thickness. Before exercise training, participants with type 2 diabetes demonstrated a 
larger artery wall thickness than controls in the SFA but not BA and CA. A two-way ANOVA 
in both groups revealed an effect of training on wall thickness in type 2 diabetes, which was 
comparable between arteries (Table 2), but no effect of training on wall thickness in controls. 
Furthermore, we found a difference in wall thickness between vessels in type 2 diabetes and 
controls (p<0.001, Table 2). 
W:L-ratio. Before training, participants with type 2 diabetes demonstrated a significantly 
larger W:L-ratio than controls in the SFA and BA, but not CA (Table 2). A 2-way ANOVA in type 
2 diabetes revealed that the effect of exercise training on W:L-ratio differed between the 3 
vessels (Table 2). Post-hoc analysis showed a significant decrease in W:L-ratio in the BA and 
SFA, but not in the CA in type 2 diabetes (Table 2). In controls, the 2-way ANOVA revealed no 
effect of exercise training on conduit artery W:L-ratio.
Bosentan. We performed a separate analysis to examine whether the effect of exercise 
training differed between type 2 diabetes patients with and without Bosentan. Separate 
2-way ANOVA revealed a significant decline in WT and wall:lumen-ratio in the T2DM patients 
with Bosentan, which was similar across the 3 vessels (Table 3). In contrast, the training effect 
in the placebo group on the wall:lumen-ratio and diameter differed between arteries (Table 
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3). Whilst no changes in CA and SFA were found after training in the subgroup on placebo, a 
decline in brachial artery wall:lumen-ratio was found (Table 3).
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Table 1
Maximal cycling test        
Peak Oxygen Uptake (mLO2/min/kg) 22.3±4.8# 24.9±5.1 33.5±7.8 34.2±9.3 0.032 0.182 0.001 
Peak workload (Watt) 159.0±37.1# 192.9±39.2 232.8±47.5 265.6.46.7 <0.001 0.888 <0.001 
Medication use        
Insulin 5  0  0.083   
Metformin 14#  0  <0.001   
Sulfonylurea 8#  0  0.020   
DPP4 inhibitor 0  0  -   
Thiazolidinedione 1  0  0.472   
ACE inhibitor 8  1  0.091   
Angiotensin II inhibitor 5  0  0.083   
Diuretic 6  2  0.559   
Statin 15#  2  0.004   
Beta-blocker 4  0  0.129   
Calcium antagonist 3  0  0.197   
Acetylsalicylic acid 2  0  0.301   
Coumarin derivative 1  0  0.472   
#Post-hoc significantly different from controls at baseline at p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Type 2 diabetes Control 2-way ANOVA 
Characteristics Pre Post Pre Post Training Training*Group Group 
Age (yrs) 59±6  58±7    0.738 
Height (cm) 177±6  180±5    0.218 
Weight (kg) 101.5±19.2# 101.0±19.0 87.1±9.1 86.1±9.1 0.253 0.726 0.050 
Body mass index (kg/m2) 32.6±6.3# 32.4±6.2 26.8±3.5 26.9±3.5 0.694 0.694 0.018 
Systolic blood pressure (mmHg) 139±14 135±11 134±17 127±10 0.056 0.522 0.201 
Diastolic blood pressure (mmHg) 85±10 82±7 84±6 80±4 0.031 0.891 0.726 
Blood parameters        
Cholesterol (mmol/L) 4.4±1.1# 4.2±0.9 5.9±1.1 5.6±1.4 0.048 0.733 0.006 
High-density lipoprotein (mmol/L) 1.0±0.4 1.0±0.3 1.3±0.2 1.3±0.2 0.604 0.473 0.032 
Low-density lipoprotein (mmol/L) 2.6±1.0# 2.5±0.9 4.0±1.1 3.6±1.3 0.031 0.144 0.016 
Triglycerides (mmol/L) 1.9±1.1 1.8±1.8 1.3±0.7 1.6±1.0 0.734 0.485 0.543 
Glucose (mmol/L) 7.6±2.5# 7.0±1.8 4.9±0.3 4.8±0.6 0.451 0.598 <0.001 
Insulin (mmol/L) 15.1±10.5# 19.3±18.8 6.0±3.1 7.0±4.1 0.271 0.500 0.020 
HOMA-IR (10/%S) 5.2±3.8# 6.7±8.4 1.3±0.7 1.6±1.0 0.381 0.513 0.021 
Anthropometrics and training effects in controls, patients with type 2 diabetes mellitus and controls. Data is 
presented as mean ± SD. P-values represent a two-way repeated measures ANOVA, except for ‘Medication use’, 
where P-values represent Pearson’s χ2. 
#Post-hoc significantly different from controls at baseline at p<0.05.
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DISCUSSION
The aim of this study was to examine whether exercise training in type 2 diabetes leads to 
site-specific adaptations on wall thickness in peripheral arteries supplying active (i.e SFA) 
versus inactive (i.e. BA) areas, and central (CA) vessels. Our results suggest that 8 weeks of 
combined aerobic (70-75% of maximal heart rate) and resistance (3 series of 12 repetitions) 
lower-limb based exercise training is associated with a significant decrease in wall-to-lumen 
ratio in both the SFA and BA, but not in the CA. These findings suggest that this type of exercise 
training in type 2 diabetes leads to a site-specific adaptation in arterial wall-to-lumen ratio, 
with systemic remodelling of peripheral vessels supplying the active and inactive regions, 
but no adaptation of central arterial wall-to-lumen ratio.
To our knowledge, this study is the first to investigate the effect of exercise training on wall 
thickness in peripheral and central conduit arteries in type 2 diabetes patients. We found 
that 8 weeks of exercise training in type 2 diabetes is associated with a significant decrease in 
arterial wall thickness of peripheral arteries (i.e. SFA and BA).  The ability of exercise training 
to decrease peripheral artery wall thickness is in line with some,17,35,36 but not all,37 previous 
studies which examined remodelling of peripheral conduit arteries after exercise training in 
healthy volunteers. An important observation in our study is that we found similar decreases 
in wall thickness of the BA and SFA, whilst subjects performed lower limb-dominant exercise 
training only. This, together with the increase in BA lumen diameter we observed, strongly 
supports the presence of systemic adaptations in wall thickness after exercise training in 
type 2 diabetes. Interestingly, a recent study from Maiorana et al. also reported a significant 
decrease in BA WT after a similar exercise training protocol in patients with heart failure. This 
suggests that exercise training, in healthy subjects and those with increased cardiovascular 
risk, has a systemic effect on peripheral conduit artery wall thickness.16
We found no improvements in the CA after exercise training both in type 2 diabetes and in 
controls, which is in marked contrast to a recent exercise training study from Kadaglou. One 
potential explanation for this discrepancy is the absence of pre-training differences in CA WT 
between patients with type 2 diabetes and controls, as a higher pre-training CA WT would 
allow for a larger decline. For example, Kadaglou et al.24 found a decrease in CA WT after 
training in T2DM patients who demonstrate a much higher CA WT at baseline than in our 
study (± 0.8 mm versus ± 0.6 mm). Another explanation is the duration of the study, which 
was markedly longer in the study by Kadaglou et al. compared to our study. Furthermore, 
Kadaglou et al. only found an effect on CA WT after aerobic exercise training, and not after 
combined exercise training. Therefore, the type of exercise may importantly impact the 
effect on WT. Other previous cross-sectional and longitudinal studies in healthy controls 
and subjects with cardiovascular risk/disease found that exercise training is associated with 
a decrease in CA WT (see review38). Also studies that specifically examined type 2 diabetes 
patients39,40 reported an association between higher physical activity levels and smaller CA 
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WT. This suggests that the ability of exercise training to decrease WT is not exclusively related 
to a priori thickening of the arterial wall. Future studies should look into specific differences 
between exercise training durations and modalities in type 2 diabetes.
Alternatively, the site-specific changes observed in our study may relate to a larger adaptive 
response of peripheral vessels for wall thickness compared to the carotid artery. In line with 
this, Moreau and colleagues found that exercise training in post-menopausal women was 
associated with a generally lower wall thickness of the SFA, but not the CA.18 In a previous 
study in older men, we also found no effect of 8-week exercise training on CA WT.37 These 
site-specific adaptations may relate to the characteristics of the wall, contributing to distinct 
vascular adaptations to stimuli between arteries.41,42 Future studies should further examine 
the potential differences in adaptation between arteries, and especially the time it takes 
for central and peripheral arteries to adapt in response to exercise training. Taken together, 
our data endorse the concept that exercise training leads to systemic adaptation of conduit 
artery wall thickness in type 2 diabetes patients, but that the effects of exercise training has a 
site-specific effect on peripheral versus central conduit arteries.
The finding of a site-specific adaptation in artery wall thickness renders the question 
regarding the mechanisms involved that relate to adaptation in artery wall thickness. 
When looking at functional as opposed to structural outcome measures, a large number 
of previous studies in animals43,44 and humans15,45 have identified shear stress as the key 
stimulus for localised adaptation in conduit arteries. For example, recent studies in humans 
found that that adaptation in BA function as measured by flow mediated dilation in response 
to 8-weeks exercise training45,46 or heat exposure47 are abolished in the contra-lateral arm 
when the increases in shear rate are mitigated by subdiastolic cuff inflation. Interestingly, 
when a similar design was used to examine the importance of the shear rate stimulus for 
adaptation in wall thickness, the abolished shear stimulus did not prevent the decreases 
in BA WT across 8-weeks of handgrip training.35 This suggests that shear stress may not 
represent the principle stimulus for adaptations in wall thickness. Alternatively, systemic 
hemodynamic stimuli, such as cyclic transmural pressure changes, have been suggested to 
explain the impact of exercise training on WT.48 Our study provides further evidence for the 
importance of systemic stimuli to induce changes in wall thickness, as we found a decrease 
in BA WT after lower limb-dominant exercise training. Studies, largely performed in animals, 
found that such stimuli are associated with remodelling and anti-atherogenic effects (e.g. 
eNOS-expression/activity,49 EDHF-synthase expression50). Alternative systemic mechanisms 
may relate to novel markers, such as endothelial progenitor cells (EPCs) and miRNA.6 Other 
potential systemic, non-hemodynamic factors that may contribute to our findings relate 
to changes in muscle sympathetic nerve activity, vasoconstrictor tone, antioxidant level or 
inflammation (see review48).
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Clinical relevance
Previous studies have suggested that arterial wall thickness represents a surrogate measure 
for (the development of) atherosclerosis. More specifically, several studies have demonstrated 
a strong and independent predictive capacity for the CA WT for future cardiovascular and 
cerebrovascular events.10 Not surprisingly, studies have also found predictive capacity of the 
SFA22 and BA20,21 WT for future development of cardiovascular events. Our findings, therefore, 
have important clinical relevance. The significant decline in peripheral artery wall thickness 
may contribute, at least partly, to the cardioprotective effects of exercise training in patients 
with type 2 diabetes.
Previous studies from our group17,35 have shown that 8 weeks of exercise training in young 
healthy controls resulted in decreases in WT, whilst the current study did not reproduce 
this finding in the control group. A possible explanation for this discrepancy could be that 
a higher physical fitness in the younger subjects in Thijssen’s study led to a higher absolute 
workload during the exercise bouts. The absolute lower workload in our study may not have 
been sufficient to elicit peripheral adaptations in controls. Also, as suggested by Maiorana 
et al.,16 the type of exercise training may partly explain the discrepancies, as the previous 
studies employed continuous cycling17 and handgrip35 exercise, as opposed to combined 
aerobic and strength training in the current study. 
It is important to emphasise that some of the type 2 diabetes subjects ingested Bosentan. 
Before training we did not expect any impact of Bosentan on wall thickness and/or that 
Bosentan would alter the impact of exercise training on wall thickness in type 2 diabetes. 
However, a post-hoc analysis between type 2 diabetes patients with and without Bosentan 
revealed a significant difference in the impact of exercise training on BA, SFA and CA wall 
thickness between type 2 diabetes patients with and without Bosentan. Interestingly, type 2 
diabetes patients using Bosentan did not demonstrate the site-specific change in diameter 
and wall:lumen-ratio as observed in the pooled data set or in the type 2 diabetes subjects 
using placebo (Table 3). This suggests that Bosentan induces a systemic change in diameter 
and wall:lumen-ratio, possibly by influencing the vascular tone that, subsequently, can alter 
diameter and wall:lumen-ratio.29  This systemic effect is not present in the placebo group and 
disappears when combining both data sets. Taken together, Bosentan may have contributed 
somewhat to the effects of exercise training on diameter and wall:lumen-ratio. However, since 
these effects are likely to be systemic, the use of Bosentan does not alter the main findings of 
our study, in that exercise training can lead to site-specific adaptations in wall:lumen-ratio. 
Limitations
The strengths of our study relate to the highly controlled exercise training, inclusion of 
a control group, within-subject comparisons, the use of semi-automated and validated 
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analysis software and the blinded analysis of our data. A potential limitation of our study is 
the a priori differences between type 2 diabetes subjects and controls in physical fitness. The 
type 2 diabetes patients were less fit at baseline, meaning that the window of opportunity 
for improvement in this group was larger than in controls. Another possible limitation is that 
we did not record WT under complete relaxation, effectively eliminating the influence of 
resting tone on WT.29 Our results may therefore relate to a lower vascular tone after training. 
However, observation of a similar WT in the carotid artery after exercise training suggests 
that (systemic) changes in vascular tone unlikely explain the main finding of our study. 
Another limitation is that even though subjects were instructed to minimize the gripping of 
handlebars, we cannot fully rule out the possibility that subjects were gripping handlebars 
during some of the resistance exercises. This may have impacted our results, especially the 
increase in BA diameter may relate to a higher activity level of upper limbs as anticipated.15 A 
final limitation is the difference between groups concerning medication use, which is difficult 
to control for statistically or methodologically. Therefore, we cannot rule out the possibility 
that our results are influenced by the systemic effects of the medication interacting with 
exercise training in patients with type 2 diabetes mellitus.
In conclusion, we found that an 8-week exercise training program in patients with type 2 
diabetes mellitus is associated with site-specific decreases in WT. As training involved lower 
limb-dominant exercise, the significant decrease in WT of both the SFA and BA suggests 
the presence of generalised adaptation in the peripheral arterial wall in arteries that supply 
active and non-active regions, respectively. However, the absence of changes in the CA 
suggests that the effects of exercise training on WT differ between peripheral and central 
vessels. Whether this site-specific difference relates to the a priori differences in WT between 
groups or to site-specific sensitivity in adaptation remains to be elucidated. Based on the 
prognostic information of conduit artery WT for future cerebro- and cardiovascular events, 
the site-specific decreases in arterial WT may contribute to the beneficial impacts of exercise 
training on cerebro-and cardio-vascular events in type 2 diabetes.
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ABSTRACT
Background Exercise training improves physical fitness, insulin resistance and endothelial 
function in type 2 diabetes. Hypoxia may further optimize these beneficial effects. The aim of 
this study was to compare the effects of hypoxic versus normoxic exercise training on physical 
fitness, endothelial function, and insulin resistance in type 2 diabetes.
Methods Peak oxygen consumption, flow mediated dilation (endothelial function), and 
glucose homeostasis were assessed in 19 patients (55±7 years) before and after an 8-week 
intervention. Subjects were randomly allocated to normoxic (21% O2, n=9) or hypoxic 
(16.5% O2, n=10) exercise training. Endothelium-independent dilation was examined using 
sublingual administration of glyceryl trinitrate, and used to calculate the ratio between 
endothelium-dependent and -independent dilation.
Results Exercise training improved physical fitness and brachial artery ratio between 
endothelium-dependent and -independent dilation (both P<0.05), whilst these exercise 
training-induced changes were similar in both groups (interaction-effects P>0.05). Exercise 
training did not significantly change brachial artery flow-mediated dilation or glyceryl 
trinitrate-response, superficial femoral artery flow-mediated dilation, or glucose homeostasis, 
whilst hypoxia did not alter the impact of exercise training.
Conclusion Contrary to our hypothesis, hypoxia does not potentiate the effect of exercise 
training on physical fitness, vascular function, or glucose homeostasis in type 2 diabetes.
KEYWORDS: cardiovascular risk; exercise training; metabolic disease; hypoxia; type 2 
diabetes
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INTRODUCTION
Type 2 diabetes is associated with an impaired endothelial function,1 contributing to the 
development of cardiovascular disease.2 Exercise training improves glucose homeostasis 
and endothelial function, and consequently reduces the risk of cardiovascular disease in 
type 2 diabetes.3
In a previous study in healthy subjects, an acute bout of hypoxic endurance exercise 
demonstrated to have superior effects on maximal oxygen uptake and insulin sensitivity 
compared to a single bout of normoxic endurance exercise.4 In addition, the addition 
of hypoxia to resistance training in healthy subjects lead to significantly larger muscle 
hypertrophy than performance of resistance training under normoxic conditions.5 Specifically 
in type 2 diabetes, a single bout of hypoxic endurance exercise had superior effects on insulin 
sensitivity compared to normoxic exercise.6 However, the effect of hypoxic exercise training 
on insulin sensitivity has not been studied in type 2 diabetes.
Hypoxic exercise may also potentiate the effects on the vasculature. Combining hypoxia 
with exercise leads to an improved flow-mediated dilation (FMD) and larger blood flow to 
the active muscles than exercise under normoxia in healthy men.7 Given the importance of 
exercise-induced blood flow to induce vascular adaptations,8 the combination of exercise 
with hypoxia may lead to superior effects on vascular adaptation compared to normoxic 
exercise training, especially in type 2 diabetes patients, who typically demonstrate an 
attenuated exercise-induced blood flow. Therefore, the aim of this study is to examine 
the hypothesis that hypoxic exercise training leads to superior effects on maximal oxygen 
uptake, endothelial function, and insulin resistance in type 2 diabetes patients compared to 
normoxic exercise training.
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METHODS
Subjects
19 subjects (55±7 years, 14 male, 5 female) who were diagnosed with type 2 diabetes at 
least two years ago were recruited. Exclusion criteria included overt cardiovascular disease, 
smoking, type 1 diabetes mellitus, age <40 or >65 years, and/or diabetes-related manifest 
complications. The study procedures were approved by the medical ethical committee of the 
Radboud University Nijmegen Medical Centre and adhered to the Declaration of Helsinki. All 
subjects gave written informed consent before participation in this study.
Experimental design
Patients reported to the laboratory twice. First, we examined brachial artery function and 
structure, insulin resistance, and physical fitness. Subsequently, subjects underwent an 
8-week, supervised exercise training program. Before the start of the training program, in 
a randomized manner, subjects were assigned to either perform exercise training bouts 
under normoxia (21% O2) or under hypoxia (16.5% O2). Since we adopted a randomization 
procedure, factors such as age, weight, and sex, were not taken into account. After the 8-week 
intervention, with at least 24 hours between the last exercise bout and testing, we repeated 
all tests as listed above. Subjects were not blinded to the type of intervention. However, the 
researcher that performed the echo-Doppler measurements and who performed the analysis 
was blinded to the intervention.
Measurements: subject characteristics, insulin resistance and physical fitness
Subject characteristics. During a screening procedure at the first visit, all subjects 
completed a questionnaire concerning their medical history and medication use. We 
measured height, weight, resting blood pressure after a 5-minute seated rest using a manual 
sphygmomanometer. A venous blood sample was taken for assessment of fasting glucose, 
insulin, total cholesterol, HDL, LDL, and triglycerides. 
Insulin resistance. Besides using HbA1c to assess insulin resistance, from the glucose 
and insulin levels we also calculated the HOMA-IR index via the formula HOMA-
IR=(Glucose*Insulin)/22.5.9
Physical fitness Subjects performed an incremental cycle exercise test on a cycling ergometer 
(Lode, Excalibur, Groningen, the Netherlands) before and after the training program to 
examine maximal workload and peak oxygen consumption. The tests started at a power 
output of 10 W for 1 min and power output increased by 10 W/min until exhaustion. We 
continuously recorded oxygen consumption (VO2, in ml O2/kg per min), ventilation (Ve, in 
l/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) and heart rate (HR, in bpm). 
Furthermore, we measured blood lactate levels (mmol/l) using Accutrend® Lactate (Roche 
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Diagnostics GmbH, type 3012522, Mannheim, Germany) before and 2 min after finishing the 
maximal exercise test. Data from this test were used to determine maximal heart rate, which 
was used to calculate work load during exercise training.
Measurements: vascular function
All subjects refrained from alcohol, caffeine, and vigorous physical exercise for at least 24 
hours prior to vascular testing. All tests were performed in laboratory conditions with constant 
temperature (22°C) and humidity (35%). We performed all tests between 8 AM and 4 PM. To 
control for variation in FMD, pre- and post-exercise training measurements for each subject 
were performed at the same time of day to prevent diurnal variation in the FMD response.10
Brachial artery endothelium-dependent dilation. Measurement of brachial artery 
endothelium-dependent dilation (via the flow-mediated dilation (FMD)) was performed as 
described in detail before.11 
Brachial artery peak blood flow. After a >15-minute rest period, a 1 min baseline recording 
of brachial artery diameter and blood flow was performed. Next, brachial artery dilation was 
examined after a 5-minute period of ischemia, consisting of 1 min ischemia, followed by 
3-min isotonic handgrip exercise and a final 1 min of ischemia. Handgrip exercise involved 
1 contraction every 2 s of a 3-kg load. The peak hyperemic forearm blood flow in response 
to this stimulus in humans provides a valid and accepted index of resistance artery size or 
remodeling.12 We resumed diameter and flow recordings 30 s prior to cuff deflation and 
continued for 3 min thereafter.
Superficial femoral artery endothelium-dependent dilation. The cuff was placed at the 
thigh of the imaged leg, directly above the knee. Measurement of superficial femoral artery 
endothelium-dependent function was performed as described above for the brachial artery. 
Measurements continued for 5 minutes after cuff deflation. A previous study found that 
this procedure results in a largely NO-mediated, endothelium-dependent dilation of the 
superficial femoral artery.13
Brachial artery endothelium-independent dilation. Following a rest period of at least 
15 minutes to allow brachial artery diameter and flow to return to baseline levels, a 
1-minute baseline recording of diameter and flow was taken. Subsequently, brachial artery 
endothelium-independent vasodilation was examined after administration of a single spray 
of sublingual GTN (400 µg), a NO donor. The endothelium-independent dilation through GTN 
was also used to calculate the ratio between endothelium-dependent and -independent 
dilation (FMD/GTN-ratio). This measure is assumed to correct endothelial function for 
potential differences and/or changes in endothelium-independent dilation.
Post-test analysis of brachial and superficial femoral artery diameter and velocity was 
performed using custom-designed edge-detection and wall-tracking software, as described 
elsewhere.11 
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Exercise training
Exercise training was performed for 8 weeks, 3 times a week. Each session was supervised 
by an experienced fitness coach and consisted of a warming-up, a cycling protocol of 45 
minutes, and a series of weight training exercises. A heart rate monitor (Polar Electro Oy, 
Kempele, Finland) was used to continuously monitor heart rate during the aerobic exercise 
and heart rate was maintained at 70-75% of the heart rate reserve. This type of training is 
demonstrated to improve vascular function and structure in healthy subjects14,15 as well as 
in those with cardiovascular risk or disease.16,17 Exercise was performed under normoxic or 
hypoxic conditions. The hypoxic exercise training was performed in a mobile high altitude 
chamber (3.00x3.00x2.70 m, designed and manufactured by b-Cat B.V., Tiel, The Netherlands) 
where the oxygen content was artificially lowered to 16.5%, equivalent to approximately 
2.000 m altitude.
Statistical analysis
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago (Illinois), USA) software. 
According to Woodman et al. our sample size is sufficient to detect clinically relevant 
differences in our primary outcome measures.18 All data are reported as mean (SD) unless 
stated otherwise, and statistical significance was assumed at P≤0.05. Unpaired Student’s 
t-tests were used to compare baseline values between groups. A two-way repeated measures 
ANOVA was used to examine changes in physical fitness, glucose homeostasis and vascular 
function/structure across the exercise training period (‘training’; 0 versus 8 weeks), and 
whether the magnitude of the exercise training-mediated adaptations differ between groups 
(‘group’; hypoxia versus normoxia). When a significant main- or interaction-effect was found, 
post-hoc comparisons were performed to identify differences with/without ET-receptor 
blockade. According to a recent study by Atkinson et al., inadequate scaling for FMD would 
be present if the upper confidence limit of the regression slope of the relationship between 
logarithmically transformed base diameter and peak diameter is less than one.19 Therefore, 
we checked our data for this phenomenon, and where appropriate we performed the 
allometric modelling solution proposed by Atkinson et al.19
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RESULTS 
Baseline characteristics
Prior to the 8-week intervention, we found no significant differences between the groups 
that performed exercise training under hypoxia (n=10) or normoxia (n=9) for height, weight, 
BMI, blood pressure, total cholesterol and lipid profile (all comparisons P>0.05, Table 1). The 
8-week exercise training intervention did not alter these parameters in any of the groups 
(Table 1).
Physical fitness
Prior to the intervention, we found no differences between groups in peak workload or peak 
oxygen uptake (Table 2). Exercise training resulted in a significant increase in peak oxygen 
uptake and peak workload, which was comparable between hypoxia and normoxia (Table 
2). Maximal heart rate and peak lactate were similar before and after the exercise training 
program, independent of the group examined (Table 2).
Vascular function
At baseline, we found no differences between groups in brachial artery diameter, FMD, shear 
rate, GTN-response, and FMD/GTN. In addition, we found no differences between groups for 
superficial femoral artery diameter, FMD, and shear rate (all comparison P>0.05, Table 3).
Brachial artery endothelium-dependent dilation. Exercise training did not change brachial 
artery flow mediated dilation, baseline diameter, or shear rate area-under-the-curve in both 
groups (Table 3).
Brachial artery endothelium-independent dilation. Endothelium-independent vascular 
function, measured as the dilatory response to a single, sublingual dose of glyceryl trinitrate 
(GTN), was not altered by exercise training in hypoxia or normoxia. We found a significant 
training effect for FMD/GTN-ratio, independent whether exercise training was performed 
under hypoxia or normoxia (Table 3).
Brachial artery peak blood flow. Exercise training did not change brachial artery peak blood 
flow in either group (Table 3). 
Superficial femoral artery endothelium-dependent dilation. In the superficial femoral artery, 
exercise training did not change baseline diameter, flow mediated dilation, nor shear rate 
area-under-the-curve (Table 3).
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Insulin resistance
Before training, we found no differences in insulin, glucose, HbA1c and HOMA-IR between 
groups (all comparisons P>0.05, Table 4). In both groups, we found no main effect of exercise 
training on blood glucose, insulin or HOMA-IR (Table 4). We found a significant training*group 
interaction effect on HbA1c. Whilst HbA1c levels decreased after hypoxia-training and 
increased after normoxia-training, post-hoc analysis revealed that these changes did not 
reach statistical significance (Table 4).
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DISCUSSION
The aim of this study was to examine the hypothesis that exercise training under hypoxia 
has a stronger impact on physical fitness, endothelial function, and insulin resistance in type 
2 diabetes patients than exercise training under normoxia. First, we confirmed the potent 
effect of exercise training, given the significantly improved peak oxygen uptake and peak 
workload. Second, we found evidence for improvement in vascular function in the brachial 
artery, whilst no such effect of exercise training was found on vascular function in the lower 
limbs, or in glycaemic control. More importantly, we found that the effects of exercise training 
in type 2 diabetes were not different between hypoxia and normoxia. This suggests that, in 
contrast to our hypothesis, exercise under hypoxia does not further improve the effect of 
exercise training on physical fitness, endothelial function and glucose homeostasis in type 
2 diabetes.
We found a 10% increase in peak oxygen uptake after the exercise training program. This 
indicates that the training intervention was successful in improving the physical fitness of 
the subjects. The magnitude of improvement in physical fitness after 8 weeks is in agreement 
with studies that used an exercise training program of similar duration and intensity.17,20 
Regarding endothelial function, we did not observe an effect of exercise training on brachial 
or superficial femoral artery FMD, which contrasts with previous studies that typically report 
an increase in FMD after training in type 2 diabetes.21,22 In our study, when we corrected the 
brachial artery responses for smooth muscle cell dilation to GTN, we found that exercise 
training resulted in a significant increase in FMD/GTN-ratio. This measure is believed to 
reflect endothelial function and corrects for differences and/or changes in endothelium-
independent dilation. Therefore, after correcting for individual changes in endothelium-
independent dilation, we found that exercise training significantly improved endothelial 
function after exercise training in type 2 diabetes.
In the superficial femoral artery, we found no impact of exercise training on flow-mediated 
dilation. We expect that this is not due to measurement or methodological errors, given the 
relatively large group of subjects (total n=19) and the fact that the analysis was performed 
blinded. Due to practical limitations, we were not able to examine the endothelium-
independent dilation in the superficial femoral artery (or examine the FMD/GTN-ratio). 
Such analysis, like in the brachial artery, may have provided more detailed insight into 
the impact of exercise training on the superficial femoral artery endothelial function. A 
potential explanation for the absence of an effect of training on FMD is the existence of a 
time-dependent change in vascular adaptations. A previous study in healthy men found that 
exercise training leads to an initial increase in FMD in the upper and lower limbs, followed 
by a normalisation when exercise was continued.15 In recent unpublished data, we have 
confirmed the presence of such a time-dependent adaptation of upper and lower limb 
conduit artery endothelial function in middle-aged men and type 2 diabetes. Accordingly, 
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time-dependent changes in FMD during training may result in missing an increase in FMD 
in response to exercise training when examining this data at a single time point only. This 
highlights the importance of examining the time-course of adaptations to exercise training 
to truly understand the impact of exercise training in type 2 diabetes. 
Our training intervention had no effect on glycaemic control, which contrasts with several 
other studies that examined the effect of an 8-26 weeks training exercise program and reported 
that exercise training improves insulin resistance.17,23 However, the finding of a decrease in 
insulin resistance is equivocal, as other studies with similar duration and intensity of exercise 
training in type 2 diabetes reported no change in insulin resistance.24,25 This disparity may 
be, at least partly, explained by the finding that glycaemic control is less likely to improve 
during exercise training in older type 2 diabetes patients (>55 years) compared with younger 
subjects26 and in type 2 diabetes patients with lower a priori levels of insulin resistance. To 
support this hypothesis, Maiorana et al.17 found an improvement in a relatively high fasting 
glucose from 12.0±0.5 to 9.8±0.5 mmol/L, whilst we found pre-training fasting glucose 
levels that were already well below the post-training values reported by Maiorana et al (i.e. 
7.5±2.7 mmol/L). Furthermore, we included a relatively old group of type 2 diabetes patients. 
Therefore, the relatively mild level of insulin resistance, combined with the inclusion of a 
relatively older group of participants, may contribute to the absence of a marked impact of 
our exercise training program on insulin resistance.
In contrast with our hypothesis, we found no differences in effect sizes between hypoxic and 
normoxic exercise training in any of our primary outcome measures. A potential explanation 
is related to the fact that exercise intensity during each exercise bout was based on heart 
frequency, whilst exercise under hypoxia importantly alters the heart rate response to 
exercise.27 We have recalculated training intensity relative to peak oxygen uptake. A previous 
study28 found that VO2peak under hypoxia is approximately 91% of the VO2peak achieved under 
normoxia. In other words, maximal heart rate under hypoxia is reached at 91% of maximal VO2-
uptake. Therefore, training at 70-75% of the heart rate reserve under hypoxia corresponded 
with an absolute level of oxygen uptake that is already achieved at 64-68% of the heart rate 
reserve when exercise is performed under hypoxia. 
The impact of hypoxia on the heart rate and workload response should therefore be 
considered when comparing both types of exercise. To circumvent this problem, the 
incremental cycling test to determine heart rate and workload levels for the exercise sessions 
should be performed under hypoxic conditions (i.e. similar to that during the training 
sessions).28 Furthermore, previous studies have not equivocally found a positive effect of 
hypoxic training, and especially in better trained individuals, the added effect of hypoxia on 
exercise training has been found to be small.29 Alternatively, the effect of hypoxia may be 
greater when added to resistance training, via a direct effect on muscle mass and GLUT-4, 
as opposed to endurance or circuit training.5 Taken together, our data suggest that hypoxic 
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exercise training, despite being associated with a lower absolute workload, lead to similar 
adaptations in physical fitness and vascular function compared to normoxic exercise training 
in type 2 diabetes. Although associated with important practical issues, future studies 
comparing hypoxic and normoxic exercise should include isocaloric types of exercise to truly 
examine the potential additional benefit of hypoxia.
Limitations
A limitation is that the subjects were not blinded to the intervention, which may have 
introduced a bias in our study. However, because we carefully controlled each exercise 
session, by individually controlling exercise intensity via heart frequency, we have minimised 
any possibly bias in our study. Another limitation is the between-subjects setup. Nonetheless, 
we found a significant effect of exercise training on physical fitness and vascular function. 
A priori we performed a sample size calculation, which revealed that our study size was 
strong enough to detect clinically and physiologically relevant differences between both 
interventions. Another limitation of this study is the simulated altitude of 2000 meter. 
Other studies reporting synergistic effects of hypoxia and exercise have typically adopted 
higher simulated altitudes.6,7 Since our participants were deconditioned patients we chose 
an altitude of 2000 m to perform the training. However, the potential synergistic effect of 
hypoxia may depend on the magnitude of hypoxia.
In conclusion, 8 weeks of lower limb-dominant exercise training significantly improved 
physical fitness and brachial artery FMD/GTN-ratio in patients with type 2 diabetes mellitus, 
but failed to improve superficial femoral artery function or glycaemic control. Furthermore, 
in contrast to our hypothesis, hypoxia had no additional effect on our primary outcome 
parameters. This suggests that training under hypoxia does not potentiate the effect of 
exercise training on physical fitness, the vasculature, and glucose homeostasis in type 2 
diabetes.
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ABSTRACT
Retrograde shear rate (SR) in the brachial artery is associated with endothelial dysfunction; 
a precursor to atherosclerosis. The brachial artery (BA) does not typically manifest clinical 
atherosclerosis, whilst the superficial femoral artery (SFA) is more prone to developing 
plaque.
Aim Examine whether the impact of incremental levels of retrograde SR differs between 
atherosclerosis-prone (i.e. SFA) and –resistant vessels (i.e. BA) in healthy men.
Methods Thirteen healthy young men reported 3 times to the laboratory. We examined BA 
flow-mediated dilation (FMD) before and after 30-minutes exposure to cuff inflation around 
the forearm at 0, 30 and 60 mmHg, to manipulate retrograde SR. Subsequently, the 30-minute 
intervention was repeated in the SFA, using the same cuff pressure as in the forearm. Order of 
testing (vessel and intervention) was randomised among subjects.
Results We found a dose-dependent increase in retrograde SR with 30 and 60 mmHg cuff 
inflation, which was present in both the BA and SFA (all p<0.05). BA and SFA FMD decreased 
after the 30-minute intervention (‘time’: P=0.012), and this was dependent on cuff pressure 
(‘cuff*time’: P=0.024). A significant decrease in FMD was observed after 60 mmHg only and 
this change were similarly present in both arteries (‘time*artery’: P=0.227). Moreover, the 
BA and SFA demonstrate a similar relationship between changes in retrograde SR and FMD 
(r=0.498 and 0.475, respectively).
Conclusion Our study demonstrates that acute exposure to an increase in retrograde shear 
leads to comparable decreases in flow-mediated dilation in atherosclerotic-prone and –
resistant conduit arteries in humans.
KEYWORDS: retrograde shear stress, endothelial function, shear stress pattern, echo-
doppler, atherosclerosis..
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INTRODUCTION
Shear stress, i.e. the frictional force of blood on the arterial wall, represents an important 
stimulus for arteries to adapt.1-3 Changes in shear stress directly influence the endothelium 
of arteries, which plays a crucial role in the regulation of blood flow and maintenance of the 
quality of blood vessels.4 Across the cardiac cycle, shear stress demonstrates a typical pattern, 
flowing towards the periphery during systole (antegrade shear), and back to the heart during 
diastole (retrograde shear). Previous animal studies demonstrated that antegrade shear 
stress is associated with positive, anti-atherogenic effects on the endothelium,1,5-9 whilst 
retrograde shear stress is associated with pro-atherogenic effects on the endothelium,2,10,11 
In a previous study in humans, we manipulated the magnitude of retrograde shear rate 
and reported an inverse and dose-dependent relationship between retrograde shear rate 
and brachial artery endothelial function.2 However, the impact of retrograde shear rate on 
endothelial function may differ between different arteries.
The brachial artery is not commonly associated with atherosclerosis-related complications,12 
which raises the question of whether the impact of retrograde shear rate on endothelial 
function can be extrapolated to other vascular beds, such as the atherosclerotic-prone 
arteries of the lower limbs. Previous studies have examined dilatory responses to ischemia-
induced increases in shear13,14 and intra-arterial infusion of vasoactive substances15 in upper 
and lower limb arteries of young subjects and found more pronounced dilator responses in 
the upper limbs. These observations suggest differences in vascular responsiveness between 
upper and lower limbs in healthy, asymptomatic subjects. To date, no study has compared 
the impact of exposure of retrograde shear on conduit artery endothelial function between 
lower and upper limbs.
Therefore, the principle aim of this study was to compare the immediate (i.e. 30-minute) 
impact of incremental steps of retrograde shear rate on brachial artery and superficial 
femoral artery endothelial function in healthy young men. We hypothesised that exposure 
to incremental levels of retrograde shear rate would result in a smaller decrease in an upper 
limb, atherosclerosis-resistant conduit artery compared to a pro-atherosclerotic, lower limb 
artery. For this purpose, we examined flow-mediated dilation (FMD, a surrogate measure of 
endothelial function) before and after 30-minute manipulation of retrograde shear rate by 
cuff inflation around the forearm and thigh.
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METHODS
Subjects
Thirteen healthy, recreationally active men (24 ± 3 years, BMI: 22.8 ± 2.7 kg/m2) were recruited 
from the community. Recreationally active was defined as 1-7 h of exercise training per week. 
No subject reported having been diagnosed with cardiovascular disease or risk factors such 
as hypercholesterolemia or hypertension. Subjects who were on medication influencing the 
cardiovascular system were excluded.  The study procedures were approved by the Ethics 
Committee of Radboud University Nijmegen Medical Centre, adhered to the Declaration of 
Helsinki and all subjects gave prior written consent.
Experimental Design
Each subject reported three times to the laboratory. On each day, we examined the impact 
of a 30-minute intervention on the brachial and femoral artery endothelial function. 
Measurements in the upper and lower limb artery were performed consecutively, whilst the 
cuff pressure was randomised between days and between subjects. All measurements are 
done under standardized conditions and unilaterally (i.e. right side). Endothelial function 
was examined using the flow mediated dilation (FMD), which involves an ischemic stimulus 
induced by distal cuff inflation to supra-systolic level for 5-minutes. Brachial and superficial 
femoral artery FMD was performed before and immediately after each 30-minute intervention, 
which consisted of inflating an occlusion cuff (placed around the forearm or thigh) to 0, 30 or 
60 mmHg (randomised between the 3 days).
Experimental Procedures
Vascular function assessments were conducted in a quiet, temperature controlled 
environment and according to recent expert consensus guidelines.16 Repeated laboratory 
visits were conducted at the same time of day to control for diurnal variation.  Before each 
test, subjects were instructed to fast for at least 6 hours, abstain from alcohol and caffeine for 
18 hours and avoid any exercise for 24 hours. 
Flow-mediated endothelium-dependent vasodilator function (FMD%). 
Before and after the 30-minute intervention, we assessed the flow-mediated dilation (FMD); 
i.e. an endothelium-dependent, partly nitric oxide mediated dilation.17-19 First, subjects rested 
in the supine position for a period of at least 15-minutes to facilitate baseline assessment of 
heart rate and blood flow.  Heart rate, systolic, diastolic, and mean arterial pressure were 
determined from a manual sphygmomanometer by an experienced researcher, measured 
twice in the left brachial artery after a resting period in the supine position of at least 5 minutes. 
To examine brachial artery FMD, the right arm was extended and positioned at an angle of 
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~80o from the torso.  A rapid inflation and deflation pneumatic cuff (D.E. Hokanson, Bellevue, 
WA) was positioned on the forearm of the imaged arm immediately distal to the olecranon 
process to provide a stimulus to forearm ischaemia.20 A 10-MHz multi-frequency linear array 
probe attached to a high resolution ultrasound machine (T3000; Terason, Burlington, MA) 
was used to image the brachial arteries in the distal 1/3rd of the upper arm.  When an optimal 
image was obtained, the probe was held stable and the ultrasound parameters were set 
to optimize the longitudinal, B-mode images of lumen-arterial wall interface. Continuous 
Doppler velocity assessment was simultaneously obtained using the ultrasound machine, 
and was collected using the lowest possible insonation angle (always <60o), which did not 
vary during each study. Baseline images were recorded for 1-minute.  The forearm cuff was 
then inflated (>200 mmHg) for 5-minutes.  Diameter and blood flow recordings resumed 30 
sec prior to cuff deflation and continued for 3 minutes thereafter.
After performance of the post-intervention measurement of the brachial artery FMD, we 
repeated this procedure for the superficial femoral artery. Subjects rested supine with 
the lower leg slightly elevated, while resting on ~15 cm thick foam. The rapid inflation/
deflation pneumatic cuff was positioned approximately 15 cm below the inguinal ligament 
to induce the 5 minute ischemic stimulus. Recording of the right superficial femoral artery 
were performed in the proximal third of the thigh, at least 3 cm distal from the bifurcation 
and above the occlusion cuff. Post-deflation recording of the superficial femoral artery was 
performed for 5 minutes. Performance of the ultrasound recordings for a single subject was 
performed by the same experienced sonographer.
Interventions. 
Immediately after the initial FMD assessment, a 30-minute intervention was performed.  To 
manipulate brachial artery shear, an occlusion cuff was placed around one forearm and 
inflated to 0, 30 or 60 mmHg. Manipulation of shear patterns in the superficial femoral artery 
was performed placing the cuff around the thigh. Placement of the cuff was consistently 
performed around the right forearm and thigh.  The order of cuff intervention (0, 30, 60 mmHg) 
was randomized across the 3 testing days, but similar for both arteries on a testing day. Pilot 
observations revealed that cuff inflation to 30 and 60 mmHg acutely alters retrograde shear 
rate in a dose-dependent manner, which was present in the brachial and superficial femoral 
artery.  Brachial and superficial femoral artery mean shear rate and the pattern of shear rate 
(antegrade versus retrograde) were recorded at 10-minute intervals during each intervention. 
Conduit artery diameter, blood flow and shear rate analysis
Analysis of brachial and superficial femoral artery diameters and shear rate before, during 
and after the intervention was performed using custom-designed edge-detection and wall-
tracking software which is largely independent of investigator bias.21 The initial phase of 
image analysis involves the identification of regions of interest (ROI) on the first frame of every 
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ultrasound study.  These ROI’s allow automated calibration for diameters on the B-mode image 
and velocities on the Doppler strip.22 Another ROI is drawn around the Doppler waveform and 
the peak of the waveform is automatically detected. The mean diameter measures derived 
from within the B-mode diameter ROI are automatically synchronized and combined with the 
velocity measures derived from the Doppler ROI, at 30 Hz. Ultimately, from this synchronized 
diameter and velocity data, blood flow (the product of lumen cross-sectional area and 
Doppler velocity (n)) and shear rate (4 times velocity divided by diameter)23,24 are calculated 
at 30 Hz. All data is written to file and retrieved for analysis in a custom designed analysis 
package (see below). We have shown that reproducibility of diameter measurements using 
this semi-automated software is significantly better than manual methods, reduces observer 
error significantly, and possesses an intra-observer, within-day CV of 6.7%.21 Furthermore, 
our method of blood flow assessment is closely correlated with actual blood flow through a 
“phantom” arterial flow system.25 
Data analysis
FMD%. Baseline diameter, blood flow, and shear rate were calculated as the mean of data 
acquired across the 1 minute preceding the cuff inflation period.  Peak diameter following 
cuff deflation was automatically detected according to an algorithm which identified the 
maximum bracket of data (with each bracket consisting of ~100 frames), subsequent to 
performance of a moving window smoothing function 22. FMD% was calculated as the 
percentage rise of this peak diameter from the preceding baseline diameter.  The software 
described above was also used for analysis of shear rate, derived from simultaneously 
acquired velocity and diameter measures at 30 Hz, during the three interventions.  
Statistics
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago, Illinois) software. All 
data are reported as mean (SD) unless stated otherwise, while statistical significance was 
assumed at p<0.05. To examine whether the impact of an increase in retrograde shear rate 
(‘intervention’: 0, 30 versus 60 mmHg) on endothelial function differs between arteries (‘artery’: 
brachial versus superficial femoral artery), we employed a linear mixed model analysis. Post-
hoc t-tests were performed when the linear mixed model reported a significant main or 
interaction effect. In addition to this ‘traditional’ approach, a recent study by Atkinson et al. 
indicated that inadequate scaling for FMD would be present if the upper confidence limit of 
the regression slope of the relationship between logarithmically transformed base diameter 
and peak diameter is less than one.26 In such an event, FMD% may not be an appropriate 
measure to estimate endothelial function. We checked our data for this phenomenon, and 
subsequently also performed the allometric modelling solution proposed by Atkinson et al.26 
Pearson correlations were used to examine the relation between the change in retrograde 
shear rate and the change FMD% induced by the intervention. FMD reproducibility was 
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assessed by calculating the coefficient of variance (CV), using the pre- and post-intervention 
retrograde shear data from the 0 mm Hg cuff intervention.. The CV was calculated following 
the classical approach based on the pooled SD, as described previously.27 Briefly, the root 
mean square of the error term (square root of the error term of the adjusted mean squares) 
of an Analysis of Variance is used to calculate the pooled variance. The CV can be calculated 
by taking the square root of the exponent of the pooled variation minus 1, times 100 
(√(exp(var)-1)*100).
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RESULTS 
Baseline characteristics are described in Table 1. Systolic, diastolic, and mean arterial 
pressures were not significantly different among the 3 different interventions days (P=0.276, 
P=0.783 and P=0.566, respectively). At baseline, we found no difference in pre-intervention 
superficial femoral artery shear rate patterns, whilst the brachial artery showed a significantly 
higher baseline retrograde shear rate before the 30 mmHg intervention (Table 2). No 
differences in brachial artery mean or antegrade shear rate were observed between testing 
days (Table 2). For the brachial artery retrograde shear, the coefficient of variation is 32.4, and 
for the superficial femoral artery retrograde shear, the coefficient of variation is 28.0.
Table 1
 
Table 1. Body characteristics in healthy subjects (N=13). Data is presented as mean ± SD. 
 
Variable Mean±SD 
Age (yrs) 24±3 
Height (cm) 185±7 
Weight (kg) 78.1±12.1 
Body mass index (kg/m2) 22.8±2.7 
Systolic blood pressure (mmHg) 119±9 
Diastolic blood pressure (mmHg) 74±7 
Mean arterial pressure (mmHg) 89±7 
Body characteristics in healthy subjects (N=13). Data is presented as mean ± SD.
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Table 2
 
Table 2. Pre-intervention resting mean, antegrade and retrograde shear rate in the brachial and 
superficial femoral artery of healthy young men (n=13). Data is presented as mean ± SD. P-values 
represent repeated measures ANOVA. 
 
 0 mmHg 30 mmHg 60 mmHg P-value 
Brachial Artery     
Mean shear rate (s-1) 95±67 59±31 79±52 0.109 
Antegrade shear rate (s-1) 108±64 82±30 95±47 0.283 
Retrograde shear rate (s-1) -13±12 -24±15 -16±14 0.009 
Superficial Femoral Artery     
Mean shear rate (s-1) 36±22 45±58 23±19 0.309 
Antegrade shear rate (s-1) 61±17 75±52 53±15 0.191 
Retrograde shear rate (s-1) -25±13 -30±13 -30±13 0.368 
 
Pre-intervention resting mean, antegrade and retrograde shear rate in the brachial and superficial femoral artery of 
healthy young men (n=13). Data is presented as mean ± SD. P-values represent repeated measures ANOVA.
Shear rate patterns
Increased cuff pressure during the intervention resulted in large dose-dependent increases 
in retrograde shear in both the brachial (Figure 1A) and superficial femoral arteries 
(Figure 1B). Similarly, we found that cuff inflation around the thigh resulted in a small, but 
significant increase in superficial femoral artery antegrade shear during the 30 and 60 mmHg 
interventions, leading to a small decline in mean blood flow at these cuff pressures. In the 
brachial artery, antegrade shear was elevated during the 60mmHg intervention only (Figure 
1).
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Figure 1 
 
Figure 1 
 Mean (grey), antegrade (white) and retrograde shear  rate (black) in the brachial (A) and superficial femoral artery 
(B) during the 30-minute intervention at 0, 30, and 60 mmHg in healthy young men (n=13). Error bars represent SE. 
*Significantly different from baseline at p<0.05. 
0 mmHg              30 mmHg              60 mmHg
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Flow-mediated vasodilation
At baseline, we found no differences in brachial artery or superficial femoral artery FMD 
between the 3 testing days, whilst the brachial artery FMD was significantly larger than the 
response in the superficial femoral artery (‘artery’, P<0.001). In both arteries, a decrease in FMD 
was observed as a result of cuff placement (Figure 2; ‘time*cuff’-interaction effect p<0.05). 
Post-hoc analysis revealed that, for both arteries, FMD did not change after the 0 mmHg 
and the 30 mmHg interventions, whilst a significant decrease was observed after 60 mmHg 
(Figure 2). More importantly, we found that the change in FMD was not different between 
both arteries (Figure 2; ‘time*cuff*artery’-interaction P=0.660). A repeat of this analysis using 
allometric scaling, including resting diameter as a covariate, reinforced the presence of a 
significant impact of cuff on the change in FMD (‘time*cuff’-interaction effect: P<0.05), which 
was not different between the brachial and superficial femoral artery (‘time*cuff*artery’-
interaction effect: P=0.616). However, using the allometric scaling method, the difference in 
FMD between vessels was no longer present (P=0.201). 
Using the non-adjusted FMD-values, we found a comparable correlation between the cuff-
inflation induced change in retrograde shear and the change in FMD in the brachial artery 
(P=0.001, r=0.498), superficial femoral artery (P=0.002, r=0.475), and the pooled data set 
(p<0.001, r=0.497) (Figure 3).
For baseline diameter and shear rate area-under-the-curve, we did not find any significant 
effects for any of the variables (all p>0.05), except for ‘artery’ (p<0.01).
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Figure 2 
 
Figure 2 
 
Flow mediated dilation before (black) and after the 30-minute intervention (white) in the brachial (A) and superficial 
femoral artery (B) for interventions at 0, 30, and 60 mmHg in healthy young men (n=13). Error bars represent SE. 
*Significantly different from pre-intervention at p<0.05.
A
CHAPTER 8
163
8
Figure 3 
 
Figure 3 
 
 
Correlation between change in retrograde shear (y-axis) and change in flow mediated dilation (x-axis) for the brachial 
(black dots) and superficial femoral artery (open dots).
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DISCUSSION
The purpose of this study was to examine the acute impact of dose-dependent increases 
in retrograde shear on endothelial function in atherosclerotic-prone (i.e. superficial femoral 
artery) and –resistant arteries (brachial artery) in humans. Our findings indicate that 
increase in retrograde shear is followed by a decrease in endothelial function, which was 
similarly present in an artery in the upper and lower limb. Therefore, the present study 
provides evidence for the presence of an inverse relationship between retrograde shear and 
endothelial function, which is similarly present in an atherosclerosis-prone and –resistant 
peripheral conduit artery in healthy young humans.
In line with previous findings from our laboratory,2 and those of others,28,29 an increase in 
cuff pressure resulted in an upstream, dose-dependent increase of retrograde shear in 
the brachial artery. We extend this knowledge by reporting that similar dose-dependent 
increases in retrograde shear are also present in the superficial femoral artery following 
partial cuff inflation around the thigh. This confirms that our intervention was effective, and 
that both brachial and superficial femoral artery retrograde shear can be manipulated using 
an externally placed cuff around a limb. More importantly, we examined the immediate 
impact of these manipulations in shear rate pattern on conduit artery endothelial function. 
In line with a previous observation from our laboratory, we found that an increase in 
retrograde shear rate decreases FMD in the brachial artery.2 Moreover, the superficial femoral 
artery responded in a similar way, indicating that short-term exposure to retrograde shear 
in both atherosclerosis-prone and atherosclerosis-resistant arteries results in endothelial 
dysfunction. The similarity in responsiveness between both arteries is supported by the 
agreement in the slope, direction and magnitude of correlations between the change in 
retrograde shear and the change in FMD in both vessels (Figure 3).
The finding that upper and lower limb conduit arteries demonstrate a similar responsiveness 
to elevations in retrograde shear rate in humans in vivo contrasts with our hypothesis as well 
as findings from previous studies. These studies found that upper limb arteries possess a 
larger responsiveness when exposed to stimuli causing an increase in antegrade shear rate 
compared to lower limb arteries.15,30 One potential explanation for the different finding in 
our study may relate to the stimulus used. The present study exposed arteries to a change 
in shear stress, which directly impacts endothelial function. Previous studies infused 
pharmacological substances or used prolonged arterial occlusions;15,30 forms of stimulus 
which depend upon distinct signal transduction pathways to those associated with shear 
stress, the physiologically valid approach. An alternative explanation is that we examined 
responsiveness to an increase in retrograde shear rate, rather than stimuli that cause an 
increase in antegrade shear rate.
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In both arteries, the 30 mmHg intervention was not associated with a significant change 
in FMD, despite a significant increase in retrograde shear rate. In a previous study, Thijssen 
et al. found that somewhat lower cuff inflation (i.e. 25 mmHg) also caused an increase in 
retrograde shear rate, but did not affect brachial artery FMD.2 In contrast, an effect on FMD 
was present at 50 and 75 mmHg cuff interventions in the brachial artery.2 These observations 
between studies suggest that a ‘threshold’ for the application of an external pressure exists 
that lies between 30 and 50 mmHg. Actually, the ‘threshold’ does not relate to the pressure 
applied to a limb, but rather to the associated increase in retrograde shear that represents a 
potent stimulus to impair conduit artery endothelial function. The presence of a threshold in 
retrograde shear rate to impair FMD is supported by the correlation between the change in 
retrograde shear rate and FMD, as the regression line of both arteries crosses the X-axis around 
-25 s-1. This suggests that acute elevation in retrograde shear rate should be substantial 
before inducing a significant decrease in FMD, which is typically achieved by an external cuff 
pressure of 30-50 mmHg. It should be emphasised that the potential presence of a threshold 
level for retrograde shear rate is likely dependent upon the duration of the stimulus, but also 
possibly the vessel studied. Future studies should further examine the potential presence of 
a threshold for changes in FMD.
Recent studies found that changes in the contribution of NO31 and alpha-adrenergic 
sympathetic nervous system32 to vascular tone contribute to the magnitude of retrograde 
shear rate, at least in older humans. Possibly, changes in these vasoactive substances may 
contribute to the development of endothelial dysfunction during prolonged exposure to 
potentially harmful shear patterns. However, no previous study has examined the impact 
of prolonged exposure to elevated levels of retrograde shear rate. Future studies are 
warranted to examine the impact of chronic exposure to elevated levels of retrograde shear 
rate in humans to better understand the importance of shear pattern in the development of 
endothelial dysfunction.
Clinical Relevance
Previous animal and in vitro studies have demonstrated that arteries exposed to a low or 
oscillatory shear stress are associated with the development of atherosclerotic plaques. 
Although upper and lower limb arteries demonstrate differences in susceptibility for the 
development of atherosclerosis in humans,12 we found that short-term exposure to retrograde 
shear leads to a similar acute decrease in FMD in the both the brachial and the superficial 
femoral artery. The development of atherosclerosis in the superficial femoral artery may, 
at least in part, relate to the larger and/or longer exposure to adverse shear patterns under 
physiological conditions. In a previous study, Newcomer et al. found that the superficial 
femoral artery is exposed to lower levels of mean shear rate in the supine, seated and standing 
position,7 possibly because of a higher retrograde shear rate. This suggests that prolonged 
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exposure of vessels to retrograde shear rate may have detrimental effect for vascular health 
in humans. Elevated levels of retrograde shear have been reported in clinical populations 
(e.g. older humans)31 and can be augmented in several common clinical scenarios, such as 
elevations in blood pressure due to sympathetic control,31 changes in posture,7 or changes 
in resting vascular tone, or exercise.25 Therefore, the findings in the present study are highly 
relevant from a clinical point of view.
Limitations 
Strengths of this study include the use of a tightly controlled protocol, the use of well-trained 
sonographers, and the use of automated analysis software. A potential weakness is that this 
study does not provide insight into the mechanisms explaining the relationship between 
retrograde shear and endothelial function. Also, because we included a healthy group 
of subjects without endothelial dysfunction and/or clinical evidence of atherosclerosis, 
we cannot directly extrapolate our findings to other populations, including those with an 
increased risk for CVD, who are likely to have developed atherosclerosis and endothelial 
dysfunction. Future studies should focus on these groups and examine whether vascular 
responses to retrograde shear rate differ between subjects with and without a priori 
endothelial dysfunction. Another potential limitation is that our shear stimulus, due to the 
possible presence of a threshold in retrograde shear as described above, is not sufficient to 
evoke differences in endothelial function.
In conclusion, we found that cuff inflation around the forearm and thigh resulted in a dose-
dependent increase in retrograde shear, which was comparable in both atherosclerotic-prone 
and –resistant arteries. Moreover, we found that an increase in retrograde shear is associated 
with a decrease in conduit artery endothelial function, whilst this relation between retrograde 
shear and endothelial function was similar between the brachial and superficial femoral 
arteries. This demonstrates, for the first time in humans, that the potentially detrimental 
impact of short-term increases in retrograde shear are associated with a similar decrease in 
endothelial function in atherosclerosis-prone and –resistant vessels.
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GENERAL DISCUSSION
The general aim of this thesis was to optimize the effects of exercise training in patients with 
type 2 diabetes mellitus (T2DM). In this chapter, the findings of the studies are summarized 
and I aim to provide a birds-eye-view of the implications of these findings. Finally, I try to add 
some pieces of the puzzle and solve the question how exercise training can be optimized in 
T2DM patients.
A hopeful start – So far, so good
In chapter 2, we explored the borders of the spectrum between untrained and trained 
T2DM patients. Therefore, we examined the impact of a life-long active lifestyle in T2DM by 
comparing physical fitness, cardiovascular risk and vascular function between long-term 
physically active T2DM patients versus sedentary T2DM patients, and healthy controls. We 
found that T2DM patients that employed a physically active life-style have higher insulin 
sensitivity, a lower cardiovascular risk and better vascular function. More importantly, we 
found no differences in these parameters between these physically active T2DM patients and 
healthy controls. This cross-sectional study provides some evidence that a life-long active 
lifestyle, which is regarded as an independent cardiovascular risk factor, can effectively 
normalize cardiovascular risk even in subjects with T2DM. An important observation, 
however, is that physical fitness, vascular function and cardiovascular risk in T2DM patients 
that had been physically active for a long period of time, were comparable to inactive 
controls. This suggests that T2DM patients may not optimally benefit from exercise training, 
and that even if subjects with T2DM remain physically active they are not able to gain the 
benefits of exercise like healthy physically active individuals.
The system has failed – or has it?
If T2DM patients do not optimally benefit from exercise training, it is important to understand 
the primary stimuli of exercise training. Previous studies have demonstrated that shear stress 
is the main stimulus for vascular adaptations,1-3 and Chapter 3 acts as a proof of concept for 
the idea that endothelin blockade can be used to optimize the exercise stimulus for vascular 
adaptation by increasing exercise-induced blood flow, and consequently shear stress. 
Indeed, we found that endothelin-blockade increased exercise-induced brachial artery 
blood flow in diabetes patients, and not in controls. However, this increase in blood flow did 
not result in a higher shear stimulus, and we found no impact of endothelin-blockade on 
baseline or post-exercise endothelial function in diabetes patients or controls. Shear rate is 
calculated from blood velocity and vessel diameter. Although ET-blockade increased blood 
flow (and velocity), the subsequent increase in diameter resulted in a normalization of the 
shear rate stimulus. Arguably, the normalization of the shear rate stimulus indicates that 
T2DM patients successfully respond with an increase in diameter in response to elevation in 
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velocity (and shear). Also, the lack of an acute effect on endothelial function may be related 
to the normalization of the shear stimulus during exercise. One of our assumptions before 
the start of this research was that T2DM patients would have endothelial dysfunction,4,5 and 
that this system of shear normalization through vasodilation would be impaired. At least in 
our group, it seems that this assumption was not accurate, as normalization did occur.
Despite the normalization of the shear stimulus, we proposed that the successful increase 
in blood flow during exercise in diabetes patients through endothelin-blockade will have 
beneficial effects in repeated exercise training. Furthermore, the increase in exercise-induced 
blood flow may improve insulin sensitivity, and may enable a higher total workload during 
exercise, resulting in a better physical fitness. We tested this hypothesis in chapter 4, 
where we assessed the effect of an 8-week exercise training program combined with either 
endothelin-blockade or a placebo on the vasculature, fitness and glucose homeostasis in 
T2DM patients. Although we found a significant improvement in physical fitness level in 
T2DM patients, we found no adaptation in vascular function and glucose homeostasis after 
8 weeks of training. Furthermore, endothelin-blockade combined with exercise training did 
not lead to a superior effect on physical fitness, vascular function or structure, or glucose 
homeostasis. Also in chapter 7, we aimed to optimise the effects of exercise training by 
combining exercise training with hypoxia on maximal oxygen uptake, endothelial function, 
and insulin resistance in T2DM patients. In line with training with ET-blockade, a previous 
study suggested that hypoxia would lead to an increase in exercise-induced blood flow, 
thereby improving physical fitness, vascular function and glucose homeostasis more than 
exercise under normoxia. Nonetheless, we found that increasing the exercise-induced blood 
flow response by combining exercise training with hypoxia did not potentiate the effect of 
exercise training on physical fitness, vascular function, or glucose homeostasis in T2DM.
A possible explanation – time-course
A possible explanation, at least for the inconsequent findings in the training effect on 
endothelial function, is the existence of a time-course in vascular adaptations. Previous 
studies have shown that time-course plays an important role in vascular adaptations in 
healthy subjects, and that adaptations in endothelial function commonly occur in the first 2-4 
weeks of exercise training, after which a return to baseline occurs within 8 weeks.6 In chapter 
5, we confirmed that this phenomenon is also present in the brachial artery in T2DM patients. 
Therefore, it is possible that in the studies where we only described pre- versus post-training 
comparisons of endothelial function (i.e. chapters 4 and 6) the existence of a time-course 
could have concealed an exercise effect. Furthermore, we showed in unpublished data that 
also the superficial femoral artery FMD initially increases after 2-4 weeks, only to return to 
baseline after 8 weeks. In chapter 7, superficial femoral artery FMD was not changed after 8 
weeks of exercise training, but what happened in weeks 2, 4, and 6 is unknown. As illustrated 
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in figure 1, it is possible that also in the hypoxia study the FMD increased and returned to 
baseline, but we have not collected data at weeks 2, 4, and 6 in this study.
Figure 1
Superficial femoral artery flow-mediated dilation in weeks 0, 2, 4, 6, and 8 of an unpublished study (black bars) and 
in weeks 0 and 8 of the ‘hypoxia-study’ (white bars).
While we found a return to baseline in superficial femoral artery FMD in an unpublished study 
regarding the time-course in the superficial femoral artery, in the brachial artery (Chapter 
5) we observed no such return to baseline, and brachial artery FMD was still increased after 
8 weeks of exercise training. This is in line with our expectation that subjects with a priori 
endothelial dysfunction would not show a complete return to baseline. The finding that this 
adaptation in site-specific may suggest that maladaptations exist in the brachial, but not in 
the femoral artery, as the latter behaves similar in our groups with increased cardiovascular 
risk as it does in healthy controls. Remarkably, in chapter 6 we have shown that structural 
adaptations (i.e. decrease in wall:lumen ratio) after 8 weeks of exercise training in T2DM occur 
both in the brachial and the superficial femoral artery, but not in the carotid artery. This site-
specific finding is in line with the site-specific (and time-dependent) adaptation in vascular 
function during exercise training in T2DM. This suggests that exercise-training stimuli differ 
for functional and structural adaptations.7-9 This may have implications for future training 
methods, which could be optimized to develop vascular structure if the stimulus for this 
specific adaptation is known.
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The effects of exercise training
We and others have shown, in cross-sectional and intervention studies, that exercise training 
is an effective strategy to improve insulin resistance and vascular function and structure in 
patient groups and healthy controls.10-12 Especially an exercise program consisting of, both 
aerobic and resistance training, has been show to be highly effective in improving insulin 
resistance in T2DM.13,14 We have performed four training studies, each consisting of 8 weeks 
of lower-limb oriented, aerobic and resistance training. In each of these studies, exercise 
training significantly improved physical fitness with ~10%, indicating a successful training 
stimulus. However, insulin resistance did not improve in any of these studies. Endothelial 
function improved in some, but not all of these studies. We also found that the impact of 
exercise training on vascular function appeared to be site-specific rather than systemic. An 
important question is why we did not find the typical improvement in endothelial function 
and insulin resistance reported by several previous studies.
When taking a closer look at previous studies that performed exercise training in T2DM, 
the finding of a decrease in insulin resistance after exercise training is unequivocal. Some 
studies with similar duration and intensity of exercise training as our studies reported no 
change in insulin resistance,15-17 while other studies reported that exercise training improves 
insulin resistance.18-20 A possible explanation for the conflicting results may relate to baseline 
characteristics of T2DM patients. For example, glycaemic control has been shown to be less 
likely to improve during exercise training in older T2DM patients compared with younger 
T2DM patients (see review).21 The reason for this finding is unclear, but the authors put 
forward complicating diseases, pre-training metabolic control and bodyweight as possible 
explanations. Second, T2DM patients with higher a priori levels of insulin resistance may benefit 
more from exercise training leading to improvements in insulin resistance . We compared our 
results with the results from an exercise-training program quite similar to our program.18 In 
this study, Maiorana et al.18 found an improvement in group of T2DM patients with a relatively 
high fasting glucose from 12.0±0.5 to 9.8±0.5. Glucose level is not a direct measure of insulin 
resistance per se. However, in our studies, pre-training fasting glucose levels were well below 
the post-training values reported by Maiorana et al. (Table 1). Furthermore, the mean age of 
the T2DM subjects in the studies in this thesis was 57±7 years, as opposed to 52±2 years in 
Maiorana et al. Together, the relatively mild level of insulin resistance, combined with the 
relatively high mean age in our studies, may, at least partly, explain the absence of a marked 
impact of our exercise training programs on insulin resistance in this thesis.
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In an unpublished study, we have found that 4-month walking exercise training (2-3 times 
per week) in T2DM (54±12 years) resulted in a near significant decrease in fasting glucose 
level from 7.8±4.1 to 6.0±2.1 (p=0.06, table 1). This suggests that even in a walking exercise-
training program, where the intensity is lower than in the training programs in this thesis, 
improvements in glucose homeostasis can be found, if the program is sufficiently long. 
Therefore, we propose that exercise-training programs in studies in T2DM should be of 
a longer duration than 8 weeks. Furthermore, as the exercise-training program in this 
unpublished study included exercise bouts of up to 8 hours, future studies should also 
include exercise bouts of longer duration, as longer exercise bouts of lower intensity seem to 
be more effective than shorter bouts of higher intensity in this group.
Previous studies have suggested that medication intake may interfere, positively or 
negatively, with the effects of exercise training. A possible explanation for the lack of an effect 
of exercise training on insulin resistance may relate to the effect of metformin on the intensity 
of exercise. In our exercise training programs, exercise intensity was set at 70-75% of heart 
rate reserve. This intensity has previously been shown to be sufficient to improve insulin 
resistance and endothelial function in healthy subjects and subjects with impaired insulin 
resistance.13,17,18,22-24 Recently, Boulé et al. described that metformin elevates heart frequency 
both at rest and during exercise, although the mechanism behind this finding is unknown.25 
Table 1 
compared our results with the results from an exercise-training program quite similar to our 
program.18 In this study, Maiorana et al.18 found an improvement in group of T2DM patients 
with a relatively high fasting glucose from 12.0±0.5 to 9.8±0.5. Glucose level is not a direct 
measure of insulin resistance per se. However, in our studies, pre-training fasting glucose 
levels were well below the post-training values reported by Maiorana et al. (Table 1). 
Furthermore, the mean age of the T2DM subjects in the studies in this thesis was 57±7 years, 
as opposed to 52±2 years in Maiorana et al. Together, the relatively mild level of insulin 
resistance, combined with the relatively high mean age in our studies, may, at least partly, 
explain the absence of a marked impact of our exercise training programs on insulin 
resistance in this thesis. 
Table 1 – Pre- and post-training fasting glucose in different studies. Data are presented as mean±SD. 
 Fasting glucose (mmol/L) 
Study/chapter Pre-training Post-training 
Maiorana et al. 2002 12.0±0.5 9.8±0.5 
This thesis, chapter 4 (“bosentan”) 7.2±1.9 6.6±1.1 
This thesis, chapter 5 (“time-course”) 8.2±2.8 6.9±2.3 
This thesis, chapter 6 (“IMT”) 7.6±2.5 7.0±1.8 
This thesis, chapter 7 (“Hypoxia”) 7.5±2.7 7.6±2.1 
Unpublished data (“4 months walking”) 7.8±4.1 6.0±2.1 
 
 
In an unpublished study, we have found that 4-month walking exercise training (2-3 times per 
week) in T2DM (54±12 years) resulted in a near significant decrease in fasting glucose level 
from 7.8±4.1 to 6.0±2.1 (p=0.06, table 1). This sug ests that even in a walking exercise-
training program, where the intensity is lower than in the training programs in this thesis, 
Pre- and post-training fasting glucose in different studies. Data are presented as mean±SD.
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In our study populations, metformin use was very common, and possibly this may have led 
to an insufficient workload during the exercise bouts. However, our significant increase in 
physical fitness of ~10% after only 8 weeks of training suggests that we successfully improved 
fitness levels. Interestingly, Maiorana et al. employed a similar exercise intensity, and they did 
find an effect of exercise training on both insulin resistance and vascular function, despite the 
inclusion of metformin users.18,24
Pooled data, the spectrum of adaptations, and identifying responders and non-
responders
In an attempt to better understand factors that may contribute to the absence of effects of 
exercise training on FMD, we pooled the data from our training studies. First, we examined 
the pooled effects of our training studies on physical fitness relative to the ‘fitness-inactivity-
spectrum’ we defined in chapter 2 (Figure 2). This figure shows that sedentary and physically 
active T2DM patients cover the physical fitness spectrum between ~20 and ~35 mlO2/kg/min, 
respectively. The groups that we included in our training studies were close to the sedentary 
reference group (Figure 2). Although subjects in our training studies significantly improved 
physical fitness, there is still a long way to go to reach the level of our life-long active T2DM 
subjects from chapter 2.
Glucose levels after 8 weeks of training are comparable to those in life-long active T2DM 
subjects, so apparently exercising for several more years does not bring any further 
improvements in glucose level. For endothelial function, we found that subjects in our 
training studies are, at baseline, already at the level of the life-long active T2DM patients, and 
endothelial functions improves even a bit further after training. It should be noted that in the 
subjects that enrolled in the training program, baseline levels of fitness, glucose homeostasis 
and endothelial function were already better than in the sedentary T2DM group, and in some 
cases even better than the lifelong active group. This seems to suggest that there is less 
room for improvement in the training groups, and therefore smaller improvements are to be 
expected.
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Figure 2
Spectrum of adaptations in peak oxygen uptake (A), fasting glucose (B), and brachial artery flow mediated dilation 
(C) in sedentary, pre-training, post-training, and life-long active T2DM patients, and healthy sedentary controls. Error 
bars represent SD.
To better understand factors that may contribute to an increase in insulin resistance after 
exercise training in T2DM, we divided our T2DM patients in groups of those who improved 
insulin resistance (measured as HOMA-IR) during the exercise training program (“responders”) 
and those who did not improve (“non-responders”). Subsequently, we compared the 
characteristics between these two groups (table 2). Subjects that showed an improvement of 
the HOMA-IR during the exercise programs had a higher glucose level at baseline compared 
with the non-responders (Table 2), further supporting our point that we made earlier in 
this chapter in that subjects with a higher a priori level of insulin resistance are more likely 
to respond to exercise training. Interestingly, even though the responder/non-responder 
distinction was made based on HOMA-IR improvement, responders and non-responders 
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had similar HOMA-IR and insulin levels at baseline (p=0.869 and p=0.865, respectively). 
Furthermore, we found no differences between responders and non-responders for baseline 
brachial artery FMD, superficial femoral artery FMD, the improvements in FMD, or the 
improvements in maximal oxygen uptake (all p>0.05).
Table 2
responder distinction was made based on HOMA-IR improvement, responders and non-
responders had similar HOMA-IR and insulin levels at baseline (p=0.869 and p=0.865, 
respectively). Furthermore, we found no differences between responders and non-responders 
for baseline brachial artery FMD, superficial femoral artery FMD, the improvements in FMD, 
or the improvements in maximal oxygen upt k  (all p>0.05). 
 
Table 2 – baseline and change (Δ) in characteristics for responders and non-responders on HOMA-IR. 
Data are presented as mean±SD. 
 Responders 
(N=15) 
Non-responders 
(N=20) 
P-value 
Age (years) 57±8 57±7 0.856 
Body mass index (kg/m2) 34.9±6.0 32.0±5.8 0.184 
Δ Body mass index (kg/m2) -0.3±1.1 -0.2±0.9 0.891 
Peak oxygen uptake (mLO2/min/kg) 21.9±4.1 24.9±6.6 0.116 
Δ Peak oxygen uptake (mLO2/min/kg) 2.9±3.9 2.1±2.6 0.487 
Glucose (mmol/L) 8.6±2.8 6.8±2.1 0.036 
Δ Glucose (mmol/L) -1.5±2.4 0.6±2.6 0.018 
Insulin (mmol/L) 11.4±7.9 12.0±11.1 0.859 
Δ Insulin (mmol/L) -4.2±3.3 6.5±13 0.005 
HOMA-IR (10/%S) 4.1±2.9 3.9±3.9 0.863 
Δ HOMA-IR (10/%S) -2.0±2.0 2.7±5.0 0.002 
BA FMD (%) 3.6±1.3 4.0±1.8 0.419 
Δ BA FMD (%) 0.8±1.6 -0.1±1.8 0.130 
SFA FMD (%) 3.7±2.2 3.0±0.9 0.231 
Δ SFA FMD (%) -0.4±2.7 0.1±1.3 0.514 
 
 baseline and change (Δ) in characteristics for responders and non-responders on HOMA-IR. Data are presented as 
mean±SD.
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For endothelial function, we made a similar division between responders and non-responders 
(table 3). Interestingly, this comparison revealed that responders had a significantly lower 
endothelial function at baseline, which was found for the brachial as well as for the superficial 
femoral artery. This suggests that T2DM subjects that have a low a priori endothelial function 
are more likely to show an improvement after 8 weeks of exercise training. Furthermore, 
subjects that showed an improved brachial artery endothelial function after exercise training 
had a significantly lower body mass index compared with non-responders (30.8±5.7 and 
35.6±5.1, respectively). We also found a significant correlation between body mass index 
Table 3
Table 3 – baseline and change (Δ) in characteristics for responders and non-responders for brachial 
artery and superficial femoral artery FMD. Data are presented as mean±SD. 
 Brachial artery response  Superficial femoral artery response 
 
Responders 
 
(N=22) 
Non- 
responders 
(N=18) 
P-value  Responders 
 
(N=23) 
Non- 
responders 
(N=17) 
P-value 
Age (years) 58±6 55±7 0.216  57±7 57±6 0.983 
Body mass index (kg/m2) 30.8±5.6 35.6±5.1 0.010  33.1±6.4 32.9±5.3 0.930 
Δ Body mass index (kg/m2) -1.5±5.7 -0.2±0.7 0.344  -0.2±0.9 -1.9±6.5 0.230 
Peak oxygen uptake (mLO2/min/kg) 24.8±5.9 22.8±4.8 0.261  23.7±5.4 24.0±5.7 0.842 
Δ Peak oxygen uptake (mLO2/min/kg) 2.8±3.5 2.3±2.4 0.635  2.5±3.5 2.7±2.3 0.832 
Glucose (mmol/L) 7.2±2.5 8.1±3.4 0.352  7.7±3.0 7.5±2.9 0.852 
Δ Glucose (mmol/L) -0.5±2.6 -0.1±2.7 0.592  -0.5±2.6 -0.1±2.8 0.703 
Insulin (mmol/L) 11.3±8.9 12.7±10.7 0.665  11.2±7.2 13.0±12.6 0.582 
Δ Insulin (mmol/L) -0.3±4.8 5.0±15.6 0.169  0.1±6.1 5.5±16.5 0.172 
HOMA-IR (10/%S) 3.6±3.1 4.6±3.9 0.402  4.0±3.0 4.2±4.2 0.833 
Δ HOMA-IR (10/%S) -0.8±2.2 2.2±6.0 0.054  -0.3±2.7 2.4±6.6 0.179 
BA FMD (%) 3.4±1.7 4.6±1.6 0.026  3.9±1.5 3.9±2.0 0.976 
Δ BA FMD (%) 1.9±1.7 -1.1±1.0 0.000  0.1±1.8 1.1±2.6 0.119 
SFA FMD (%) 3.4±1.9 3.5±1.2 0.860  2.9±1.2 4.2±1.9 0.018 
Δ SFA FMD (%) -0.4±2.3 -0.1±1.6 0.644  1.0±0.9 -2.1±1.6 0.000 
 
Finally, we also performed a responders versus non-responders analysis for physical fitness. 
Interestingly, from the 36 eligible T2DM patients for this analysis, 4 patients did not improve 
maximal oxygen uptake. These 4 individuals all met the internationally recognised criteria for 
a valid test to examine maximal oxygen uptake, and successfully finished the 8-week exercise 
training intervention. Interestingly, baseline maximal oxygen uptake in the responders was 
baseline and change (Δ) in characteristics for responders and non-responders for brachial artery and superficial 
femoral artery FMD. Data are presented as mean±SD.
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and brachial artery FMD improvement (r=-0.479, p=0.002), indicating that subjects with 
lower body mass index are more likely to improve brachial artery endothelial function. Such 
a significant correlation did not exist for superficial femoral artery improvement, HOMA-IR 
improvement, or improvement in physical fitness. This suggests that the effect of exercise 
training on vascular adaptation is blunted in subjects with higher body mass index. As we 
found no significant correlation between body mass index and baseline FMD (p=0.138), we 
believe that this effect is not due to a smaller room for improvement in endothelial function. 
Possibly, the shear stimulus is blunted in these subjects, or the signal transduction of this 
stimulus over the vessel wall is attenuated in subjects with higher body mass index.
Finally, we also performed a responders versus non-responders analysis for physical fitness. 
Interestingly, from the 36 eligible T2DM patients for this analysis, 4 patients did not improve 
maximal oxygen uptake. These 4 individuals all met the internationally recognised criteria for 
a valid test to examine maximal oxygen uptake, and successfully finished the 8-week exercise 
training intervention. Interestingly, baseline maximal oxygen uptake in the responders was 
markedly lower than that observed in the four non-responders (23.3±5.0 and 28.9±8.4, 
respectively), again suggesting that exercise training is more effective when there is more 
room for improvement.
An interesting question remains why some subjects in our studies don’t respond to exercise 
training with an improvement of physical fitness, insulin resistance or endothelial function. 
This phenomenon has been studied in healthy, sedentary individuals by Bouchard et al, 
who found that individuals respond differently to exercise training where improvements in 
cardiovascular and metabolic risk profile are concerned, and some individuals even respond 
with an adverse adaptation to exercise.26,27 For instance fasting insulin increased in ~8% of the 
subjects after a training period of up to 20 weeks.26 In our studies, however, the percentage 
of non-responders is markedly higher (Figure 3). To our knowledge, no previous studies have 
looked into this phenomenon specifically for T2DM patients. The most striking observation 
is that physical fitness improves in 89.2% of the subjects in our studies, while the percentage 
of responders for insulin resistance and endothelial function is markedly lower. Possibly, the 
relatively short training duration of 8 weeks is too short for some subjects, explaining the 
high percentage of non-responders in our study. These non-responder percentages could 
decrease in longer duration programs, as the review by Bouchard et al. studied training 
programs of up to 20 weeks, and possibly some individuals may require a longer training 
period to facilitate adaptations.27 Alternatively, this finding indicates that the stimulus for 
improving physical fitness is present, but is suboptimal for improving insulin resistance and 
endothelial function. This underlines the importance of optimizing the training stimulus in 
T2DM, specifically for insulin resistance and endothelial function.
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Figure 3
Individual responses to exercise training for physical fitness (A), insulin resistance (B), brachial artery endothelial 
function (C), and superficial femoral artery endothelial function (D).
The effects of our interventions
We have studied two interventions in an attempt to optimize the exercise-training stimulus 
for vascular adaptation, i.e. endothelin-blockade and hypoxia. Both interventions did not 
prove to be successful. Here we propose a number of potential explanations for this lack of 
effect.
A possible explanation for this finding is provided in a recent study by Womack et al.. Using 
contrast-enhanced ultrasound perfusion imaging, this study examined forearm capillary 
blood flow and blood volume at rest and during handgrip exercise in T2DM patients with 
versus without microvascular complications.28 The authors concluded that during exercise, 
capillary recruitment is impaired in subjects with microvascular complications, but is normal 
in uncomplicated T2DM patients. In our exercise training studies, the presence of overt 
diabetes-related complications was one of the exclusion criteria. Therefore, we may have 
included a population in which a small or negligible superior effect of combining exercise 
with interventions were to be expected, as a priori impairment may not even exist in these 
groups. We speculate that such a superior effect may be present in DMT2 patients with micro 
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and/or macrovascular complications. However, this requires further studies that include 
DMT2 patients with complications to examine this speculative hypothesis.
The exercise-associated elevation in shear represents a key stimulus for arteries to adapt. 
The presence of hyperglycaemia may interfere with the impact of elevation in shear stress in 
humans. Previous studies have demonstrated that shear stress activates an Act-dependent 
mechanism in the endothelium, leading to the production of nitric oxide (NO; a strong dilator 
with anti-atherogenic effects).29 Recent data in animals indicate that hyperglycaemia impairs 
the shear stress signaling pathway, leading to a smaller NO production.30,31 Also in humans, 
some evidence for this is found by Zhu and others who demonstrated an immediate decrease 
in NO-dependent endothelial function after a glucose tolerance test (which acutely increases 
glucose levels) in healthy volunteers and T2DM.32-35 Despite optimization of pharmacological 
therapy, hyperglycaemia is frequently present in T2DM.36 Especially during exercise, it is 
conceivable that T2DM patients have taken less medication or have eaten before the exercise 
session, to compensate for the increased glucose consumption during exercise. The presence 
of hyperglycaemia may prevent an optimal effect of exercise on the endothelial function in 
T2DM by changing the impact of the shear stimulus. Furthermore, if hyperglycaemia prevents 
the shear stress stimulus from being properly transferred to the endothelium, increasing the 
shear stress stimulus via endothelin-blockade may be less effective under the presence of 
hyperglycemia. Further research should look into the role of hyperglycaemia in the regulation 
and signal transduction of shear stress.
Taken together, we believe that our finding of an absence of a superior effect of endothelin-
blockade or hypoxia combined with exercise training does not completely invalidate these 
strategies as a potential therapeutic target. If we consider all points discussed in the previous 
paragraphs (i.e. the role of age, presence of microvascular dysfunction, and hyperglycaemia), 
we believe that the concept of increasing the exercise-induced shear stress (via endothelin-
blockade, hypoxia or any other potential intervention) to optimize the effects of exercise 
training on insulin resistance and endothelial function is valid, especially when adopted in a 
population that will potentially benefit from exercise training the most.
Methodological considerations
Endothelium-dependent and independent dilation. 
Flow mediated dilation has been used extensively as a measure for endothelial function,6,12,37-40 
and clear guidelines exist describing its application and interpretation.41 The methodology 
of measuring flow mediated dilation, and correction for possible interfering factors such as 
baseline diameter and the eliciting post-deflation shear rate stimulus is an ongoing subject 
of debate.42,43 One of the outstanding issues relates to the correction of the FMD response, 
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which is endothelium dependent,44 for potential changes (within subjects) or differences 
(between subjects) in smooth muscle cell function (or endothelium-independent dilation). 
In this thesis, we provide some data that clearly demonstrate the importance of measuring 
both FMD and GTN-responses. Indeed, we have performed the FMD and GTN-responses in 
chapters 4, 5, and 7, and subsequently divided the flow mediated dilation by the dilatory 
response to a single dose of glyceryl trinitrate (FMD/GTN). Theoretically, the FMD/GTN-ratio 
corrects the flow mediated for within-subject changes in smooth muscle cell function. This is 
of special importance given recent observations of differences in smooth muscle cell function 
within subjects, and between subjects with and without atherosclerosis.45,46 Also in this thesis, 
correction for the endothelium-independent dilation importantly altered the conclusions of 
our studies. Whilst exercise training did not significantly alter the FMD-response in chapter 
4, 5 and 7, we consistently found a change in endothelial function when the FMD was 
corrected (on an individual basis) for the GTN-response. This highlights the importance of 
measuring the GTN-response and correcting the FMD-response for within-subject changes 
or between-group differences in the GTN-mediated dilation. We propose that assessment 
of endothelium-independent dilation via GTN should always be adopted in addition to the 
traditional flow mediated dilation in studies where endothelium-independent dilation can 
change over time, or where different (clinical) groups are compared.
Arterial wall thickness. 
For arterial wall structure, intima-media thickness is a widely used measure.47-50 However, 
a recent study demonstrated that changes in smooth muscle vascular tone, the smooth 
muscles representing the media layer, may alter wall thickness.51 In this study, carotid and 
femoral artery diameters and wall thickness were examined before, and ten minutes after 
a single dose sublingual glyceryl trinitrate was administered. Glyceryl trinitrate significantly 
increased carotid and femoral artery diameter and decreased wall thickness. Changes in 
wall thickness approximated those considered prognostically relevant. Therefore, one 
may question the validity of the IMT as a marker for atherosclerosis, since atherosclerotic 
plaques are believed to be structurally stable and do not change in response to a vasoactive 
substance.51 In our studies, care has been taken to exclude variation in resting tone in our 
measures of IMT (i.e. fasted state for >4 hours, abstain from alcohol and caffeine for 16 hours, 
not to perform any exercise for 24 hours before testing). Furthermore, to correct for any 
differences in diameter, we also calculated the wall-to-lumen ratio (W:L). Another method 
for correcting wall thickness for differences in vascular tone is to calculate cross-sectional 
area of the wall.52,53 This would represent a more accurate measure to examine differences 
between groups, especially in situations where no change in wall mass is expected (i.e. 
when examining acute changes in wall thickness in response to interventions). We have 
performed these additional calculations for chapter 6, and we found that these different 
methods to examine the arterial wall did not alter our main outcome. In other words, in 
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all cases we observed an effect of exercise training in the peripheral vessels, but not in the 
carotid artery in T2DM patients. This excludes the potential of variation in vascular tone to 
explain our finding of a site-specific change in IMT in conduit arteries in T2DM after exercise 
training. Nonetheless, studies that examine arterial wall thickness after interventions 
(pharmacological or non-pharmacological) or across time do not typically correct for vascular 
tone. Given the importance of vascular tone for IMT, we strongly advise that such future 
studies take appropriate measures (as discussed above) to correct for variation in vascular 
tone and improve the validity of intima-media thickness as a measure of vascular ‘structure’. 
An alternative method to exclude vascular tone is measurements of wall thickness during 
maximal dilation (for example after a sublingual dose of glyceryl trinitrate). This suggests 
that the GTN-response may be more important than initially anticipated in the non-invasive 
assessment of vascular function and structure; as a measure to correct the FMD-response, 
but also to exclude the vascular tone in the assessment of wall thickness.
 
Back at square one? – The search goes on
The modest improvements in insulin resistance and vascular function we observed in 
our training studies confirms our initial hypothesis that exercise training in T2DM is not as 
effective as it could be. Obviously, we had hoped that one of our interventions would be the 
answer, but as of yet, this has not proven to be the case. Apparently, there still is an unknown 
physiological factor that attenuates the effects of exercise training in this group. Possibly, 
we should first confirm that also in T2DM, blood flow and shear stress are main stimuli for 
metabolic and vascular adaptations. We then need a better understanding of the nature of 
this stimuli in T2DM, and find out what causes an attenuation in our patients.
The next step would be to study ways to increase the stimulus. Performing exercise sessions 
in a warm temperature to increase skin blood flow, and therefore an increase in the exercise-
induced blood flow and shear rate, could be an option. Another option would be to exercise 
in alternating hot and cold environments, which could help increase the stimulus through 
further activation of the microcirculation of the skin.
We still believe in the rationale behind the interventions, and we think that other techniques, 
to increase exercise-induced shear rate, and to optimize signal transduction over the vessel 
wall could be used to increase the effectiveness of exercise training in T2DM. For optimizing 
signal transduction, the role of hyperglycaemia is a target of interest for future study.30,31,35 
For an effective exercise training program, prevention of hyperglycaemia during exercise 
bouts can become an important factor, and guidance regarding food intake before and 
during exercise may help. Also, other interactions of food and exercise should be a subject of 
research, such as the timing of food intake relative to a bout of exercise.54
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A better understanding of the interaction between exercise and medication should be 
another area of future research. T2DM patients use a variety of pharmacological agents, 
which can influence exercise, and vice versa. Some of these interactions have been briefly 
discussed in this chapter.
Furthermore, we have found methodological entry points for improving the way we 
perform research in this field. In this chapter, we have discussed the selection of the 
research population, and solving methodological issues, such as correction of FMD and 
IMT measurements. Also the duration of exercise training programs have been mentioned. 
Even though 8 weeks of training has proven to be sufficient for improving physical fitness, 
possibly adaptations in insulin resistance and vascular function require a longer duration. 
Future studies can build upon this experience. One thing we have to keep in mind is that as 
a scientist trying to unravel a mechanism, it is very easy to lose track of why we started this 
research in the first place. The benefit of the patient, and the clinical implementation of our 
work. If we manage to find the ultimate method of training for T2DM patients, it is of no use if 
that method has become so complicated that no patient wants to use it.
As a final thought, the fact that it has proven difficult to elicit effects of exercise training in 
T2DM only accentuates the importance of our quest to optimize the training stimulus in 
this group. Unfortunately, we have not found the holy grail in the studies outlined in this 
thesis, but the concept as listed above provides a potential roadmap to optimize the effects 
of exercise training. This thesis will aid in this ongoing search, and we are a few small steps 
closer in defeating the ‘creeping death’ that is type 2 diabetes mellitus.
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Summary
SUMMARY
Chapter 1 introduced diabetes mellitus, its pathophysiology, and the complications that 
are associated with this disease. The general role of exercise training is described, and in 
particular the potential of exercise training to improve vascular function and structure. Also, 
several possibilities to optimize the beneficial effects of exercise training are put forward.
In chapter 2, we wanted to examine the impact of a life-long active lifestyle by comparing 
physical fitness, cardiovascular risk and vascular function between long-term physically active 
T2DM patients versus sedentary T2DM patients and healthy controls. We concluded that life-
long active T2DM patients have superior fitness levels, insulin sensitivity, cardiovascular risk 
and vascular function compared to sedentary peers, whilst no differences were found when 
compared to healthy controls. This study provides evidence that a life-long active lifestyle, 
even in T2DM, can effectively normalize cardiovascular risk.
In chapter 3 we examined the impact of Endothelin-blockade on exercise-induced blood flow 
in the brachial artery, and on pre-and post-exercise endothelial function in diabetes patients 
and healthy peers. Endothelin-blockade increased exercise-induced brachial artery blood 
flow in diabetes, but not in controls. Despite this effect of Endothelin-blockade on blood 
flow, we found no impact on baseline or post-exercise flow mediated dilation in diabetes 
patients or controls, possibly related to normalization of the shear stimulus during exercise. 
We proposed that the successful increase in blood flow during exercise in diabetes patients 
through Endothelin-blockade might have beneficial effects in repeated exercise training, we 
tested this hypothesis in chapter 4. To this end, we assessed the effect of an 8-week exercise 
training program combined with either ET-blockade or a placebo on the vasculature, fitness 
and glucose homeostasis in T2DM patients. However, we found no adaptation in vascular 
function and glucose homeostasis after 8 weeks of training in long-term T2DM patients. ET-
blockade combined with exercise training did not additionally alter vascular function or 
structure, physical fitness or glucose homeostasis in T2DM.
Chapter 5 focused on time-dependent adaptations in vascular function and structure 
after exercise training in middle-aged men and diabetes mellitus type 2. We concluded 
that exercise training leads to a rapid increase in vascular function of the brachial artery in 
subjects with increased cardiovascular risk, and the impact of exercise on vascular function 
was preserved in the brachial artery. These data suggest the presence of a site-specific time-
course in vascular adaptation in subjects with an increased cardiovascular risk.
We examined the local and systemic impact of exercise training on superficial femoral (SFA), 
brachial (BA), and carotid artery (CA) wall thickness in type 2 diabetes patients and controls 
in chapter 6. We found that lower-limb dominant exercise training causes remodelling of 
peripheral arteries, supplying active and inactive vascular beds, but not central arteries in 
type 2 diabetes.
The aim of chapter 7 was to examine the effects of hypoxic exercise training on maximal 
oxygen uptake, endothelial function, and insulin resistance in T2DM patients compared with 
normoxic exercise training. In contrast to our hypothesis, we found that exercise training 
under hypoxia does not potentiate the effect of exercise training on physical fitness, vascular 
function, or glucose homeostasis in T2DM.
In Chapter 8, we aim to further understand the shear stimulus, and examine whether the 
impact of incremental levels of retrograde SR differs between atherosclerosis-prone (i.e. 
superficial femoral artery) and –resistant vessels (i.e. brachial artery) in healthy men.
In chapter 9, we summarize and explain the findings of the studies and aim to provide a 
birds-eye-view of the implications of these findings. We discuss future prospects, look at 
the pooled data from a broader perspective, and try to answer the question how exercise 
training can be optimized in T2DM patients.

Samenvatting
SAMENVATTING
Hoofdstuk 1 geeft een introductie voor wat betreft diabetes mellitus, haar pathofysiologie, 
en enkele complicaties die met deze ziekte in verband worden gebracht. De rol die training 
hierbij speelt wordt beschreven, en in het bijzonder de mogelijkheid om via training de 
vaatfunctie en –structuur te verbeteren. Daarnaast worden verschillende mogelijkheden 
aangedragen om de positieve effecten van training te optimaliseren.
In hoofdstuk 2 wilden we in kaart brengen wat de impact is van een levenslange actieve 
levensstijl, door fysieke fitheid, cardiovasculair risico, en vasculaire functie te vergelijken 
tussen diabetespatiënten die hun hele leven actief zijn geweest, inactieve diabetespatiënten, 
en gezonde controles. We concludeerden dat actieve diabetespatiënten fitter zijn, een betere 
insulinegevoeligheid en vaatfunctie, en een lager cardiovasculair risico hebben vergeleken 
met inactieve patiënten, terwijl er geen verschillen werden gevonden vergeleken met 
gezonde controles. Dit hoofdstuk geeft sterke aanwijzingen dat een levenslange actieve 
levensstijl, zelfs in diabetespatiënten, cardiovasculair risico kan normaliseren.
In hoofdstuk 3 hebben we gekeken naar de impact van Endotheline-blokkade op de 
doorbloeding tijdens inspanning, en op de endotheelfunctie voor en na inspanning bij 
diabetespatiënten en gezonde controles. Endotheline-blokkade zorgde voor een sterkere 
bloedstroom in de Arteria Brachialis bij diabetespatiënten, maar niet bij controles. Desondanks 
hebben we geen effect van endotheline-blokkade gevonden op de endotheelfunctie voor 
en na inspanning, wat mogelijk verklaard kan worden doordat de shear stimulus tijdens 
inspanning genormaliseerd werd door een verwijding van het bloedvat. We opperden dat 
de vergroting van de bloeddoorstroming in diabetespatiënten die veroorzaakt werd door 
endotheline-blokkade positieve effecten zou kunnen hebben bij herhaalde trainingsarbeid, 
en we testten deze hypothese in hoofdstuk 4. Hier bestudeerden we het effect van een 
8-weken durend trainingsprogramma gecombineerd met Endotheline-blokkade of een 
placebo op de vaatfunctie, fitheid, en glucosehuishouding bij diabetespatiënten. We vonden 
echter geen aanpassingen in vaatfunctie of de glucosehuishouding van diabetespatiënten 
na 8 weken trainen. Endotheline-blokkade gecombineerd met inspanning had ook geen 
extra effect op de vaatfunctie, glucosehuishouding, of de fysieke fitheid.
 
Hoofdstuk 5 richt zich op tijdsafhankelijke aanpassingen in vaatfunctie en vaatstructuur na 
training bij diabetespatiënten en controles van middelbare leeftijd. We concludeerden dat 
training in deze groepen met een verhoogd cardiovasculair risico tot snelle aanpassingen 
in de vaatfunctie leidt, en dat deze aanpassing ook na 8 weken blijft bestaan, waar dat bij 
gezonde jonge mannen niet het geval is. Dit suggereert dat er een specifieke vaatadaptatie 
over de tijd plaatsvindt bij mensen met een verhoogd cardiovasculair risico.
 
We bekeken het lokale en systemische effect van training op de wanddikte van de 
Arteria Femoralis Superficialis, de Arteria Brachialis, en de Arteria Carotis Communis van 
diabetespatiënten en controles in hoofdstuk 6. Hier ontdekten we dat training van de benen 
zorgde voor aanpassingen in zowel actieve als passieve perifere vaatbedden, maar niet in 
centrale arteriën in diabetespatiënten.
Het doel van hoofdstuk 7 was om het effect van hypoxische training op fysieke fitheid, 
vaatfunctie, en insulinegevoeligheid van diabetespatiënten te vergelijken met de effecten 
van normoxische training. In tegenstelling tot onze hypothese zagen we dat hypoxie in 
deze patiëntengroep geen extra effect heeft voor wat betreft fysieke fitheid, vaatfunctie, en 
insulinegevoeligheid.
In hoofdstuk 8 richten we ons verder op de shear stimulus, en we bestuderen of de invloed 
van oplopende niveaus van retrograde shear op de endotheelfunctie bij gezonde mannen 
verschilt tussen vaten die gevoelig of juist ongevoelig zijn voor atherosclerose.
In hoofdstuk 9 gaan we dieper in op de uitkomsten van de studies en geven we een 
overzicht van de implicaties van deze uitkomsten. We bediscussiëren toekomstig onderzoek, 
kijken naar de samengenomen data van de verschillende studies, en proberen de vraag te 
beantwoorden hoe training voor diabetespatiënten geoptimaliseerd kan worden.

Dankwoord
DANKWOORD
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wil beginnen met een verontschuldiging aan diegenen die ik niet met voldoende woorden 
eer, niet specifiek genoeg bij naam noem, of gewoon volledig vergeet. Aan eenieder die zich 
gepasseerd voelt: het spijt me, ik heb je hulp ongetwijfeld echt wel gewaardeerd. Zie dit als 
een persoonlijk woord van dank.
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medewerkers vrijheid in hun werk, en geeft ze vertrouwen. Je bewaakt de grote lijn, omdat 
je niet elk detail kunt controleren. Ik vind dat fijn. Na een werkbespreking zag ik het vaak 
allemaal weer helder, en wist ik weer wat me te doen stond. Ik wil je bedanken omdat je het 
in mij zag zitten, mij aan boord haalde, en voor de uitstekende sfeer waarin we samenwerken.
Dick, niemand heeft zozeer zijn stempel op dit proefschrift gedrukt als jij. Je bent samen 
met Maria het brein achter de onderzoeken, je hebt me leren echoën, en je hebt me leren 
schrijven (niet letterlijk, maar je weet wat ik bedoel). Je hebt me de regels van het spel tussen 
reviewer en onderzoeker geleerd, en je feedback op stukken was altijd belachelijk snel, en 
bijzonder adequaat. Ik heb veel geleerd van jouw inzicht in data-analyse, en je motiveerde 
me vaak door je positieve instelling bij de interpretatie van datasets. Maar niet alleen ben 
je mijn mentor, copromotor, een vraagbaak, en een klaagmuur, maar ook ben je al jaren 
mijn kamergenoot. Ik heb veel respect voor jouw concentratievermogen, je focus, en ik vind 
het prachtig hoe je hebt geleerd om me volkomen te negeren als ik als een dwaas door het 
kantoor stuiter. Je maakte altijd tijd als ik het even wat minder zag zitten, en ik waardeer je 
humor ontzettend. Als ik in een dappere bui ben zou ik je een vriend durven noemen, tot ik 
me zou realiseren dat je de illustere professor Thijssen bent. Dick, bedankt voor je vertrouwen 
in mij, en bedankt voor je steun en gezelligheid de afgelopen jaren.
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ouwe dibbes, en Seeger, makker, laten we nooit meer samen fietsen en gewoon Paulaner 
bestellen. Klompie, schele, bedankt voor het lachen. Doc B., bedankt, je was een fijn publiek, 
en heel veel succes met de afronding van jouw proefschrift, het gaat zeker lukken! Bex, 
bedankt voor een luisterend oor en een overlopende mond, je bent een aanwinst voor 
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adviezen? Bregina, dank voor jarenlang lol in de samenwerking, en natuurlijk voor de omslag 
die dit boekwerk siert. Ctrl-P, we gaan snel weer een biertje drinken, en Fleur, bedankt dat 
ik af en toe je klinische blik mocht lenen. Jozef, fijn dat je me een hoop werk uit handen 
nam door een deel van de fietstesten voor me uit te voeren, zelfs na je pensioen. Klaas-Jan, 
bedankt voor de goede gesprekken. Madelino en Scholten, bedankt voor de screeningen en 
voor jullie gezelligheid. Frank, bedankt dat je in me geloofde aan de start. Inge, dank voor alle 
IMT-analyses. Matthijs en Martijn, bedankt voor de tech-reviews. Coen, leuk dat je altijd moet 
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Lidewij, Ronique, Marloes, en Jeroen, bedankt voor alle trainingen die jullie verzorgd hebben, 
en voor de gezelligheid tijdens de lange, lange meet-uren. Urenlang alleen de beschikking 
over Sky Radio is een beproeving op zich.
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vorm van vriendschap, vertrouwen, geborgenheid, en meer van dat soort ongrijpbare zaken. 
Ik prijs me gelukkig dat mijn kring veel groter is dan alleen degenen die ik verderop nog 
bij naam ga noemen. Mijn vrienden en familie wil ik dan ook graag bedanken, en ik begin 
meteen maar bij mijn lieve omaatjes (Oma R., sorry dat ik u altijd in de maling neem), en mijn 
fantastische schoonouders Rob en Thea.
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mijne. Mijn bandleden, Robbert, Wim, Emre, onze trouwe roadie Mark, en iedereen die met 
mij de concerten en festivals onveilig maakt, bedankt dat ik met jullie kan ontsnappen. Jan 
en Alwin, bedankt dat jullie lang geleden mijn praktische kant wakker geschud hebben, het 
vermogen om aan te pakken is de afgelopen jaren goed van pas gekomen.
Natuurlijk vergeet ik de ‘Oude Garde’ niet. Gerrit, Jeurdi, Sjoepke, Q, Tommoe, en Djomla. En 
Wompel, mijn trouwe wingman en dus ook paranimf. Dennis ‘Madness’, jij ook bedankt ouwe 
gek. Mannen, jullie zijn belangrijk voor me. Omdat jullie me jarenlang steunden zonder ook 
maar het flauwste benul te hebben wat ik eigenlijk deed, maar vooral omdat we elkaar altijd 
belachelijk zullen maken, wat we ook bereiken. Jullie zijn een club nare ploerten. Maar wel 
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Lukas, brother, captain. Niet alle mensen die kunnen helpen willen dat altijd, en weinig 
mensen de me altijd willen helpen kunnen dat. Maar jij staat altijd voor me klaar, en weinig 
meningen respecteer ik zozeer als de jouwe. Of het nu om de medische wetenschap gaat, 
of om het leven in het algemeen, aan jou heb ik wat. Uiteraard sta je naast me als paranimf, 
mijn consigliere.
Pa en ma, niemand zal kunnen ontkennen dat het bij jullie allemaal begonnen is. Voor jullie 
een speciaal woord van dank, omdat jullie me altijd alle kansen hebben gegeven in het leven. 
Zonder jullie onvoorwaardelijke steun, vertrouwen, en al dan niet subtiele coaching, was ik 
nooit zover gekomen. Ik weet dat jullie trots zijn, en ik kan jullie niet genoeg bedanken. Mam, 
stille kracht, ik zeg het te weinig, maar je weet het wel toch? Pa, high five, en bedankt voor 
alle uren aan de telefoon.
En dan is daar Kiki. Mijn meisje. Ja, zonder jou was dit proefschrift er mogelijk ook wel geweest, 
maar ik laat me daardoor niet weerhouden om je via dit podium te bedanken voor alles wat 
je aan mijn leven hebt toegevoegd, en voor alles wat je uit mijn leven hebt weggenomen. Ik 
ben een gelukkig man omdat jij mijn veilige haven wilt zijn. Ik hou van je, en dat mag ik hier 
best opschrijven. Bedankt dat jij elke dag de moeite waard maakt.
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